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Abstract 
 
Introduction: Recent estimates in 2010 for the number of infants born prematurely, 
defined as those born before 37 weeks gestation, was 15 million worldwide. The 
complications of preterm birth can be extensive and include low birth weight, 
respiratory complications, cardiac defects, necrotising enterocolitis, sepsis, and 
intraventricular haemorrhage. Preterm infants have lower body reserves of many 
nutrients compared to term infants, that can lead to poor weight gain, growth and 
development. 
Human milk is recognised as the optimum source of nutrition to ensure normal growth 
and development in infants. It contains a unique composition of macronutrients (fat, 
protein), micronutrients (vitamins, minerals) as well as immunological components. 
Women who deliver prematurely often cannot produce sufficient quantities of milk for 
their infant initially. This has led to the development of milk banks worldwide, where 
milk can be donated by women meeting certain criteria. In most cases the donated 
milk is pasteurised and frozen until required. Such milk is known as pasteurised donor 
human milk (PDHM) and is considered to be life saving for many premature infants.  
Essential trace elements are vital in early neonatal nutrition to promote normal growth. 
Trace elements are present in human milk but information regarding optimal 
concentrations in milk is lacking. Trace element deficiencies although rare, have been 
reported in exclusively breastfed infants and can lead to adverse health outcome if left 
untreated. The composition of preterm milk is recognised to be different to that of term 
milk. Studies are lacking investigating trace element concentrations in preterm milk 
compared to term milk, and if concentrations of trace elements vary over lactation 
stage, as is the case with other components of milk such as protein and fat.  
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Aim: To investigate essential trace element content of human breast milk.  
Research objectives: 
1. To validate a robust, reproducible and sensitive method to simultaneously 
determine the concentration of trace elements in human milk.  
2. To investigate the effect of the pasteurisation process on the concentration of 
trace elements in donor human milk.  
3. To explore the effect of lactation stage on the concentration of trace elements 
in human milk.  
4. To investigate differences in the concentration of trace elements between 
preterm milk and term milk. 
Methods: The studies undertaken for this thesis received ethical approval from the 
Royal Brisbane & Women’s Hospital (RBWH) and the University of Queensland Ethics 
Committee. A fully validated, robust and reproducible method was established to 
simultaneously analyse and quantify eight essential trace elements in small samples 
of human milk, using inductively coupled plasma mass-spectrometry.  To investigate 
the effects of pasteurisation in human milk, 16 women were recruited to the study and 
analysis of pre- and post-pasteurisation samples was undertaken. To investigate any 
variation in concentration of trace elements in human milk over time, a case study of 
one mother who delivered an extremely preterm neonate was included looking at 
samples taken over 10 weeks postpartum. To investigate any differences between 
preterm milk and term milk, women (21 preterm and 9 term) donated expressed breast 
milk (EBM) over the first three months postpartum.  
Results: The validated method was able to quantify eight essential trace elements in 
0.2 mL samples of human milk: zinc, copper, selenium, manganese, iodine, iron, 
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molybdenum and bromine. This method was the first to report bromine, a newly 
recognised essential element in human milk.  
The Holder pasteurisation process used to reduce the bacterial load of donor milk had 
minimal effects on the concentration of trace elements, except for iron (p < 0.05).  
The case study of a mother delivering an extremely premature neonate (24 weeks 
gestation) revealed that certain trace elements may be present in breast milk at 
suboptimal concentrations for normal health and development in the neonate.  
During the first three months postpartum, preterm milk samples (n = 384) and term 
milk samples (n = 165) were compared. Higher median zinc concentrations were 
observed in preterm (3647 µg/L) compared to term samples (2478 µg/L) in the first 
month postpartum.  Similar concentrations in both groups were observed for selenium, 
manganese, iodine, iron, molybdenum and bromine during the first three months 
postpartum. A general decrease in concentration was observed for zinc, copper and 
bromine over the same period.  
Conclusion: The newly validated analytical method using alkaline dissolution was 
suitable for use in clinical application investigating trace element concentrations in 
small volume human milk samples. The Holder pasteurisation process used in the 
preservation of donor human milk did not cause significant loss of trace elements, 
except for iron. Few differences were found in the concentration of trace elements 
between preterm and term milk overall, except for zinc, but further work is needed to 
establish these findings. Preterm and term milk exhibited a general decline in zinc, 
copper and bromine concentrations over lactation stage but relatively stable 
concentrations were found for selenium, manganese, iodine, iron and molybdenum.  
 
v 
 
Declaration by author 
This thesis is composed of my original work, and contains no material previously 
published or written by another person except where due reference has been made in 
the text. I have clearly stated the contribution by others to jointly-authored works that 
I have included in my thesis. 
I have clearly stated the contribution of others to my thesis as a whole, including 
statistical assistance, survey design, data analysis, significant technical procedures, 
professional editorial advice, and any other original research work used or reported in 
my thesis. The content of my thesis is the result of work I have carried out since the 
commencement of my research higher degree candidature and does not include a 
substantial part of work that has been submitted to qualify for the award of any other 
degree or diploma in any university or other tertiary institution. I have clearly stated 
which parts of my thesis, if any, have been submitted to qualify for another award. 
I acknowledge that an electronic copy of my thesis must be lodged with the University 
Library and, subject to the policy and procedures of The University of Queensland, the 
thesis be made available for research and study in accordance with the Copyright Act 
1968 unless a period of embargo has been approved by the Dean of the Graduate 
School.  
I acknowledge that copyright of all material contained in my thesis resides with the 
copyright holder(s) of that material. Where appropriate I have obtained copyright 
permission from the copyright holder to reproduce material in this thesis. 
 
 
 
vi 
 
Publications during candidature 
The following is a list of publications during candidature: 
 
Conference abstracts: 
 
 N. Mohd Taufek, D. Cartwright, M. Davies, A.K. Hewavitharana, P. Koorts, H. 
McConachy, P. N. Shaw, K. Whitfield. Investigating the effect of the 
pasteurisation process on trace elements in donor breast milk, at Conference 
on Neonatology, 25th-27th June 2015 in Avignon, Provence, France. 
 
 N. Mohd Taufek, D. Cartwright, M. Davies, A.K. Hewavitharana, P. Koorts, H. 
McConachy, P. N. Shaw, K. Whitfield. Investigating the effect of the 
pasteurisation process on trace elements in donor breast milk, at Neonatal & 
Paediatric Pharmacist Group conference, 6th-9th November 2015, United 
Kingdom. 
 
 N. Mohd Taufek, D. Cartwright, M. Davies, A.K. Hewavitharana, P. Koorts, K. 
Palmer-Field, P. N. Shaw, K. Whitfield. Investigating the variation of eight 
essential trace elements in preterm breast milk in the first month of lactation, at 
The Neonate – An International Symposium for Asia, 30th March - 1st April 
2016, Shanghai, China. 
 
 N. Mohd Taufek, J. A. Duley, H. G. Liley, P. N. Shaw, K. Whitfield. The 
longitudinal variation of eight essential trace elements in preterm human milk – 
a case study, at The Neonate – An International Symposium for Asia, 30th 
March - 1st April 2016, Shanghai, China. 
 
 
 
 
 
 
vii 
 
Peer-reviewed papers:  
 
 Nor Mohd-Taufek, David Cartwright, Mark Davies, Amitha K. Hewavitharana, 
Pieter Koorts, Paul N. Shaw, Ronald Sumner, Eugene Lee, Karen Whitfield 
(2016). The simultaneous analysis of eight essential trace elements in human 
milk by ICP-MS, Food Analytical Methods, 2016:9(7):2068-2075.doi: 
10.1007/s12161-015-0396-z. 
 
 Nor Mohd-Taufek, David Cartwright, Mark Davies, Amitha K Hewavitharana, 
Helen McConachy, Pieter Koorts, Paul N Shaw, Ronald Sumner, Karen 
Whitfield (2016). The effect of pasteurization on trace elements in donor breast 
milk, Journal of Perinatology, 2016:36:897–900. doi:10.1038/jp.2016.88. 
 
 
 
 
 
 
 
 
 
 
 
 
viii 
 
Publications included in this thesis 
 Nor Mohd-Taufek, David Cartwright, Mark Davies, Amitha K. Hewavitharana, 
Pieter Koorts, Paul N. Shaw, Ronald Sumner, Eugene Lee, Karen Whitfield. 
The simultaneous analysis of eight essential trace elements in human milk by 
ICP-MS, Journal of Food Analytical Methods, 2016:9(7):2068-2075. doi: 
10.1007/s12161-015-0396-z – incorporated as Chapter 3.  
Contributor Statement of contribution 
Nor Hidayah Mohd Taufek Designed study and experiments (50%)  
Ethics application and data collection 
(40%) 
Wrote and edited the paper (40%) 
Karen Whitfield Designed study and experiments (20%) 
Ethics application and data collection 
(40%) 
Wrote and edited paper (20%) 
Paul N. Shaw,  Designed study and experiments (10%), 
wrote and edited the paper (20%) 
Amitha K. Hewavitharana Designed study and experiments (10%) 
Mark Davies Ethics applications (10%), wrote and 
edited paper (10%) 
David Cartwright Ethics applications and support data 
collection (5%) 
ix 
 
Pieter Koorts Ethics applications and support data 
collection (5%) 
Ronald Sumner Designed study concept and 
experiments (5%), Wrote and edited 
paper (5%) 
Eugene Lee Designed study concept and 
experiments (5%), Wrote and edited 
paper (5%) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
 
 Nor Mohd-Taufek, David Cartwright, Mark Davies, Amitha K. Hewavitharana, 
Helen McConachy, Pieter Koorts, Paul N. Shaw, Ronald Sumner, Karen 
Whitfield. The effect of pasteurization on trace elements in donor human milk, 
Journal of Perinatology; 2016:36:897–900. doi:10.1038/jp.2016.88 – 
incorporated as Chapter 4. 
Contributor Statement of contribution 
Nor Mohd Taufek Designed study and experiments (35%)  
Ethics application and data collection 
(40%) 
Data analysis and interpretation (30%) 
Wrote and edited the paper (35%) 
Karen Whitfield Designed study and experiments (35%) 
Ethics application and data collection 
(35%) 
Data analysis and interpretation (30%) 
Wrote and edited paper (35%) 
Paul N. Shaw,  Designed study and experiments (10%) 
Wrote and edited the paper (20%) 
Ethics application and data collection 
(5%) 
Data analysis and interpretation (20%) 
Amitha K. Hewavitharana Designed study and experiments (10%) 
Ethics applications and data collection 
(5%) 
xi 
 
Wrote and edited the paper (5%) 
Mark Davies Ethics applications and data collection 
(5%) 
Wrote and edited paper (5%) 
Data analysis and interpretation (20%) 
David Cartwright, Ethics applications and data collection 
(5%) 
Pieter Koorts, Ethics applications and data collection 
(5%) 
Ronald Sumner Designed study and experiments (10%) 
xii 
 
Contributions by others to the thesis  
 
The thesis consists of primary data collection and analysis. This work involved a large 
research team as the study populations were mothers who delivered their infants at 
the Royal Brisbane and Women’s Hospital (RBWH) and breast milk donors at the 
human milk bank. The ethical applications of the National Ethics Application Form, 
received the support and approval from the RBWH governance to access the study 
population in this setting. The participant recruitment, samples and data collection 
were carried out by the neonatal pharmacist, milk bank staff nurse and lactation 
consultant.  
The studies undertaken herein were designed, and undertaken with the involvement 
and collaboration of three different settings. The research teams involved were from 
the School of Pharmacy of the University of Queensland, Grantley Stable Neonatal 
Unit of the RBWH, and the technical laboratory support by the Inorganic Laboratory, 
Queensland Health Forensic and Scientific Services (QHFSS), in Brisbane, 
Queensland, Australia. The advice for statistical data analysis options used in this 
thesis were received from statisticians at the Queensland Institute of Medical 
Research Berghofer, Brisbane, Australia. 
I am responsible for the sample coding, record keeping of the data, and sample 
analysis, following a period of training at the laboratory with the support of the experts 
working with the instruments at the QHFSS. I also analysed the data collected in the 
studies and reported the findings in manuscripts included in this thesis, co-authored 
by the co-investigators. 
 
xiii 
 
Statement of parts of the thesis submitted to qualify for the award of another 
degree 
 
None 
 
xiv 
 
Acknowledgements 
I would like to express special appreciation to my advisor, Dr. Karen Whitfield for 
encouraging my research and helping me grow as a research scientist in the field of 
clinical pharmacy (neonatology). I would like to also thank the advisory committee 
members Professor Nick Shaw and Dr Amitha Hewavitharana for providing priceless 
advice, comments and suggestions particularly involving laboratory work and research 
publications. 
I would like to especially thank the laboratory team at Queensland Health Forensic 
and Scientific Services (QHFSS); Mr. Eugene Lee and Mr. Ronald Sumner and all the 
support team that were involved directly and indirectly in completing this project. 
I would like to also express my gratitude to have a tremendous team assisting me with 
participant recruitment, clinical sample and data collection at Royal Brisbane & 
Women’s Hospital (RBWH). I would like to thank Ms Helen McConachy, the staff nurse 
at Human Milk Bank, RBWH who was involved directly in the pasteurisation study, and 
Ms Kristina Palmer-Field, the lactation consultant who has been of great help with the 
study of preterm and term breast milk. Furthermore, the team of neonatologists that 
have provided full support for this project, addressing particularly the ethical issues, 
the setting and participants, technical resources and advice on the manuscripts 
produced from the studies; Associate Professor David Cartwright, Associate Professor 
Mark Davies and Dr. Pieter Koorts who have provided advice throughout the project. 
I would like to thank statisticians from Queensland Institute of Medical Research 
Berghofer, Ms. Anita Pelecanos and Mr. Lachlan Webb for the statistical advice they 
provided during data analysis process. 
xv 
 
I would like to thank the School of Pharmacy, the University of Queensland for the 
continuous research support that I received until the completion of this project 
including The University of Queensland International scholarship, as well as my 
scholarship providers, the Ministry of Education Malaysia and International Islamic 
University Malaysia. 
At the end, I would like to express special appreciation to my family and friends who 
have been supporting me throughout this journey, particularly my beloved husband, 
Mohd Iszamir Ismail and my parents who have always been there with incredible 
support and courage. To my friends who have always been there to provide assistance 
with all the technical challenges upon completing this project, special thanks to Nur 
Sofiah Abu Kassim, Sabariah Noor Harun, Siti Sarah Fazalul Rahiman and Nurul Azrin 
Ab Rahman. 
 
 
 
 
 
 
 
 
 
 
xvi 
 
Keywords 
Trace elements, human breast milk, pasteurised donor human milk, neonates, trace 
element deficiency, lactation stage, inductively coupled plasma mass-spectrometry. 
 
Australian and New Zealand Standard Research Classifications (ANZSRC) 
 
ANZSRC code: 111403, Paediatrics 70% 
ANZSRC code: 111503 Clinical Pharmacy and Pharmacy Practice, 30% 
 
Fields of Research (FoR) Classification 
 
FoR code: 1114 Paediatrics and Reproductive Medicine, 70% 
FoR code: 1115 Pharmacology and Pharmaceutical Sciences, 30% 
 
 
 
 
 
 
 
 
 
 
 
xvii 
 
TABLE OF CONTENTS 
 
Abstract ..................................................................................................................... ii 
Declaration by author .............................................................................................. v 
Publications during candidature............................................................................ vi 
Publications included in this thesis .................................................................... viii 
Acknowledgements ............................................................................................... xiv 
TABLE OF CONTENTS ......................................................................................... xvii 
LIST OF FIGURES.................................................................................................. xxi 
LIST OF TABLES ................................................................................................. xxiii 
LIST OF ABBREVIATIONS ................................................................................... xxv 
CHAPTER 1. GENERAL INTRODUCTION ........................................................... 1 
1.1. Trace elements. ............................................................................................ 1 
1.2. Neonates. ..................................................................................................... 2 
1.3. Trace element nutrition in neonates. ............................................................. 3 
1.4. Method for quantifying trace elements in human breast milk. ....................... 4 
1.5. Pasteurised donor human milk. .................................................................... 5 
1.6. Trace element variation in human breast milk. ............................................. 5 
1.7. Significance of the current study ................................................................... 6 
1.8. Research Questions, Hypothesis and Objectives ......................................... 7 
1.9. Research Protocol ........................................................................................ 9 
xviii 
 
1.10. Layout of the Thesis ................................................................................... 9 
CHAPTER 2. LITERATURE REVIEW .................................................................. 11 
2.1. Trace elements ........................................................................................... 11 
2.2. Neonates .................................................................................................... 29 
2.3. Human milk nutrition and lactation stages .................................................. 43 
2.4. Other nutritional Strategies in Neonates ..................................................... 44 
2.5. Trace Element Nutrition of Human Breast Milk ........................................... 47 
2.6. Inductively coupled plasma mass spectrometry (ICP-MS) and its application 
for simultaneous determination of trace elements in biological matrices. .......... 54 
2.7. Summary .................................................................................................... 57 
CHAPTER 3. THE SIMULTANEOUS ANALYSIS OF EIGHT ESSENTIAL TRACE 
ELEMENTS IN HUMAN MILK BY ICP-MS ........................................................... 59 
Abstract ............................................................................................................. 60 
3.1. Introduction ................................................................................................. 62 
3.2. Materials and Methods ............................................................................... 63 
3.3. Results ........................................................................................................ 72 
3.4. Discussion .................................................................................................. 79 
CHAPTER 4. THE EFFECT OF PASTEURISATION ON TRACE ELEMENTS IN 
DONOR BREAST MILK ........................................................................................ 82 
Abstract ............................................................................................................. 85 
4.1. Introduction ................................................................................................. 86 
xix 
 
4.2 Material and methods .................................................................................. 89 
4.3. Results ........................................................................................................ 90 
4.4 Discussion ................................................................................................... 94 
CHAPTER 5. THE LONGITUDINAL VARIATION OF EIGHT ESSENTIAL TRACE 
ELEMENTS IN PRETERM HUMAN MILK – A CASE STUDY .............................. 98 
5.1. Introduction ................................................................................................. 99 
5.2. Case presentation ..................................................................................... 101 
5.3. Discussion ................................................................................................ 108 
5.4. Conclusion and recommendations ............................................................ 113 
CHAPTER 6. A PILOT STUDY TO INVESTIGATE VARIATION IN TRACE 
ELEMENT CONCENTRATIONS OVER LACTATION STAGE IN PRETERM AND 
TERM HUMAN MILK. ......................................................................................... 114 
6.1. Introduction ............................................................................................... 115 
6.2. Methods .................................................................................................... 118 
6.3. Results ...................................................................................................... 120 
6.4. Discussion ................................................................................................ 134 
6.5. Conclusion ................................................................................................ 142 
CHAPTER 7. GENERAL DISCUSSION AND CONCLUSION ........................... 144 
7.1. Introduction ............................................................................................... 144 
7.2. Overview of Thesis Results ...................................................................... 144 
7.3. Main Findings ........................................................................................... 146 
xx 
 
7.4. Thesis Strengths and Limitations .............................................................. 151 
7.5. Implications and Future Research Directions ........................................... 153 
7.6. Thesis Conclusion .................................................................................... 154 
CHAPTER 8. REFERENCES ............................................................................ 156 
APPENDICES ........................................................................................................ 193 
xxi 
 
LIST OF FIGURES 
Figure 5-1.The variation of zinc concentrations between days 16 - 68 postpartum.
 ............................................................................................................................... 104 
Figure 5-2. The variation of copper concentrations between days 16 - 68 postpartum.
 ............................................................................................................................... 104 
Figure 5-3. The variation of selenium concentrations between days 16 - 68 
postpartum. ............................................................................................................ 105 
Figure 5-4. The variation of manganese concentrations between days 16 - 68 
postpartum. ............................................................................................................ 105 
Figure 5-5. The variation of iodine concentrations between days 16 - 68 postpartum.
 ............................................................................................................................... 106 
Figure 5-6. The variation of iron concentrations between days 16 - 68 postpartum.
 ............................................................................................................................... 106 
Figure 5-7.The variation of molybdenum concentrations between days 16 - 68 
postpartum. ............................................................................................................ 107 
Figure 5-8. The variation of bromine concentrations between days 16 - 68 postpartum.
 ............................................................................................................................... 107 
Figure 6-1.Concentration (median and IQR) of zinc in preterm and term breast milk 
over 12 weeks postpartum. .................................................................................... 127 
Figure 6-2. Concentration (median and IQR) of copper in preterm and term breast milk 
over 12 weeks postpartum. .................................................................................... 127 
Figure 6-3. Concentration (median and IQR) of selenium in preterm and term breast 
milk over 12 weeks postpartum. ............................................................................. 128 
xxii 
 
Figure 6-4. Concentration (median and IQR) of manganese in preterm and term breast 
milk over 12 weeks postpartum. ............................................................................. 128 
Figure 6-5. Concentration (median and IQR) of iodine in preterm and term breast milk 
over 12 weeks postpartum. .................................................................................... 129 
Figure 6-6. Concentration (median and IQR) of iron in preterm and term breast milk 
over 12 weeks postpartum. .................................................................................... 129 
Figure 6-7. Concentration (median and IQR) of molybdenum in preterm and term 
breast milk over 12 weeks postpartum. .................................................................. 130 
Figure 6-8. Concentration (median and IQR) of bromine in preterm and term breast 
milk over 12 weeks postpartum. ............................................................................. 130 
 xxiii 
 
LIST OF TABLES 
Table 2-1. Types of trace elements present in humans and environment, reported by 
WHO in 1996. ........................................................................................................... 13 
Table 3-1. Internal Standard Solution ....................................................................... 67 
Table 3-2. ICP-MS instrument operating condition ................................................... 70 
Table 3-3.Calibration data, limit of detection (LOD), and limit of quantification (LOQ) 
for 21 trace elements covered in alkaline dissolution methods. ............................... 73 
Table 3-4.Repeatability (expressed as percentage standard deviation, %RSD) for 
eight trace elements in pooled breast milk samples intra-day and inter-day. ........... 75 
Table 3-5. Repeatability (expressed as relative standard deviation, RSD) for certified 
reference material NIST 1549 non-fat formula milk and accuracies for eight elements.
 ................................................................................................................................. 76 
Table 3-6. Observed value and certified values for NIST 1549, mean ± SD (mg/kg).
 ................................................................................................................................. 77 
Table 3-7. The median (range) and mean ± SD (µg/L) of eight essential elements in 
donor breast milk, n=12. ........................................................................................... 77 
Table 4-1.Comparison of trace elements in pre-and post-pasteurisation aliquots donor 
milk, n=16, in µg/L. ................................................................................................... 92 
Table 5-1. The difference in median (range) in the concentrations of eight essential 
trace elements in mature preterm milk in week 3 and weeks 5-10 postpartum, in µg/L.
 ............................................................................................................................... 103 
Table 6-1.Characteristics of participants, presented as mean ± SD. ...................... 123 
Table 6-2. The concentration of trace elements in preterm and term breast milk over 
a period of three months postpartum (µg/L). .......................................................... 124 
 xxiv 
 
Table 6-3. Differences in trace element concentration (µg/L) in breast milk collected in 
the morning (AM) and evening (PM), n = 22. ......................................................... 131 
 
 xxv 
 
LIST OF ABBREVIATIONS 
 
AE     Acrodermatitis enteropathica 
Ag     Silver 
Al     Aluminium 
As     Arsenic 
Bi     Bismuth 
BW     Birth weight 
BPD     Bronchopulmonary dysplasia 
Br     Bromine 
Cd     Cadmium 
Co     Cobalt 
Cr     Chromium 
Cu     Copper 
DNA     Deoxyribonucleic acid 
EBM     Expressed Breast Milk 
Fe     Iron 
FAO/WHO Food and Agriculture Organisation of World 
Health Organisation 
g Grams 
GA     Gestational age 
GSH-Pxs    Glutathione Peroxidases 
He     Helium 
HIV     Human Immunodeficiency Virus 
 xxvi 
 
I     Iodine 
ICP-MS   Inductively coupled plasma mass-    
                                                      spectrometry 
IQR     Inter-quartile range 
LBW     Low birth weight 
Mn     Manganese 
Mo     Molybdenum 
NEC     Necrotising enterocolitis 
Ni     Nickel 
Pb     Lead 
PDHM    Pasteurised Donor Human Milk 
Sb     Antimony 
Se     Selenium 
Tl     Thallium 
TPN     Total Parenteral Nutrition 
U     Uranium 
V     Vanadium 
VLBW     Very low birth weight 
vs     versus 
WHO     World Health Organization 
Zn     Zinc 
 
 1 
 
CHAPTER 1. GENERAL INTRODUCTION 
This thesis reported a number of studies investigating trace element concentration in 
human breast milk. Previous research has focused on certain trace elements, but 
there remain many gaps in the literature regarding trace element content in human 
breast milk. The thesis initially reviewed the background information of trace elements, 
particularly those which have been acknowledged as essential in humans, 
predominately for early growth and development. It has been well recognised that 
mothers’ breast milk is the optimal nutrition for neonates but comprehensive data 
regarding trace element status in breast milk was lacking. The optimal concentrations 
of trace elements have not been established in different types of breast milk. Although 
several trace elements have been recognised as essential in humans and suboptimal 
concentration may lead to deficiencies, many studies have concentrated on a few well-
recognised elements, such as zinc, iodine, and iron. This chapter summarises the 
literature into the following sections: trace elements, neonates, trace element nutrition 
in neonates, methods for quantifying trace elements in human breast milk, pasteurised 
donor human milk and trace element variation in human breast milk.   
1.1. Trace elements. 
Trace elements are micronutrients which play vital roles in metabolism and human 
growth and development. Interest has increased during the past 10-20 years because 
of a number of case reports which have highlighted the consequences of trace element 
deficiency in humans – until then only small number of studies had reported the 
importance of trace elements to human health. Previously, trace element deficiencies 
in humans were primarily associated with zinc, iodine and iron and isolated reports for 
copper and selenium (1-5). Vulnerable groups such as infants, pregnant and lactating 
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women are susceptible to trace element deficiencies. However, comprehensive 
information remains unavailable about trace elements in human health and 
deficiencies may have gone unreported. Recently, ‘new’ trace elements have been 
recognised as essential. These include molybdenum, chromium, cobalt and bromine. 
More research is needed to inform their role in human health and to improve our 
knowledge and understanding about any potential risks of deficiency or toxicity. Trace 
element content in different biological matrices varies considerably and thus reporting 
about a specific matrix will improve our overall knowledge and understanding of these 
elements in human health (6, 7).   
1.2. Neonates. 
Early human growth and development have been closely linked to the status and 
requirements of several trace elements. Neonates are defined as newborn infants with 
an age up to 28 days; they undergo rapid growth and development and require, for 
appropriate growth, optimal intake of trace elements. Term neonates are born between 
37 to 42 weeks gestation, whereas premature or preterm neonates are born at less 
than 37 weeks gestation (8). Extremely preterm neonates are born at less than 28 
weeks gestation (9). Appropriate reference ranges for trace elements in neonates 
have yet to be clearly defined and are complicated by variables occurring in neonates. 
Factors that should be considered in order to tailor neonatal nutritional requirements 
include; small body reserves of nutrients (10), high metabolic demand (11-13), 
gestation (14, 15), enteral and parenteral nutrition (14), surgery (16), chronic neonatal 
lung disease (17, 18), sepsis (19), and multiple organ failure (20) to name but a few. 
There are only a small numbers of clinical guidelines that have outlined the importance 
of trace element nutrition and supplementation in specific neonatal populations (21). 
 3 
 
1.3. Trace element nutrition in neonates. 
It has been recognised that the optimal source of nutrition in neonates is mother’s own 
milk, and thus breastfeeding is highly recommended where possible. In many 
circumstances where breastfeeding is difficult to achieve, other alternatives such as 
pasteurised human donor milk (PDHM), formula milk and parenteral nutrition are 
possible options to use. Nonetheless, human milk has always been regarded as 
superior to formula milk owing to its unique bioavailability and the well-documented 
benefits of improved health outcomes in infants. Human milk is known to provide many 
advantages to infants including: immunological; developmental and nutritional benefits 
(22). Some of the vital micronutrients that present in human milk are essential trace 
elements. Trace elements have been reported to play essential roles including, 
components of hormones, antioxidants, enzymes cofactors, and in many aspects of 
metabolism cascades that have not yet been well described in humans (23). However, 
studies addressing trace element composition in human milk have been scarce, since 
only a limited number of studies in the past 20 years have reported the concentration 
variation in essential elements in human milk in different geographical regions (24-30). 
This could be due in part to the technical complexities surrounding the analytical 
methods to accurately measure the concentration of trace elements in human milk. In 
addition, recruitment of participants in this population is often challenging owing to the 
stressful environment of the Intensive Care Unit, where many premature infants need 
to receive appropriate care. Further studies addressing trace element analysis in 
human milk will therefore provide valuable data about nutrition received by the 
neonatal population. 
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1.4. Method for quantifying trace elements in human breast milk. 
Over recent years, a number of methods using various sample preparation and 
instruments have been used to analyse trace elements in human milk (7, 31, 32). The 
common methods used in previous years include: atomic absorption spectroscopy (24, 
33, 34); neutron activation analysis (35); inductively coupled plasma atomic emission 
spectrometry (ICP-AES) (36, 37); and total reflection X-ray fluorescence (38) to 
measure single or a very small number of trace elements in human milk. One of the 
highly sensitive and effective methods reported to date is that of inductively coupled 
plasma mass-spectrometry (ICP-MS) (39, 40).  
A robust and reliable method of analysis is essential to undertake this type of work. 
This includes care around sample preparation to avoid contamination and to provide 
reliable and consistent results. Sample preparation for trace element analysis has 
previously involved various procedures that have necessitated validation for each 
matrix e.g. human serum, plasma, blood, breast milk, hair, nail. A sample preparation 
method described in the literature for trace element analysis is that of alkaline 
dissolution (41). Alkaline dissolution is simple and effective, and has been previously 
used to examine trace elements in a human blood matrix. A simple and effective 
method to allow routine simultaneous analysis of several trace elements in human milk 
was, however, lacking. This thesis therefore developed a robust and reliable analytical 
method using alkaline dissolution and ICP-MS to quantify eight essential trace 
elements in small volumes of human milk. The importance of using small sample 
volume for research purposes cannot be underestimated when investigating milk from 
mothers delivering preterm infants, as often milk is only available in very small 
quantities initially (e.g. 1-2 mL). 
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1.5. Pasteurised donor human milk. 
Pasteurised donor human milk (PDHM) has been used in premature neonates when 
there is insufficient mother’s milk and where parents’ consent to PDHM. Pasteurised 
donor human milk is preferred over formula milk and is considered the second best 
source of nutrition for preterm infants. The National Institute for Health and Care 
Excellence (NICE) clinical guidelines for donor Milk Bank service and operation (42) 
have been adopted in many health care settings to establish Donor Human Milk 
Banks, of which only three are available in Australia to support a human milk bank 
service.  
Pasteurisation processes have been adopted to preserve the safety and quality of the 
milk and research is ongoing to explore all aspects of the nutritional qualities of PDHM. 
The pasteurisation process has been widely adopted to preserve human milk at 
human milk banks for an extended period of time. Although studies are available to 
provide information about the effects of pasteurisation on other nutritional components 
(43, 44), information concerning the effects on micronutrients such as trace elements 
is lacking. The conditions of the pasteurisation process are quite harsh, using high 
temperatures which may adversely affect trace elements that are bound to proteins. 
The effects of pasteurisation on the binding process are unknown but lower 
concentrations of certain trace elements in breast milk have been attributed to the 
effects of pasteurisation (45). This thesis explored the effects of the pasteurisation 
process on trace elements as part of this research. 
1.6. Trace element variation in human breast milk. 
It has been proposed that preterm neonates may have lower body reserves of some 
trace elements, as a result of transfer of micronutrients during the last trimester of 
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pregnancy (10). As such, preterm neonates are potentially at a higher risk of deficiency 
when compared to their term counterparts. It is therefore essential to assess whether 
preterm milk contains sufficient quantities of trace elements to provide optimal nutrition 
for preterm infants. These aspects have not been thoroughly investigated in preterm 
milk and term milk for all essential trace elements. It is recognised that the content of 
macronutrients such as protein and fat differ between term and preterm milk. However, 
the content of trace elements in preterm and term milk has not been fully evaluated. 
In addition, the concentration of trace elements in different types of milk such as 
colostrum, transitional and mature milk have not been well defined. Subsequently, the 
optimal concentrations of trace elements in different types of human milk require 
further clarification. The complexities of addressing such issues include the individual 
variability of mothers producing the milk, as well as different types of milk produced at 
different lactation stages. It has been reported that the concentrations of some trace 
elements decrease over lactation stages but these have also not been well studied. 
1.7. Significance of the current study 
Essential trace elements as defined by the World Health Organisation include zinc, 
copper, selenium, manganese, chromium, magnesium, cobalt, iron, fluoride, 
potassium, molybdenum, iodine and lithium and are primarily acquired from dietary 
intake (46). Neonates in particular preterm neonates can be vulnerable to trace 
element deficiency owing to their rapid growth and development and lower body 
reserve. Little is known about trace element concentrations in breast milk, particularly 
of mothers who have delivered preterm. Optimal concentrations have yet to be 
defined, partly due to complexities in the estimation of the intake and bioavailability of 
trace elements in human milk. Breast milk is considered optimal nutrition for healthy 
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growth and development in infants, however, women who deliver early often produce 
small amounts of breast milk that contains different compositions of fat, protein and 
nutrients when compared to term breast milk (47, 48). Many premature infants whose 
mothers are not able to produce sufficient milk, receive pasteurised donor human milk 
from human milk banks. It has been well accepted in the recent years that pasteurised 
donor human milk is a better alternative than formula milk. However, data regarding 
the nutritional qualities of human milk and the quantities of essential elements therein 
have not been extensively studied.  
It is important to gain a better understanding of trace element composition and 
variability in preterm, term and pasteurised donor human milk to ensure optimal 
nutrition in infants. Furthermore, there is a question surrounding lactation stage and 
possible variability in trace element concentrations over postpartum period. This thesis 
investigated the variation of trace element concentration found in preterm and term 
breast milk. It is hoped that the results reported in this thesis will assist in providing 
more data on reference ranges for trace element nutrition in preterm and term breast 
milk. It is known that the composition of breast milk over time does change and some 
trace elements including zinc can decrease (24). This thesis added to the current 
knowledge by investigating the content of essential trace elements in human milk of 
preterm and term infants, PDHM and changes in concentration over postpartum 
period.  
1.8. Research Questions, Hypothesis and Objectives 
1.8.1. Research Questions: 
1. What are the currently available methods to analyse trace elements simultaneously 
and effectively in minimal amounts of human milk? 
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2. Does the pasteurisation process adversely affect trace elements concentrations in 
human milk? 
3. Do trace elements concentrations vary in human breast milk over an extended 
postpartum period? 
4. Do trace element concentrations differ between preterm and term breast milk? 
1.8.2 Research Hypothesis: 
1. The pasteurisation process does not adversely affect trace element concentrations 
in human milk. 
2. There are no variations in trace element concentrations in human milk over 
postpartum period. 
3. There is no differences between the concentration of trace elements in premature 
and term human breast milk. 
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1.8.3. Research Aim and Objectives: 
Aim: To investigate essential trace element content of human breast milk.  
Research objectives: 
1. To validate a robust, reproducible and sensitive method to simultaneously 
determine the concentration of trace elements in human milk.  
2. To investigate the effect of the pasteurisation process on the concentration of trace 
elements in donor human milk.  
3. To explore the effect of lactation stage on the concentration of trace elements in 
human milk.  
4. To investigate differences in the concentration of trace elements between preterm 
milk and term milk. 
1.9. Research Protocol 
All the studies received ethical approval from the Royal Brisbane and Women’s 
Hospital (RBWH) ethics committee and the University of Queensland ethics 
committee. Informed consent was obtained from all participants in the studies. 
1.10. Layout of the Thesis 
Chapter 1 provides an introduction and a brief description of the study aims, 
objectives, significance, study hypothesis and the structure of the thesis.  
Chapter 2 presents a review of the available evidence surrounding the roles and 
concentrations of essential trace elements in human milk and recent knowledge about 
the nutritional aspects of trace elements in human milk. Information concerning the 
importance of these elements in infants’ nutrition is provided in this chapter, as 
different groups of neonates may require different amounts of trace elements. This 
chapter also includes a section on the pasteurisation process undertaken to preserve 
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donor human milk, which is increasingly practiced at human milk banks. The effects 
of this process on various nutritional components in human milk are also described. In 
addition, the variation of trace element concentration over different lactation stages 
are highlighted. The literature surrounding the use of inductively-coupled plasma mass 
spectrometry (ICP-MS) and its application in the determination of trace elements in 
human biological samples are summarised at the conclusion of this chapter.  
Chapter 3 presents the findings of a method validation that has been undertaken to 
determine the simultaneous concentration of trace elements in minimal amounts of 
human milk using ICP-MS. 
Chapter 4 presents the findings of a study investigating the effect of pasteurisation on 
the concentration of trace elements in donor human milk. 
Chapter 5 presents the findings from a case study involving a mother who delivered 
an extremely premature neonate and reports the concentration variation of eight 
essential trace elements between 3-10 weeks postpartum in mature preterm milk. 
Chapter 6 presents the findings of a pilot study examining the differences in the 
concentration of eight essential trace elements in preterm and term human milk during 
the first three months postpartum. 
Chapter 7 provides the general discussion, conclusions and recommendations 
derived from the studies documented in the thesis. 
Appendices 
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CHAPTER 2. LITERATURE REVIEW 
2.1. Trace elements 
Trace elements are also known as micronutrients. Primarily, trace elements are 
available in minute quantities in the human body to regulate normal biochemical 
function of enzymes and other proteins and promote health (23, 46). Minute, is also 
termed as ‘trace’ amounts and is applied to concentrations not exceeding 250 
microgram per gram of matrix (46).  In the event of excess or deficient amounts, 
adverse health effects may occur. 
2.1.1. Types of Trace Elements 
Trace elements are classified by the World Health Organisation (WHO) Expert 
Consultation into three types (Table 2-1), which are  
 essential  
 probably essential 
 non-essential (46).  
Essential trace elements are not only present in the environment, but also in the 
human body and primarily act as catalysts in biochemical activities for enzymes and 
hormones (23). These trace elements are considered essential for human 
physiological functioning and can only be acquired from dietary intake before being 
stored in, or eliminated from the body (49, 50). To date, trace elements that are 
recognised by the World Health Organisation as essential include zinc, copper, 
selenium, manganese, chromium, magnesium, cobalt, iron, fluoride, potassium, 
molybdenum, iodine and lithium (46). Trace elements occurring in the group “probably 
essential” (silicon, nickel, boron and vanadium) are recognised as possessing both 
pharmacological properties and potentially toxic effects on the human body but further 
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studies are required to confirm essential properties (51, 52). Non-essential trace 
elements pose potential toxicity to humans and are not found in the human body but 
are abundantly present in the environment (53). Examples include lead and cadmium 
(46). Trace elements can be found in many biological fluids and parts of the human 
body such as nail (54), hair (55), urine (56), whole blood, plasma (57), serum (58) and 
breast milk (32). 
The definition of trace elements may also be considered by individual element 
concentration. The feature of nutritionally significant trace elements is their essentiality 
or potential toxicity when present at low concentration in the body. Essential is defined 
as “when reduction of its exposure below certain limits results in consistent reduction 
in physiological vital functions”(46). This aspect is important since optimal trace 
element concentration range, in different matrices, is not well established. 
Furthermore, different matrices contain different amounts of individual elements. Data 
is sparse describing appropriate trace element concentrations in humans. 
The essentiality of certain trace elements has been proven such as fluoride in the roles 
of dental structures and selenium as part of glutathione peroxidases enzyme structure 
(46). Recent findings have also identified that bromine is a newly recognised essential 
element owing to its role in cellular membrane structure (59). Maret has emphasised 
recently that the specific meaning of “essential” needs to refer to a biological species 
(60). There are many gaps in nutritional research on the essentiality of trace elements 
in humans to date. Animal studies need careful interpretation when relating to human 
requirements owing to differences in genetic and protein sequencing (23). Where 
possible, research in human biological samples is necessary to establish the 
knowledge surrounding essential trace elements in humans. 
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Table 2-1. Types of trace elements present in humans and environment, reported by 
WHO in 1996. 
Essential Probably essential Non-essential / toxic heavy 
metal 
Zinc, Copper, Selenium, 
Manganese, Chromium, 
Magnesium, Cobalt, 
Iron, Fluoride, 
Potassium, 
Molybdenum, Iodine, 
Lithium 
Silicon, Nickel, Boron, 
Vanadium 
Lead, Cadmium, Mercury, 
Thallium, Aluminium, Tin, 
Silver, Barium, Tungsten, 
Bismuth, Platinum, 
Beryllium, Strontium, 
Antimony, Tellurium, 
Palladium, Arsenic, 
Rubidium, Germanium, 
Gallium Uranium 
Reference: (46) 
A recent review of current evidence by Chellan and Sadler (23) has comprehensively 
categorised all elements across the periodic table into different groups based on 
chemical properties as follows:  
 hydrogen + alkali metals,  
 the transition metals,  
 lanthanides and actinides,  
 p-block elements,  
 mostly non-metals and metalloids,  
 the noble gases.  
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They have highlighted that, despite only 25 out of 60 detectable elements in humans 
that are believed to play roles in human body functions, the essentiality remains 
difficult to establish owing to lack of data on appropriate nutritional concentrations (23). 
They also have concluded that data have primarily been extrapolated from animal 
studies since nutritional research in humans is complex, time consuming and 
expensive. 
2.1.2. The Roles of Trace Elements 
2.1.2.1. Zinc (Zn) 
Zinc is an essential trace element that is found abundantly in the human body. It is a 
cofactor for enzymes that mediate protein and nucleic acid biochemistry (61). It 
participates in structural roles of deoxyribonucleic acid (DNA) transcription protein, 
genes expression and nuclear hormonal receptors, regulation of cellular growth, 
differentiation and apoptosis especially in neurogenesis (62). Furthermore, zinc also 
supports the immune system, tissue growth and maintenance, bone mineralisation, 
foetal growth, cognitive functions and human reproduction (63, 64). The versatility of 
zinc makes its complex combination of roles incompletely understood. However, 
generalised impairment of vital bodily functions may happen in cases of zinc deficiency 
(65, 66).  
A review on zinc and neurogenesis has described its roles in embryonic stem cell 
development (62). It involves division process to form embryonic notochord, neural 
tube and neural crest, followed by differentiation of cells into mature neurons, 
aggregation, synaptogenesis and synaptic pruning (62). These processes require 
zinc-dependent enzymes such as DNA polymerases, histone deacetylases, 
metalloproteinases and other dehydrogenases in intermediary metabolic pathways 
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which play roles in normal central nervous system functions (65). Moreover, zinc also 
mediates nuclear receptors for retinoic acid, vitamin D, thyroid hormones, 
glucocorticoids, oestrogen in the brain and regulates key genes involved in brain 
development (62). Zinc also regulates the presynaptic delivery of neurotransmitters to 
the synaptic cleft and is present in regional brain mass in cerebellum, the limbic system 
and cerebral cortex (65).  
Homeostasis ensures the balance of zinc status in the human body. Disturbance to 
homeostasis is common, multifactorial and can affect zinc concentrations. It can be 
caused by diet inadequacy, bioavailability of dietary enriched zinc, intestinal 
conservation of endogenous zinc, malabsorption, stress, infections and catabolic 
metabolism (67), age, gender and socioeconomic status (64). Overall, efficiency of 
zinc homeostasis in the body plays a vital part in this process. Partial understanding 
of the fundamental importance of zinc in cellular growth has raised questions about 
the impact of potential deficiency for the rapidly growing neonate in terms of immune 
response and tissue repair (68). 
2.1.2.2. Copper (Cu) 
Copper is the third most abundant trace element in human body after iron and zinc 
(69). It can be found in the liver, brain, kidney heart and pancreas. It participates in 
enzymatic activities such as a cofactor for ferroxidases to support normal biochemical 
and physiologic functioning (70). It also participates in the production of bony protein 
matrix, thus insufficient formation of these components can result in metabolic bone 
disease (71). In the human body, copper absorption occurs mostly in the small 
intestine, transported to the liver by albumin or transcuprein, incorporated into 
ceruloplasmin then released from the liver into the blood. In blood, copper is bound to 
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ceruloplasmin and delivered to peripheral tissues. Following this process, 
ceruloplasmin binds to its receptors on the cell surface. More than 90% of copper in 
blood is bound to ceruloplasmin as opposed to albumin and amino acids and excreted 
through bile (71). 
2.1.2.3. Selenium (Se) 
Selenium was recognised to be essential in humans in 1957, when deficiency was 
associated with the development of necrotic degeneration of the liver, pancreas, heart 
and kidney in mammals (72). Prior to this it was considered to be a toxic element (73). 
Nowadays, evidence of selenium essentiality and its antioxidant properties in humans 
is well established. Selenium exists as a component in subsets of enzymes called 
selenoenzymes such as glutathione peroxidase and its subtypes play vital roles in 
reducing hydrogen peroxides within cytosol, protect against free radical damage, and 
reduce unstable lipid peroxidases to more stable hydroxyl acids (72, 74). Moreover, 
selenoproteins which play nutritional roles are glutathione peroxidases, 
selenophosphate synthases, selenoprotein P, selenoprotein W, DNA-bound 
spermatid selenoprotein, prostate epithelial selenoprotein and thioredoxin reductases 
(74). These cellular pathways maintain membrane integrity, protect prostacyclin 
production, and reduce the risk of propagation of oxidative damage in proteins and 
DNA that leads to the incidence of cancer and atherosclerosis.  Other roles include 
participation in thyroid hormone production, immune system, counteract virulence 
development, inhibit Human Immunodeficiency Virus (HIV) progression, improve 
mood, protection from cancer and cardiovascular disease (72).  A recent review 
proposed that selenium has a role to play in bone health (75). Nutritionally, it has been 
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considered that selenium may also reduce the incidence of rheumatoid arthritis, 
osteoarthritis and osteoporosis (75). 
Selenium enters the food chain from soil to plant and human selenium intake is highly 
varied geographically. It is difficult to describe its deficiency across different regions, 
as well as across populations and different age groups.  
2.1.2.4. Manganese (Mn) 
Manganese is found in all human tissue.  It regulates many biological processes in 
human body such as blood clotting (76), skeletal system development, energy 
metabolism, nervous and immune system, cellular energy and connective tissue 
growth (77). It is also a vital component in many metabolic enzymes such as pyruvate 
carboxylase, protein arginase, lipid and amino acids (77, 78). It is utilised by many 
antioxidant enzymes such as superoxide dismutase e.g. Manganese superoxide 
dismutase (MnSOD), activates glycosyltransferase which is important for cartilage, 
bone and connective tissue (78). Three main roles of manganese are;  
 activator of gluconeogenic enzymes, 
 protect mitochondrial membranes, and 
 activates glycosyl transferase that synthesises mucopolysaccharides (79). 
Manganese enters the brain by binding to transferrin, the primary iron 
binding/transport protein in plasma which is regulated by transferrin receptor (80). The 
safety margin is regulated by efficient homeostasis in terms of absorption and 
excretion in the body. Generally, manganese is obtained from the diet. The estimated 
safe and adequate dietary manganese intake is 2 to 5 mg per day for adults (81). 
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Drinking water contains 1 to 100 µg/L, whereas airborne exposure in industries is 
substantial and has been associated with changes in basal ganglia causing 
neurotoxicity resembling Parkinson’s disease (82, 83). It is known that manganese-
induced neurotoxicity is associated with motor dysfunction syndrome, referred to as 
manganism (84). 
2.1.2.5. Iodine (I) 
Iodine is primarily obtained through diet and diet contents of iodine are affected by 
iodine content in soil and water (85). The role of iodine in humans is primarily in the 
regulation of thyroid metabolism that involves iodide uptake by the follicular cells of 
the thyroid gland, synthesis and secretion of thyroglobulin, oxidation of iodide and 
organification of the thyroglobulin to form thyroxine (T4) and triiodothyronine (T3) 
hormones that circulate in the blood stream (85). Iodine deficiency is well established 
and it is known that people of different age groups exert different symptoms of iodine 
deficiency. Iodine deficiency can lead to medical problems such as hypothyroidism, 
goitre, and increased susceptibility to nuclear radiation (86). A review by Zimmermann 
has indicated that iodine deficiency can cause multiple adverse effects including 
inadequate production of thyroid hormone and mental impairment (87). Universal salt 
iodisation has decreased iodine deficiency worldwide from 110 countries in 1993 to 47 
in 2007 (2) and has shown benefits in addressing iodine deficiency issues (88).  
2.1.2.6. Chromium (Cr) 
Chromium regulates insulin action in humans and plays an important role in improving 
outcomes from diabetes mellitus and atherosclerosis (89).  It has been suggested that 
chromium concentration decreases with age, pregnancy and lactation (89). Chromium 
deficiency in organisms may cause impaired metabolism of carbohydrate, lipid and fat 
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(90) as well as impaired growth, elevated blood lipids, increased aortic plaque 
formation, and decreased fertility and longevity (91). As such it has been proposed 
that chromium deficiency may present with symptoms such as,  insulin-resistant 
hyperglycaemia, glucose intolerance, weight loss and high plasma free fatty acid 
concentrations (14). A recent randomised controlled trial of 30 type 2 diabetes mellitus 
patients, reported that chromium-enriched bread consumption has shown a significant 
decrease in body weight and blood pressure of the treatment group as well as 
improved glucose tolerance and insulin resistance (92). It has also been suggested 
that supplementation with chromium dinicocysteinate can improve blood markers of 
vascular inflammation, insulin resistance and oxidative stress (93). 
 It remains unclear whether chromium deficiency, latent or overt, is common in humans 
except in those who present with generalised malnutrition and those receiving long 
term total parenteral nutrition without added chromium (91). Recent issues have 
addressed the limited evidence available on appropriate dosage of chromium for 
parenteral nutrition (94). A review conducted by the WHO investigating mineral 
requirements of human nutrition concluded that three out of the included fifteen studies 
found no benefit following chromium supplementation. However, the remaining studies 
reported improved insulin efficiency or blood lipid profile of subjects  supplemented 
with chromium (95).  It is unclear whether dietary supplementation 
with chromium should be routinely recommended, since beneficial effects of 
chromium has not been consistently observed (96).  
2.1.2.7. Molybdenum (Mo) 
Molybdenum is as essential trace element in humans. Molybdenum is present in sulfite 
oxidase - an enzyme located in mitochondria that is responsible for amino acid and 
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lipid metabolism (97). Little is known about the role of molybdenum in humans but it 
has been proposed that molybdenum has an association with neurodevelopment (98). 
Deficiency or toxicity cases have not been reported in the literature and is probably 
due to the limited information regarding clinical presentation. It is known that defects 
of the sulphite oxidase enzyme can cause infant morbidity and mortality but very little 
information is  available in this area (99). Molybdenum cofactor is a complex of 
molybdenum and is required for several enzyme systems. Deficiency of molybdenum 
cofactor has been shown to lead to accumulation of toxic metabolites which can cause 
disturbances in neurotransmitters in humans (100). More research is required to 
elucidate the mechanisms involve in this particular condition. 
2.1.2.8. Iron (Fe) 
Iron is an essential element in humans and is required for haemoglobin synthesis that 
occurs in blood cells (101). Iron balance in the human body is regulated by the 
gastrointestinal tract, bone marrow, blood, liver, and spleen. Iron dysregulation will 
cause either iron deficiency or iron overload to occur (101). Iron deficiency is well 
established in humans and is associated with iron-deficiency anaemia. Other than that, 
iron deficiency can cause impaired cognitive functions, fatigue, susceptibility to 
infections, as well as increased risk of adverse outcomes in pregnancy (102).  
In women, iron supplements have been reported to provide a significant positive 
influence on iron status in those who are of pre-menopausal age but no effect in those 
of post-menopausal age (103). It is well known that without supplementation, pregnant 
women have significantly poorer iron status than non-pregnant women  (104). It has 
been reported that neonates of mothers who took iron supplementation during 
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pregnancy had higher cord serum ferritin concentrations than newborns of mothers 
taking a placebo (105). 
A review has identified that anaemia in both antenatal and postpartum women is more 
prevalent in developing countries than in Western societies (106). 
Postpartum anaemia is defined as a haemoglobin concentration of less than 110 g/L 
at 1 week postpartum and less than 120 g/L at 8 weeks postpartum. The prophylaxis 
of postpartum anaemia should begin in early pregnancy with prophylactic oral ferrous 
iron supplements 30-50 mg daily (106). In the treatment of slight-to-moderate 
postpartum iron deficiency anaemia, the first choice is oral ferrous sulfate 100 to 
200 mg daily. In severe iron deficiency anaemia, intravenous iron in doses ranging 
from 800 to 1500 mg should be considered as first choice (106). It has been suggested 
that the requirements during the first trimester of pregnancy is 0.8 mg/day whereas in 
the third trimester is 7.5 mg/day. Furthermore, the average requirement during the 
entire gestation is approximately 4.4 mg/day. In placebo-controlled studies on healthy 
pregnant women, there is no relationship between the women's haemoglobin and birth 
weight of the newborn (107). 
A randomised, double-blind study involving 301 healthy Danish pregnant women 
divided into four groups taking ferrous iron (as fumarate) in doses of 20 mg (n = 74), 
40 mg (n = 76), 60 mg (n = 77) and 80 mg (n = 75) from 18 weeks gestation to eight 
weeks postpartum. They concluded that iron deficiency can be prevented by providing 
supplementation of 80-100 mg ferrous iron per day to women having ferritin 
concentrations less than 30 µg/L, whereas 40 mg ferrous iron per day to women 
having ferritin concentrations of 31-70 µg/L. They recommended 40 mg ferrous iron 
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per day to women having ferritin concentrations less than 70 µg/L to prevent iron 
deficiency anaemia (108).  
2.1.2.9. Bromine (Br) 
Bromine has only recently been recognised as an essential trace element in humans 
(59). It is classified in the halogen group similar to iodine, fluorine and chlorine and its 
chemical properties are comparable to other halogens. It has been proposed that 
bromine is masked by iodine and chlorine in chemical analyses (109). Recently, it has 
been discovered that bromine in the form of bromide plays a vital role in membrane 
integrity at cellular concentrations (59). Very few studies report bromine and its roles 
in human health.  
Historically, bromide toxicity has been reported in a few isolated cases in the literature. 
Studies have concentrated on reporting the toxicity of bromine in humans which 
include the methyl bromide toxicity and bromism. These conditions have been 
characterised by the symptoms of lethargy, neurological disorders in adults as a result 
of excessive ingestion or exposure to bromide-containing products (110-113). A study 
reporting the outcome of 64 patients diagnosed with psoriasis and the topical 
application of a naturally high mineralised bromine-iodine brine found some interesting 
results. Clinical remission and marked improvement was found in 77.4% of cases 
compared to 27.8% of the control group (114). The authors concluded marked 
improvement after applying high mineralised bromine-iodine brine in patients suffering 
from progressive psoriasis (114). The essentiality of bromine might have been 
overlooked in the past as deficiency had not occurred owing to common environmental 
exposure to bromide. Recently, experts have recognised this key area and warranted 
further studies to define bromines’ essentiality through nutritional research (23, 60). 
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2.1.2.10. Cobalt (Co) 
Cobalt is known to play a role in the structure of the cobalamins, a group of cobalt-
containing compounds that are required as a co-factor for enzymes in humans: L-
methylmalonyl CoA mutase and methionine synthase (25). Cyanocobalamin that is 
also known as vitamin B12 can be converted to either of the two cobalamin coenzymes 
that are active in human metabolism: methylcobalamin and 5-
deoxyadenosylcobalamin (25). Vitamin B12 deficiency is a serious problem in human 
populations and is caused either by an inadequate dietary intake of vitamin B12 or by 
malabsorption. Untreated vitamin B12 deficiency results in potentially irreversible 
neurological damage and life-threatening anaemia. Fully breastfed infants may be at 
risk of B12 deficiency if the mother has been a strict vegetarian for at least 3 years or 
has untreated pernicious anaemia because vitamin B12 is obtained from animal foods, 
mainly meat, fish and poultry (25). Milk is a secondary source of vitamin B12 (25). 
2.1.2.11. Other Essential and Possibly Essential Trace Elements 
There are other trace elements which have been categorised as essential and toxic in 
humans. Hunt & Nielsen have summarised available information on these elements 
and their importance in humans (25). Nickel is not generally regarded as an essential 
nutrient for some animals and humans, owing to the lack of a clearly defined specific 
biochemical function. However, it is an essential component of seven different 
enzymes involved in hydrolysis and redox reactions in plants and bacteria (25).  Nickel 
may have a function that is associated with vitamin B12, because lack of this vitamin 
inhibits the response to nickel supplementation when dietary nickel is low, and nickel 
can alleviate vitamin B12 deficiency in higher animals (25).  
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Fluoride has been reported as essential for bone and dental strength and 
supplementation has been associated with a decreased incidence of caries in 
permanent teeth (115). However, it is harmful in too high a concentration and may 
cause tooth decay, bone damage and disorders of the kidneys and muscles (116).  
 Potassium is involved in cellular membrane transport and energy metabolism in 
humans. Potassium dysregulation causes abnormalities in membrane function, and 
results in deficiency (hypokalaemia) and toxicity (hyperkalaemia) (25).  
Lithium is an essential trace element that is present in plant-derived foods, and 
drinking water (117). Lithium is essential to living organism depending on exposure 
and concentration in living cells (118). The biological roles of lithium have been 
summarised in a recent review and include involvement with circadian rhythm, 
inhibition of cyclic guadinine mono-phostphatase that allows a reduction in energy 
production, involvement in the structural composition of lipid and proteins, as well as 
inhibition of specific enzymatic activity (118). A recent study has revealed a novel 
mechanism that lithium offers neuroprotection from ischemia-induced damage by DNA 
nonhomologous end-joining repair (119). Lithium is recognised to be an effective 
treatment for bipolar disorder but has a narrow therapeutic window and can cause 
toxicity at high concentrations (120). Lithium toxicity can cause adverse effects on the 
kidneys and thyroid glands (121). 
Silicon has been considered essential in humans as it plays an important role in 
connective tissue in bone and cartilage. Silicon forms the support for organic matrix 
which is affected by silicon deficiency as it is a major ion of osteogenic cells (122). 
Silicon is needed for metabolism of cells such as osteonectin, which affects cartilage 
composition and calcification (123). 
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Boron is a bioactive element and has been considered an essential element in 
humans. A borate transporter appeared to be essential for cellular boron uptake and 
cell growth in mammalian cells (25). Boron is thought to be part of metabolism of bone 
and glucose metabolism. Little is known about the speciation of boron in food. Boron 
concentrations in term human milk has been reported as stable between the first and 
fourth months postpartum with mean and SD concentrations of 42 ± 6.5 µg/L and 35 
± 6.5 µg/L, respectively (124). It has been suggested that stable milk boron 
concentrations over time imply homeostatic regulation of boron in human body (125). 
Vanadium has been reported to have bioactive properties that selectively inhibit 
protein tyrosine phosphatases at sub-micromolar concentrations in insulin-mimetic 
action (25). Vanadium reacts with hydrogen peroxide to form a pervanadate that is 
required for oxidation of halide ions and phosphorylation of receptor proteins (123). 
Based on animal findings, the dietary requirement for boron, silicon, vanadium and 
nickel is likely to be small, possibly in micrograms per day (123). Studies in humans 
are limited. 
2.1.3. Human Trace Element Requirements 
The report by the World Health Organisation (WHO) Expert Committee from 1996, 
regarding trace element dietary requirement in humans (46), has been updated by 
Chellan & Sadler (23) addressing trace elements in life and medicines. The WHO 
report has clearly defined two types of human requirement for trace elements which 
are 1) basal requirement, and 2) normative requirement as follows: 
“Basal requirement is the intake needed to prevent pathologically relevant and 
clinically detectable signs of impaired function attributable to inadequacy of the 
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nutrient. Whereas normative requirement refers to the level of intake that serves to 
maintain a level of tissue storage or other reserve that is desirable” (46).  
“Normative requirement maintains desirable tissue stores and thus provides protection 
against trace element deficiencies and illness. However, this theory is sometimes 
incorrect for certain elements such as zinc, where the body will reduce losses if status 
is threatened, compared to other elements that replenish body reserve if status is 
threatened” (46). 
Generally, recommended intake exceeds the actual requirement for almost all 
individuals (46). However, recommended intake remains unclear in high risk 
populations such as neonates, since specific needs in complex health conditions such 
as in gastrointestinal disorders, respiratory disorders (for example chronic lung 
disease) and the effects of surgery are poorly understood (126). Nonetheless, the 
concept of daily intake allows assessment of specific needs in this population. Daily 
intake is defined as ‘an individual’s average intake persisting over moderate periods 
of time without necessarily being present in those amounts each day’ (46).  
The dietary requirement for a micronutrient has been further defined by the Food and 
Agriculture Organisation of World Health Organisation (FAO/WHO) as “an intake level 
which meets a specified criteria for adequacy, thereby minimising risk of nutrient deficit 
and excess” (127). However, when there is lack of data available on certain nutrients, 
the clinical signs and symptoms of nutrient deficiency and subclinical conditions 
identified by biochemical and functional measures needs to be determined for 
adequacy. It was proposed that nutritional requirements should include consideration 
of the total health effects of nutrients and not just their roles in preventing deficiency 
(23). The estimated average requirement (EAR) has been defined by FAO/WHO as 
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the “average daily nutrient intake level that meets the needs of 50% of ‘healthy’ 
individuals in a particular age and gender group”. The FAO/WHO report in 2005 has 
further described the concepts, definitions and approaches to define nutritional needs 
and recommendations in humans.  
The recommended nutrient intake (RNI) has been defined as “the daily intake, set at 
the EAR plus 2 standard deviations (SD), which meets the nutrient requirements of 
almost all apparently healthy individuals in an age- and sex-specific population group” 
and this definition is equivalent to that of the recommended dietary intake used by the 
Food and Nutrition Board of the United States National Academy of Science (127). 
The ‘apparently healthy’ term is further defined as “absence of disease based on 
clinical signs and symptoms of micronutrient deficiency or excess, and normal function 
as assessed by laboratory methods and physical evaluation”. The concept of upper 
limits (ULs) of nutrient intake have been derived for some micronutrients and are 
defined as “the maximum intake from food, water and supplements that is unlikely to 
pose risk of adverse health effects from excess in almost all (97.5%) apparently 
healthy individuals in an age- and sex-specific population group”. It is expected that 
the “healthy” individuals consuming within the range of the RNI and the UL may 
minimise their risk of micronutrient deficit and excess (127). 
Currently there are four approaches to estimate nutritional requirements in humans:  
 the clinical approach 
 nutrient balance 
 functional indicators of nutritional sufficiency (biochemical, physiological, 
molecular) 
 optimal nutrient intake. 
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The FAO/WHO described a clinical approach that defines two sets of criteria which 
include; 1) a disease state, or functional or structural abnormality is present if the 
nutrient is absent or deficient in the diet, and 2) that the abnormalities are related to, 
or a consequence of, specific biochemical or functional changes that can be reversed 
by the presence of the essential dietary component (127). However, it was 
emphasised that understanding of the biological effects of specific nutrients, sensitive 
instrumentation to measure the effects, and accurate knowledge of the contents of 
nutrients in food is important. The nutrient balance involves calculations of input and 
output requirement at the point of equilibrium (except in the case of childhood, 
pregnancy and lactation where the additional needs for growth, tissue deposition and 
milk secretion are considered). The functional indicators require assessment of 
various biomarkers to be evaluated for specificity and sensitivity of nutrient related 
organ functions such as neurodevelopment (127).  
A relatively new approach is optimal intake to estimate nutrient requirement that 
suggests a balanced diet or specific nutrients can improve physical and mental 
performance, enhance immunity or add healthy years of human life. However, in the 
absence of population-based randomised controlled trials, the preferred approach is 
to establish the function of interest and the level of desired function to the specific 
nutrient that promotes health or prevents disease. When data is limited to derive 
recommendations using any of these approaches, the default approach of customary 
intake (based on an appropriate knowledge of food composition and food 
consumption) of healthy populations is commonly used. At present, the customary 
intake is used to recommend several mineral intakes for term infants who are 
breastfed, since human milk is assumed to be the optimal food for infants’ 
development (127). The FAO/WHO suggest that precise knowledge of human milk 
 29 
 
composition and volume of intake for postnatal age allows the definition of the range 
of intakes required for infants who are breastfed. These suggestions require further 
research to define the actual nutritional values to achieve the necessary intake. 
Currently, the recommended nutrient intake has only been reported for a few trace 
elements. Based on the assumption that zinc in human milk is highly bioavailable 
(80%), the FAO/WHO recommend that for infants who are exclusively breastfed 
according to age group zinc is required as follows; 0-6 months (assumed body weight 
6 kg), 1100 µg/day, 7-12 months (assumed body weight 9 kg), 0.8 µg/day. The RNI 
for selenium has been estimated as 6 µg/day for infants aged between 0-6 months, 
and 10 µg/day for those aged between 7-12 months. The RNI for iodine has been 
recommended by the Food and Nutrition Board of the United States National Academy 
of Sciences in 1989  as  40 µg/day for infants aged between 0-6 months, and 50 µg/day 
for infants aged between 7-12 months (127). It can be seen that information regarding 
required nutritional amounts for trace elements is lacking for infants. More data about 
human milk concentrations of trace elements is needed to estimate the required intake 
in infants for other essential elements. 
2.2. Neonates 
The WHO defines a neonate as “a child less than 28 days of age” (128). This definition 
enables identification of neonatal characteristics that relate to risk of mortality and 
morbidity between gestational ages (GA). Neonates can be divided into subgroups 
based on gestational age (GA) and/or birth weight (BW) (129, 130). Neonates born 
between 37 to 42 weeks are classified as term neonates, whereas those born at less 
than 37 weeks are categorised as premature or preterm neonates (8). Premature 
neonates can be further divided into subgroups for the purposes of distinguishing 
specific findings to assist with clinical approach and improving survival rate. 
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Micropreterm refers to neonates with a GA less than 30 weeks (130), late preterm 
neonates are those with a GA 34 and 37 weeks (129). Extremely preterm neonate is 
commonly used to indicate neonates with a GA less than 28 weeks, whereas very 
preterm neonates refers to those with a GA less than 32 weeks (9). Post-term 
neonates refers to infants who are born after 42 weeks of gestation (8). However, 
these terms have been used interchangeably in numerous clinical studies depending 
on the research types and study groups. 
Birth weight can also be used to describe premature neonate subgroups. Low birth 
weight (LBW), very low birth weight (VLBW) and extremely low birth weight (ELBW) 
are indicated by birth weight of, less than 2500 g, less than 1500 g and less than 1000 
g, respectively (8, 131). These classifications are clinically important to identify most 
appropriate assessment and management of specific health problems and best 
postnatal management to reduce morbidity and mortality (132). Each subgroup of 
neonates presents with various birth complications and therefore a tailored clinical 
approach is required. Birth weight has also been useful to further indicate differences 
in the subgroups of preterm and term neonates. 
2.2.1. Characteristics of the Neonate 
General neonatal characteristics have been established to assess the risk of morbidity 
and mortality during the first four weeks of life. These include prematurity, gestational 
age, birth weight and congenital anomalies (128). All neonates are completely 
dependent on meticulous provision and adjustment of life support strategies to 
continue optimal growth and development. The early care for all neonates within the 
first few hours of life includes early initiation of breastfeeding but specific and intensive 
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care including nutritional requirements is usually required for preterm and sick 
neonates (133-135). 
Standard neonatal assessment at birth has been developed and validated to deliver 
appropriate management and prevent adverse outcomes in neonates. Vital 
assessments include signs of fever, feeding issues, urine output, peripheral 
circulation, responsiveness, breathing difficulty, apnoea, vomiting, cyanosis, seizures 
and severe jaundice (136, 137). The Apgar score is universally used to evaluate the 
neonatal condition at 1 minute and 5 minutes after birth by assessing appearance 
(colour), pulse (heart rate), grimace (reflex irritability), activity (muscle tone) and 
respiration, in which a score of 8 or more indicates good condition (8). Despite 
criticisms of subjectivity, it is widely accepted to indicate neonatal general health status 
and is an easy, rapid and reliable prognostic indicator for neurologic outcome and 
survival rate in LBW and VLBW neonates (131, 138-140). 
2.2.2. Neonatal Health Complications 
Generally, the prevalence of neonatal health complications is higher in premature 
neonates than term neonates (141). It has been reported that one million babies die 
from preterm birth complications out of 15 million babies born prematurely worldwide 
(141). Despite certain illness seen in term neonates such as meconium aspiration 
syndrome (142), premature neonates have higher mortality owing to multiple diseases 
and complications. This is predominantly due to intrinsic factors such as immaturity of 
organ development that increase vulnerability to cell damage, poor immune and 
antioxidant systems, as well as malnutrition owing to impaired homeostasis (143-145). 
Premature neonates are usually highly dependent on supportive intensive care to 
manage these conditions and promote continuous growth (146).  
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Medical complications such as multi-organ failure are commonly associated with lower 
GA. For instance, apnoea of prematurity occurs in almost all infants born at less than 
29 weeks GA, described as cessation of breathing for 15 to 20 seconds owing to 
immature nervous and muscular system (147, 148). Multiple respiratory problems are 
also common in neonates. These include respiratory distress syndrome and chronic 
lung diseases mainly due to immature lung development and are life-threatening 
(149). Respiratory distress syndrome is the condition where lungs fail to produce 
surfactant and is a leading cause for premature morbidity and mortality in different GA 
groups (150-152). For example, respiratory distress syndrome presents with signs and 
symptoms of respiratory rate of 30 to 60 per minute, or tachypnoea with rates above 
60 rates per min after the first hour of life, or non-breathing episode of apnoea that 
lasts longer than 20 seconds accompanied by physiologic alterations (149). Higher 
risk of respiratory distress syndrome was found in males compared to females in 
premature neonates with a birth weight less than 1200 g and GA less than 30 weeks 
(9). Optimal supportive care for respiratory distress syndrome requires maintenance 
of normal body temperature, proper fluid management, good nutritional and circulatory 
support for adequate tissue perfusion and lung function (151). 
Intrauterine growth restriction (IUGR) is a significant factor that contributes to preterm 
births. Intrauterine growth restricted neonates that are delivered preterm have severe 
health problems with higher morbidity and mortality compared to infants born with an 
appropriate weight with similar GA (153). Compelling evidence has showed that 
surviving infants with IUGR are at increased risk of neurological, respiratory, intestinal, 
immunological and circulatory disorders. Intrauterine growth restriction causes 
hormonal imbalances, metabolic disorders and organ dysfunction leading to abnormal 
development (154). In conclusion, neonates have a high risk of mortality and morbidity 
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in the first four weeks of life. This is profound in premature neonates, but sick term 
neonates also require critical intensive care for healthy growth and development. 
Primary care strategies include comprehensive medical, surgical, nutrition and other 
supportive care. These strategies however require a tailored approach addressing 
different groups of neonates with different health risk. 
2.2.3. The importance of trace elements in neonates 
Neonates generally undergo rapid growth and development and require optimal 
nutrients to support normal growth, development and metabolism. To understand the 
important roles that essential trace elements play and deficiencies attributable to 
essential trace elements the available literature will be evaluated.   
2.2.3.1. Zinc deficiency in neonates 
Historically, human zinc deficiency was not reported until the late 19th century when 
a rare disorder of zinc metabolism, referred as acrodermatitis enteropathica occured, 
which was attributed to the lack of zinc being added to intravenous feeds (46). The 
clinical manifestations of zinc deficiency whether inherited or acquired are not 
thoroughly understood. However, the range of symptoms can include growth 
retardation, low blood pressure, brittle bones, loss of appetite, loss of sense of smell 
and taste, weight loss, pale skin, diarrhoea, hair loss, fatigue and white spots under 
the fingernails (64, 68). Zinc deficiency can also result in decreased brain DNA and 
protein content (64) which may adversely affect neonatal development. The clinical 
manifestations of deficiency can be acute or severe but early detection and diagnosis 
is difficult. 
From the literature it appears that term neonates do not often present with zinc 
deficiency at birth but tend to develop it later on (155). The reasons for this remain 
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unclear but possibly have been attributed to the rapid growth experienced by neonates 
and the decline of body initial stores of zinc at four to eight weeks after birth. Among 
the cases reported in the literature were zinc deficiency in infants born at term and 
exclusively breastfed, serum zinc concentrations ranged from 90 – 600 µg/L (156). All 
these cases presented with clinical signs of zinc deficiency at least eight weeks after 
birth. However, it is unclear whether zinc concentrations in mothers’ milk influenced 
the deficiency in infants as this was not thoroughly investigated or reported. 
There have been a number of case reports that have tentatively been linked to 
diseases of prematurity, such as respiratory distress syndrome, chronic lung disease, 
bronchopulmonary dysplasia and presumed sepsis with low zinc status ranging from 
163 to 610 µg/L (3, 157-163). However links with these disease states and zinc 
deficiency, with any breast milk zinc concentrations or feeding types have not been 
definitively made.  
2.2.3.2. Copper deficiency in neonates 
Copper deficiency can either be inherited such as Menkes disease, or acquired due 
to impaired dietary intake and disturbed copper homeostasis (164, 165). Reported 
copper deficiency manifestations include cardiac diseases, arthritis, loss of hair 
pigmentation, neurologic abnormalities, and symptoms mimicking vitamin B12 
deficiency (166). In adults, serum copper concentrations generally increase with age 
regardless of differences in residence, socioeconomic and occupation (167). In 
neonates, copper deficiency has rarely been reported. Generally, term neonates are 
not copper deficient. Neonatal manifestations of copper deficiency include anaemia, 
neutropaenia, skeletal abnormalities and other abnormalities due to impairment in 
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metabolic functions (168). Copper deficiency also alters immune system, thyroid 
hormone and sensorimotor activity (169).  
There are a number of case reports describing copper deficiency-related bone lesions 
in infants reported after the age of three months. Only one case was reported in an 
infant aged 7-months old born at term with a serum copper concentration of less than 
100 µg/L (170). Seven other cases have been reported in premature infants born 
between 24 to 34 weeks GA. In these preterm infant cases, the range of serum and 
plasma copper concentrations were reported between 100 to 330 µg/L (171-174). 
Normal serum copper concentrations were identified as being between 300 to 1650 
µg/L (171-174). In all cases, copper deficiency was not identified until four weeks after 
birth when clinical manifestations of copper deficiency were identified. 
2.2.3.3. Selenium deficiency in neonates 
Previously, Keshan’s disease and Keschin-Beck’s disease owing to selenium 
deficiency, have been reported in both adults and children, characterised by 
cardiomegaly and other heart problems (74). Selenium deficiency has also been 
associated with human brain disease such as cerebello-cerebral atrophy owing to a 
reduction in antioxidant selenoproteins in which selenium is considered to protect 
neurons and osteocytes from oxidative damages (175). Hence, a low plasma selenium 
concentration may cause impaired neurodevelopment as well as mood disorders and 
cardiovascular problems (176). A review by Finch described clinical signs of selenium 
deficiency which include myocardial disorders, skeletal muscle disorders, erythrocyte 
macrocytosis, fingernail-bed abnormalities, pseudoalbinism, growth retardation and 
alopecia (14). However, these symptoms may also be associated with other diseases, 
especially in the critically ill premature infant presenting with multiple comorbidities. 
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The low specificity of signs and symptoms for selenium deficiency highlights the need 
to identify risk factors associated with selenium deficiency. 
 A retrospective study involving four infants who had undergone intestinal surgery 
reported the onset of selenium deficiency at less than six months of age after primarily 
receiving an elemental diet for 2 to 6 months (177). All patients presented with growth 
retardation and alopecia with pseudo-albinism and had serum selenium 
concentrations of less than 20 µg/L. All symptoms were reversible after 1 to 2 months 
of selenite administration (177). Other studies have found higher mean selenium 
concentrations in term infants compared to premature infants (124.80 ± 13.72 µg/L vs. 
100.30 ± 11.72 µg/L) (178) and (52.0 ± 8.9 µg/L vs. 43.3 ± 7.0 µg/L), respectively 
(179). Similarly, a separate study has also reported that healthy term neonates had 
higher serum selenium than healthy premature neonates, with mean concentrations 
35.11 µg/L and 28.65 µg/L (range: 18.4 - 48 µg/L, and 15 - 44.4 µg/L), respectively 
(180).  
Selenoenzymes activity in cord blood of premature infants was found to be lower than 
those of full term infants, but no significant difference was found in placenta selenium 
concentrations (181). It is known that the optimal activity of selenoenzymes is 
achieved with blood selenium concentrations of above 80 µg/L, whereas the critical 
threshold limit for Keshan disease is less than 20 µg/L. To date, selenium deficiency 
cases are evident at a serum concentrations less than 35 µg/L (177). Despite limited 
data available regarding optimal status in infants, it seems more apparent in preterm 
infants who may be at risk of reduced stores at birth or due to rapid growth and 
development. 
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2.2.3.4. Manganese deficiency in neonates 
Manganese deposition in the neonatal brain may affect neurodevelopment owing to 
manganese uptake regulation that can be affected by other factors such as cholestasis 
(76). However, its loss can also occur in cases of traumatic injury (182) which is also 
common in neonates. Manganese deficiency may result in abnormalities of cellular 
activities. However, it is difficult to detect until symptoms such as dermatitis, slow 
growth of hair and nails appear (77). Lack of reported manganese deficiency has 
suggested manganese addition in parenteral nutrition is unnecessary (82). Regardless 
of intake, humans generally maintain stable tissue manganese concentrations as a 
result of homeostatic mechanisms that tightly regulate its absorption and excretion 
(80). Recommended manganese intake in humans of different age groups varies. 
Generally, adequate intake for infants aged less than six months is 3 µg/day then 
increased to 600 µg/day by age seven to twelve months (77). To date, cases of 
manganese deficiency have not been reported in adults or children. However, 
deficiency is speculated to cause impaired growth, poor bone formation, skeletal 
defects, reduced fertility, birth defects, abnormal glucose tolerance, and altered lipid 
and carbohydrate metabolisms (78). More research is needed to enrich the data and 
knowledge regarding manganese status in vulnerable groups including neonates. 
2.2.3.5. Iodine deficiency in neonates 
The International Child Development Steering Group has identified iodine deficiency 
as a key global risk factor for impaired child development (183). Population iodine 
deficiency occurs when less than 3% of the neonatal population have a thyroid 
stimulating hormone (TSH) concentrations above 5 mIU/L, following the standard 
guidelines published by the WHO. Iodine deficiency causes adults and children to be 
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at an increased risk of iodine-induced hyperthyroidism and impaired mental function. 
Whereas neonates may develop endemic cretinism that includes mental deficiency 
associated with mutism, spastic diplegia, squint, short stature as well as infant 
mortality (87). The foetus is prone to spontaneous abortion, stillbirth, congenital 
anomalies and perinatal mortality due to iodine deficiency (87).  
 Australia has been identified as one of the world’s 54 iodine-deficient countries. 
Recently, many studies have been conducted to provide data on iodine monitoring in 
Australia. The identification of changes in iodine status require regular monitoring in 
high risk populations such as neonates and lactating mothers. Studies have reported 
that pregnant women in all Australian States and Territories remain iodine deficient 
despite mandatory iodine supplementation since October 2009 (2, 184). In Australia, 
neonatal screening of iodine status is routinely conducted. This is usually done by 
measuring TSH concentrations in neonates between days 2 and 4 after birth (185). In 
addition, neonatal urine iodine concentration (UIC) is sometimes used to assess iodine 
status and deficiency concentrations, is defined as less than 100 µg/L (2). 
A large retrospective study in Victoria conducted between year 2001 and 2006 has 
investigated 368,552 neonates and found increasing iodine deficiency over time (185). 
Importantly, they found that metropolitan populations had significantly higher iodine 
deficiency over the study period compared to non-metropolitan populations. Pregnant 
women and lactating mothers have also been identified as vulnerable populations 
owing to increasing demands of iodine during gestation and the lactation period. It is 
well documented that maternal iodine status has significant influence on neonatal 
iodine status. In adults, urine iodine concentration is used to measure iodine status 
and concentrations of less than 90 µg/L is considered as iodine deficient. A 
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prospective study by Clifton et al. provided a perspective on the use of iodine 
supplementation during pregnancy (184). They studied women at the beginning of 
pregnancy through to 6 months postpartum and characterised iodine status of South 
Australian women as mildly deficient in women not taking supplement, with a UIC of 
less than 90 µg/L. In comparison, pregnant women who took supplements had a UIC 
between 150-249 µg/L and were within WHO recommendations for sufficiency. This 
study provided useful information on the benefits of iodine supplements in pregnancy. 
They also found that UIC increased significantly as pregnancy progressed with UIC’s 
at 36 weeks gestation significantly higher than at 12, 18 and 30 weeks gestation. 
However, it should be noted that women with thyroid disease, pre-eclampsia, 
gestational diabetes, infection and/or preterm delivery were excluded from the 
analysis.  
A study investigating a universal salt iodisation program in China reported that iodine 
deficiency still existed in some populations (186). They observed that median urinary 
iodine concentrations in infants and three groups of pregnant women (first, second 
and third trimester) were 233, and 174, 180, 147 μg/L, respectively. Lactating women 
who breastfed less than or more than six months had median urinary iodine 
concentrations of 126 and 145 μg/L, respectively. In addition, they found median iodine 
concentrations in breast milk of lactating women to be 163 μg/L. It is also interesting 
to note that a positive correlation has been reported between urine iodine of infants 
and concentrations in human milk (186). Regular monitoring of iodine status based on 
the outcome of supplementation is vital in high risk groups. 
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2.2.3.6. Iron deficiency in neonates 
Infants are at risk of developing iron deficiency anaemia as they require higher iron 
requirements for early rapid growth and development. Since iron deficiency is well-
established and vulnerable groups have been identified, food fortification with iron has 
been found to be beneficial and cost effective in addressing this issue in infants and 
young children (187). Clinical signs and symptoms of iron deficiency anaemia include 
fatigue and pallor (188). Laboratory indicators for iron deficiency anaemia include 
serum iron concentrations, total iron binding capacity, serum transferrin 
concentrations, and serum transferrin receptor status (188). Untreated iron deficiency 
in infants impairs cognitive function and can result in mental retardation if left untreated 
(188). The physiological manifestations in children include growth retardation, 
impaired immune response and risk of poor neurodevelopment (189). 
A prospective observational study involving 55 anaemic mothers (indicated by 
haemoglobin concentrations less than 110 g/L) and 20 non-anaemic healthy mothers 
has found that maternal anaemia had a significant effect on iron status in the infants, 
but had little influence on breast milk iron content (190). In these groups, early and 
late transitional breast milk on days 2-4 and days 12-18 post-delivery were compared 
and reported as following; 644.4 ± 218.9 µg/L vs. 686.5 ± 171.1 µg/L, 773.0 ± 187.7 
µg/L vs. 737.8 ± 200.6 µg/L, 808.7 ± 165.6 µg/L vs. 785.2 ± 124.1 µg/L, and 850.6 ± 
154.5 µg/L vs. 832.1 ± 134.7 µg/L, respectively (190). A different study involving 50 
anaemic and 30 healthy pregnant women reported significant differences (p < 0.01) 
were found in iron concentrations in cord blood and breast milk of anaemic mothers 
compared to controls (191). They found iron concentrations in cord blood of 1580 ± 
419 µg/L, 1080 ± 393 µg/L and 746 ± 374 µg/L in neonates of control mothers, mild 
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anaemic mother and moderate-severe anaemic mothers, respectively. The breast milk 
iron concentrations of control, mild anaemic and moderate-severe anaemic mothers 
were reported as 1600 ± 80 µg/L, 780 ± 140 µg/L, and 290 ± 120 µg/L, respectively 
(191). Hou et al. reported a study of 100 couples of mother-baby pairs that were 
followed up from the second trimester of the mothers' pregnancy till the babies were 
three to five months old between years 2006 to 2007 and found that anaemia of infants 
of this particular age group correlated with iron shortage during the foetal stage (192). 
They concluded that iron deficiency in the pregnant women during the second 
trimester could decrease the iron storage of the foetus and this could affect the iron 
status of early infancy and cause anaemia (192). 
2.2.3.7. Molybdenum deficiency in neonates 
Only a few cases of molybdenum cofactor deficiency have been reported in the 
literature. This condition is due to genetic mutation of a rare autosomal recessive 
disorder (193). The signs and symptoms of molybdenum cofactor deficiency type A 
have been reported in two siblings delivered by emergency caesarean section (194). 
They presented with seizures, multicystic lesions in the brain, clonic spasm 29 hours 
after birth and severe brain atrophy within one month (194). Another case involved an 
infant diagnosed initially with cerebral palsy that presented with neonatal seizures, 
progressive cerebral atrophy and low serum concentrations of uric acid (195). 
However, molybdenum cofactor deficiency is a rare inborn error of metabolism and 
commonly misdiagnosed as hypoxic ischaemic encephalopathy (196). A prenatal 
sonography and magnetic resonance imaging conducted at 35 weeks revealed diffuse 
brain damage, brain atrophy, and multicysticencephalomalacia. In this particular case 
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a neurological examination at 10 months showed microcephaly, profound mental 
retardation, and spasticity, low uric acid, and high urinary taurine and xanthine (193). 
Another case of a term infant presented with numerous dysmorphic features, seizures 
from the third day of life, hypertonia and serious changes on brain parenchyma (100). 
Diagnosis of molybdenum cofactor deficiency was confirmed by decreased 
concentrations of serum uric acid, increased excretion of thiosulfate and S-
sulfocysteine in urine, taurine and xanthine in urine (100). The patient died at the age 
of 28 days of life. Currently, there is no available cure for this condition (100). Cases 
of molybdenum cofactor deficiency are rare and there is no information correlating 
molybdenum deficiency. However, a recent review proposed that cardiac and 
neurologic symptoms, including tachycardia and coma; high blood concentrations of 
sulfite and urate could be signs of molybdenum deficiency (14). It has been 
recommended that very low birth weight infants require 0.3-5.0 µg/kg/day of 
molybdenum for catch up growth (197). Molybdenum concentrations in preterm and 
term breast milk have not been extensively reported in the literature. 
2.2.3.8. Bromine deficiency in neonates 
Bromine has been recently identified as essential in humans (59). Data regarding 
deficiency in humans is currently unavailable. Research is required in neonates, to 
identify the symptoms and risk factors for bromine deficiency and whether there is an 
association between bromine concentration in human milk and infant status. To date, 
the optimal range of bromine concentration in humans and the required daily intake 
are unknown.  
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2.2.3.9. Chromium deficiency in neonates 
Chromium is an essential trace element that is involved in the metabolism of protein, 
carbohydrate and lipid. Its deficiency has been associated with insulin-resistant 
hyperglycaemia, glucose intolerance, weight loss and high plasma free fatty acid 
concentrations (14) and thus recommended to be included in parenteral nutrition for 
neonates. However, it is unclear whether chromium supplementation has long-term 
health benefits because chromium deficiency is only common in humans presenting 
with conditions of generalised malnutrition and total parenteral nutrition without added 
chromium (91). Currently, the dose of 0.03-2.25 µg/kg/day of chromium in parenteral 
nutrition for very low birth weight infants is recommended but further evidence is 
required to justify this range (14). 
2.2.3.10. Other trace element deficiency in neonates 
The deficiency of other elements such as fluoride, lithium, silicon, nickel, boron and 
vanadium have not been reported in infants. Although these elements exert biological 
roles in humans, deficiency is probably less likely to occur as these elements present 
at extremely low concentrations in the human body. Furthermore, exposure to these 
elements is possibly higher from the environment. For example, fluoride presents in 
drinking water as community water fluoridation is widely practiced to prevent dental 
caries (198). Potassium is widely available in foods and as such, deficiency has been 
reported rarely (199).  
2.3. Human milk nutrition and lactation stages 
Human lactation comprises three different stages; 1) colostrum, 2) transitional, 3) 
mature milk (22). The colostrum is known to contain the highest proteins and 
immunological components and intake within the first three days after birth is 
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considered superior than at the later stage. Transitional milk is produced with the onset 
of increased milk production occurring between days 3-7 until 14 days lactation, 
whereas mature milk is produced from about 14 days postpartum (22). 
Inappropriate nutrition during early life may result in development of growth retardation 
and impairment in cognitive, behavioural and emotional aspects in later life (134, 200). 
It should be noted however, that studies involving larger or older neonates are often 
not applicable to smaller or premature neonates owing to complexities in growth 
demand and adaptation (201). For example, feeding management of the premature 
infant born before 28 weeks is vastly different from the management of late preterm 
infant born at 32 weeks and before 37 weeks (129, 130). 
Breastfeeding is strongly recommended in neonates, and any delays in, or missing 
breastfeeding in premature neonates can lead to rapid health deterioration (134, 201). 
The benefits of breast milk is undeniable to meet the demand for neonatal growth 
nutritionally, immunologically, developmentally, including short and long term health 
outcomes (202). Breastfeeding is known to lower the incidence of respiratory disease, 
infection, allergy, necrotising enterocolitis, sudden infant death syndrome, obesity, 
inflammation (203) and prevent retinopathy of prematurity in very low birth weight 
infants (204). It has been found that breast milk improves gut maturity (203) owing to 
its unique nutritional content and bioavailability (205). Nutritional content of breast milk 
is always considered the ‘gold standard’ for healthy growth and development of the 
infant (206).   
2.4. Other nutritional Strategies in Neonates 
Neonates with different characteristics and clinical conditions require tailored 
nutritional approach. Breast milk is encouraged to be the main nutritional source for 
all term infants. Similarly, expressed breast milk is used for all premature neonates 
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when enteral feeding is tolerated. Depending on the extent of prematurity, mother 
often cannot produce sufficient amounts of milk for the infant. In these cases 
pasteurised donor human milk is the preferred alternative over formula milk. Milk 
banks are becoming increasingly common worldwide and allow women to donate milk 
if they met certain inclusion criteria (202, 207). Pasteurised donor human milk is now 
widely accepted as life saving for many preterm infants and has been associated with 
a reduction in certain disease of prematurity including necrotising enterocolitis (208). 
Premature neonates who are severely ill often cannot tolerate enteral feeding and thus 
parenteral nutrition is indicated until enteral feeding can be initiated.  
2.4.1. Formula Milk and Fortifiers 
If mothers decide not to breastfeed common enteral nutrition includes formula milk 
and fortifiers. Generally, unique nutritional compositions of human milk are considered 
the first best food for neonates and have led to successful production of formula milk 
modelled on human milk. Fortification of human milk had also been found to improve 
growth of premature neonates (209). Formula milk and fortifiers have been found to 
effectively prevent and treat zinc deficiency in infants and address their nutritional 
needs during critical stages of physiological demands for development (210). Although 
fortifiers and formula milk contain trace elements and other vitamins and minerals 
required for normal health and development, bioavailability of breast milk is twice as 
high than that of formula milk (25, 211). 
2.4.2. Pasteurised Donor Human Milk (PDHM) 
Pasteurised donor human milk has recently become popular as an alternative to 
formula milk. Human milk has been increasingly reported to improve outcomes in 
infants compared to those fed formula milk (208). Pasteurised donor human milk 
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involves standard practices established at human milk banks, in which donors are 
screened and milk is collected, pasteurised and frozen (212). The use of donor human 
milk in neonatal units has been found not to reduce the proportion of infants who are 
exclusively breastfed at discharge but only reduced the proportion of infants that 
received infants’ formula during the first four weeks of life (213). Donor milk has also 
been found to enable enteral feeding earlier in preterm infants (213). 
Breast milk is considered the gold standard and as such the use of donor milk is 
encouraged where available, in premature neonates whose mothers are unable to 
provide sufficient milk (214). It has been argued that pasteurised donor milk is a better 
option than formula for the preterm infant (215).  
Some studies have reported that the pasteurisation process can alter some nutritional 
composition of human milk. It was observed that donor milk had lower concentrations 
of immunoactive compounds such as interleukin and interferon (44), and an altered 
retention of bioactive components (216, 217). The Holder Pasteurisation technique, 
commonly employed in milk banks to pasteurise milk, has been found to reduce 
insulin-like growth factors and insulin-like growth factor binding protein (218).  
However, epidermal growth factors were found not to be affected by the pasteurisation 
technique (218). Evidence surrounding the effects on trace elements is lacking. The 
pasteurisation has been found to reduce copper and zinc concentrations in colostrum 
samples but the authors stated that concentrations were within acceptable ranges for 
neonatal needs during the first week postpartum (38). More research is required to 
establish the effect of pasteurisation on micronutrients because evidence is sparse. 
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2.5. Trace Element Nutrition of Human Breast Milk 
In human milk, most trace elements are bound to specific proteins that may explain 
higher bioavailability in human milk than other types of dietary intake (127). For 
example, manganese is bound to lactoferrin, zinc to casein and copper to serum 
albumin (25). It has also been proposed that mammary gland defect can affect 
concentrations of trace elements in breast milk (219). For instance, low concentrations 
of zinc in breast milk compared to maternal blood concentrations may be due to 
genetic disorders of the zinc transporter and its regulation in the mammary gland 
(219). As such, it has been suggested that the mammary gland could exhibit 
independent mechanisms of nutrient transport into breast milk (220). 
Humans at different life stages need different amounts of trace elements owing to 
different bodily requirements (62, 221). For example, differences in immaturity and 
growth velocity may alter trace element requirements in neonates owing to a high rate 
of rapid development. As a result, higher trace element utilisation in absence of 
adequate supply may increase susceptibility to deficiency in neonates. Furthermore, 
age-appropriate reference concentrations for trace elements in neonates in particular 
preterm neonates are not well-established.   
Human milk is recognised as the best nutrition for neonates and it is vital to obtain 
data regarding its nutritional content. The investigation of trace element concentrations 
in human milk may provide information about optimal concentrations for neonates in 
particular the premature neonates for short and long term outcomes. 
2.5.1. Zinc in human milk 
Generally, concentrations of zinc in breast milk have been described as rapidly 
changing owing to internal and external factors during pregnancy and the postnatal 
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period (25). It has been reported that in term breast milk, zinc declines rapidly during 
the first six months of lactation from 4000 µg/L at two weeks to 3000 µg/L at one 
month, 2000 µg/L at two months, 1500 µg/L at three months and 1200 µg/L at six 
months postpartum (25). Zinc distribution in human milk has been characterised as 
follows:  29% in lipid fraction, 14% associated with casein, 28% whey proteins, 29% 
low molecular weight compound (as citrate) (25). Zinc that is bound to human milk 
protein is more easily digestible, and explains why there is higher zinc bioavailability 
in human milk than formula milk (38).  
A study by Mendelson et al. in 1981 found that zinc concentrations in preterm milk of 
14 mothers decreased in the first month of lactation as follows: 5300 ± 145 µg/L (day 
3-5) , 4750 ± 1560 µg/L (day 8-10), 4310 ± 1350 µg/L (day 15-17), and 3920 ± 1100 
µg/L (day 28-30) (222). Similarly, they found that term milk of eight mothers exhibited 
the same pattern with zinc concentrations of: 5350 ± 1450 µg/L (day 3-5), 4100 ± 650 
µg/L (day 8-10), 3370 ± 600 µg/L (day 15-17) and 2600 ± 650 µg/L (day 28-30) (222). 
In both preterm and term milk, zinc in week 1 was significantly higher (p < 0.01) than 
week 4, whereas during week 4, zinc concentration of preterm milk was significantly 
higher (p < 0.05) than those of term milk (222). In contrast a study by Ustundag et al. 
found that zinc of preterm breast milk (20 mothers) were significantly lower (p < 0.01) 
than those of term milk (20 mothers) throughout the first two months postpartum, as 
the following: 2410 ± 281 µg/L vs. 3080 ± 304 µg/L (0-7 days postpartum, colostrum), 
2280 ± 189 µg/L vs. 2720 ± 198 µg/L (7-14 days postpartum, transitional milk), 2390 
± 200 µg/L vs. 2650 ±203 µg/L (21st day, mature milk), and 2010 ± 175 µg/L vs. 2810 
± 180 µg/L (2nd month, mature milk) (223). A study by Kim et al. reported the variation 
of zinc concentration in preterm milk of 67 mothers over an extended period of lactation 
as the following; 7800 ± 500 µg/L (week 1) 9100 ± 800 µg/L (week 2), 7200 ± 900 µg/L 
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(week 4), 8000 ± 800 µg/L (week 6), 7400 ± 900 µg/L (week 8), and 6600 ± 1200 µg/L 
(week 12) (24). A further study reported that the median zinc concentration of breast 
milk at 4-6 months postpartum was 1570 (range: 500-3200) µg/L, with no significant 
difference between the median breast milk zinc concentrations between the fourth 
month and the sixth month (1520 and 1610 µg/L, respectively) (224). However, they 
found a positive correlation between zinc concentrations in infants’ plasma and breast 
milk (r = 0.62, p = 0.001) and between zinc concentrations in plasma of lactating 
mothers and their breast milk (r = 0.56, p = 0.016) (224).  
2.5.2. Copper in human milk 
In human milk, copper concentrations have also been reported to decline with time 
postpartum. In the first six months of lactation, the mean copper concentrations were 
found to be approximately 250 µg/L, and then reduced to 100 to 200 µg/L between 
seven to 12 months (25). Copper distribution in breast milk has been characterised as 
follows: 15% in the fat fraction, 56% bound to albumin, and the remaining bound to 
casein and citrate (25). It has been found that the bioavailability of copper in human 
milk is higher compared to infant formula, despite a high copper content in formula 
feeds (225). Under-nutrition, copper body reserves, lactation stage, adolescent 
motherhood, gestational age, infection, copper dietary intake, supplementation, 
smoking, vegetarian lifestyle, and use of contraceptives have been proposed  not to 
affect the concentration of copper in human milk (29).  
Some studies have compared copper concentrations in preterm and term breast milk 
over lactation period. The mean and SD copper concentrations have been reported in 
preterm and term milk of 830 µg/L vs. 720 µg/L (day 3-5), 780 µg/L vs.  730 µg/L (day 
8-10), 750 µg/L vs.  570 µg/L (day 15-17), and 630 µg/L vs.  580 µg/L (day 28-30) 
(222). A study conducted by Kim et al. looking solely at preterm milk found median 
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concentrations of copper in preterm milk ranged from  506 µg/L to 301 µg/L in the first 
three months postpartum (24).  
2.5.3. Selenium in human milk 
Selenium in breast milk occurs as glutathione peroxidase (4–32% total selenium), 
which is at higher proportion than selenocystamine, selenocystine and 
selenomethionine (226). A review by Hunt and Nielsen reported selenium 
concentrations in term human milk to range between 12 to 30 µg/L (227). Longitudinal 
changes have been reported by Kim et al. in preterm breast milk of: 11.8 ± 0.5 µg/L 
(week 1), 11.4 ± 0.8 µg/L (week 2), 12.7 ± 0.9 µg/L (week 4), 11.4 ± 0.8 µg/L (week 
6), 10.8 ± 0.9 µg/L (week 8) and 10.5 ± 1.3 µg/L (week 12) (24). A review by Dorea 
concluded that median selenium concentration from studies worldwide were: 26 µg/L 
in colostrum (days 0–5), 18 µg/L in transitional milk (days 6–21), 15 µg/L in mature 
milk (months 1–3), and 17 µg/L in late lactation (> 5 months) (226). Unlike zinc and 
copper, to date no studies have investigated whether selenium concentrations in 
preterm and term breast milk are different over postpartum period. 
2.5.4. Manganese in human milk 
Manganese is a trace element that is abundantly available in the diet. Human milk 
generally appears to contain relatively low concentration of manganese over 
postpartum period. A study by Vuori et al. has reported median manganese 
concentration to decrease from 5.9 µg/L (2 weeks) to 4 µg/L (2 months) and remain at 
this concentration during fifth to sixth months postpartum in term milk of 27 healthy 
lactating mothers (228). A study by Casey et al. has reported that the mean and SD 
of manganese concentration found in term milk of 13 healthy lactating women of 3.68 
± 1.32 µg/L (1 month) and 1.98 µg/L (3 months) (229). A study of 120 healthy mothers 
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in four regions in China reported manganese concentrations in term breast milk that 
ranged 0.5 - 2.1 µg/L in the first month postpartum (230). A study by Li et al. reported 
concentrations of manganese in term breast milk that ranged from 9.33 to11.53 µg/L 
(2 months), which then decreased to a mean value of 7.69 µg/L (4-6 months) over 
postpartum period (231). Manganese has been characterised in human milk as 
follows: 67% bound to lactoferrin, 11% to casein, 18% attached with fat globule 
membrane, and the remaining proportion present in low molecular weight form (225), 
and thus bioavailability is higher in human milk than formula milk (232).  To date no 
studies have investigated whether manganese concentrations in preterm and term 
breast milk are different over postpartum period. 
2.5.5. Iodine in human milk 
A comprehensive review by Dorea (233) has reported that breast milk iodine 
concentrations vary substantially owing to maternal iodine intake. Generally the 
concentrations of breast milk iodine were reported to range from 5.4 to 2170 µg/L 
(median 62 µg/L) worldwide. This review did not report whether there are differences 
in iodine concentration in preterm milk compared to term milk. However it has 
summarised that length of lactation, gestation length, and parity did not significantly 
affect breast milk iodine concentrations. Similarly, untreated maternal goitre had no 
impact on breast milk iodine. However, it is clear that iodine in human milk responds 
quickly to dietary iodine intake, either supplemented or consumed in natural foods, 
easily absorbed by the maternal thyroid and mammary glands through the Na+/I - 
symporter system (233). A positive correlation has also been found between iodine in 
infants’ urine and breast milk iodine. It has also been summarised that European 
countries with the lowest breast milk iodine concentrations had low urine iodine in 
infants who were breastfeed (233).  
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A study in Korean mothers have reported very high iodine concentrations in breast 
milk with median (range) of 2529 (355–8484) µg/L in week 1, 1153 (198–3791) µg/L 
in week 3 and 822 (236–1836) µg/L in week 6 that decreased over lactation stage 
(234). They also found that infants who received mothers’ milk containing high iodine 
concentrations were diagnosed with hypothyroidisms reflected by iodine toxicity (234). 
They reported that high iodine concentrations in breast milk were associated with daily 
maternal intake of seaweed soup during early postpartum period. Similar findings have 
been reported in another study that found a significant correlation between maternal 
iodine intake (2744 µg at days 2-5, and 1295 µg at 4 weeks postpartum) with the 
average iodine concentration in breast milk of 2170 µg/L and 892 µg/L, respectively 
(235). Maternal iodine supplements during pregnancy have also been linked to 
congenital hypothyroidism, reported in one case study in the United States in which 
an infant was confirmed to have iodine toxicity and the mothers’ milk found to contain 
high iodine concentrations (3228 μg/L) (235). Iodine supplementation is recommended 
during pregnancy to prevent iodine deficiency. However, it was suggested that the 
association between excess prenatal ingestion and potential adverse effects in the 
newborn infant are often unrecognised (235). 
A review by Azizi & Smyth has proposed geographical region differences of iodine 
status in human breast milk (236). They reported that in areas of iodine sufficiency 
breast milk iodine concentration should be in the range of 100 – 150 μg/L, and some 
countries had breast milk iodine status of less than 100 μg/L (236). The maternal 
intake of 250 µg iodine daily for lactating mothers is recommended by the 
WHO/International Council for the Control of Iodine Deficiency Disorders/United 
Nations International Children's Emergency Fund may be able to meet the iodine 
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sufficiency but further data is needed to support the recommendations (237). To date 
no studies have investigated whether iodine concentration in preterm and term breast 
milk are different over postpartum period. 
2.5.6. Iron in human milk 
A number of studies have investigated iron content in human milk. A study 
investigating iron concentrations in breast milk of 50 mothers without anaemia found 
iron concentrations ranged from 1520 to 1680 µg/L, whereas those with mild and 
moderate-severe anaemia had breast milk iron concentrations of 640 to 920 µg/L, and 
170 to 410µg/L, respectively (191). An extensive review by Dorea summarised that 
maternal factors including under nutrition, iron body reserves, stage of lactation, 
adolescent motherhood, gestation length, infection and environmental variables such 
as dietary intake, supplementation, smoking, vegetarianism, and prolonged use of 
hormonal contraceptives before and during lactation did not consistently affect iron 
concentrations in breast milk (29). This review provided information about ranges of 
iron concentrations found in breast milk in different populations as follows; 430-560 
µg/L in term milk, 780-1050 µg/L in preterm milk in Nigerian women, 900-1100 µg/L in 
preterm milk and 880-1110 µg/L for term milk in Canadian women (1-8 weeks 
postpartum), 520-650 µg/L in preterm milk and 380-610 µg/L in term milk in Italian 
women (first month postpartum) (29). It has been proposed that healthy term infants 
in the first three months do not require iron supplementation owing to sufficient iron 
stores accumulated during gestation (238). However some term infants may deplete 
their endogenous iron stores and become iron deficient as early as four months of age 
(238). Therefore, recent recommendations include that formulas designed for infants 
from 6-12 months of age contain 4000-8000 µg/L of iron (238). Low birth weight infants 
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(2000-2500 g) should receive iron supplements at a dose of 1000-2000 µg/kg/day up 
to 6 months of age, and infants with a birth weight of 1500-2000 g should receive a 
post-hospital discharge dietary iron intake of 2000 µg/kg/day (238). This may come 
from iron supplements or iron-fortified formula and should be continued to at least 6-
12 months of age. Infants with a birth weight of less than 1500 g should receive a total 
iron intake (dietary plus supplements) of 2000-3000 µg/kg during the hospital stay and 
after discharge (238). Hernell et al. has recently concluded that iron concentrations in 
human milk of 200-400 µg/L is sufficient for most healthy term infants in the first six 
months, but there is a need for additional iron intake from complementary food after 
six months of age (239). A study in Nigeria involving 96 mothers who delivered term 
babies and 68 mothers who delivered preterm babies reported that preterm milk 
contained significantly higher (p = 0.02) iron concentrations of mean values 2145 ± 
550 vs. 1803 ± 779 μg/L) in the first two weeks postpartum (240). In both groups, the 
breast milk iron concentration gradually decreased (p < 0.0001) as lactation 
progressed (240). 
2.6. Inductively coupled plasma mass spectrometry (ICP-MS) and its application 
for simultaneous determination of trace elements in biological matrices. 
Inductively-coupled plasma mass spectrometry (ICP-MS) has become one of the most 
sensitive, accurate and reliable analytical techniques for simultaneous measurement 
of trace elements. ICP-MS has been recognised as a useful instrument in measuring 
metal and metalloids compared to classic techniques using gas chromatography and 
liquid chromatography (241). These techniques do not lend themselves to 
simultaneous analysis of elements and as such require multiple samples to test and 
analyse different elements. The ICP-MS application in multi-elemental analysis has 
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previously been used in environmental monitoring of trace elements concentrations in 
water and soil (242) as well as food products (243). Some studies have also reported 
trace element concentrations in human biological samples such as hair, saliva, urine 
(244) and blood (57, 241). The advancement in its application provides the opportunity 
to monitor trace element status in humans, and any factors associated with deficiency 
or toxicity.  
It was proposed that it combines specificity, sensitivity and speed that only require 
samples sizes of 0.4 mL whole blood, plasma, urine or 25 mg of hair (241). It is 
considered as a new effective analytical method using small amounts of sample which 
provides an excellent opportunity to advance clinical application of monitoring of 
toxicity and deficiency of trace elements cost effectively.  
2.6.1. Technical aspects of ICP-MS analytical technique 
Previous studies have reported various instruments used to analyse trace elements in 
biological samples. These include atomic absorption spectrometry (24, 33, 34, 222, 
245) neutron activation analysis (35), inductively coupled plasma atomic emission 
spectrometry (ICP-AES) (36, 37), total reflection X-ray fluorescence (38) and 
inductively coupled plasma mass spectrometry (ICP-MS) (7, 26, 246). Recently, ICP–
MS has been used to quantify the concentration of elements contained in 
pharmaceutical compounds and excipients used in nonclinical and clinical studies and 
in forensic investigations (247). Validation of methods for quantification of elements in 
biological matrices such as whole blood, serum, plasma, cerebral spinal fluid, urine, 
milk, bone and homogenised organs and tissues may be performed following good 
laboratory practice protocols (248), as long as the amount of endogenous element in 
the matrix is determined during method development and properly accounted for 
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during method validation (249). Different biological matrices require different handling. 
Whole blood, serum, plasma and cerebral spinal fluid may be solubilised with 
tetramethylammonium hydroxide (TMAH) and/or along with a surfactant (e.g., Triton 
X-100), and then treated with ethylenediaminetetraacetic acid (EDTA) to chelate the 
target analytes (249). However, tetramethylammonium hydroxide is a strong base and 
can strip metal ions from every surface it contacts, making it difficult to control the 
concentrations in blank solutions. Alternatively, a better approach is to use an 
ammonium hydroxide/EDTA-based solubilisation technique. These types of sample 
preparations are generally easy to aspirate directly into the ICP systems. Urine may 
be diluted in acidified water and may require filtration. Organs, tissues and bone may 
require use of microwave digestion or hot block with acid digestion (249). The 
instrument software capabilities were originally designed to utilise one standard curve 
at the beginning of a sequence; however, some bioanalytical practices prefer 
quantification from two curves, one at the beginning and one at the end of the 
sequence. Quality control (QC) samples prepared in the same matrix as the study 
samples are required to demonstrate the accuracy and precision of the bioanalytical 
method (249). One approach to compensating for the endogenous composition is to 
analyse replicates of the control matrix lot used to prepare the QC samples. When an 
assay uses surrogate matrix calibration standards, in addition to the study matrix QC, 
some laboratories may prefer to prepare additional QC samples in surrogate matrix as 
added confidence in the calibration curve. Certified reference materials or standard 
reference materials are available from vendors such as National Institute of Standards 
and Technology (NIST) or Seronorm. These matrix-based reference materials are 
typically lyophilised biological matrices with characterised amounts of various 
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elements and it should be noted that the certified concentrations of trace elements in 
many clinical reference materials have an unusually large uncertainty (249). 
There are three types of sample preparations using alkaline methods in the 
determination of trace elements in human biological samples. The advantages of using 
EDTA alkaline method as described previously include the formation of stable 
complexes (41). The ICP-MS compensates the matrix effects of samples by using in-
line addition of internal standards. This method is carried out as automatic addition of 
internal standard is usually accomplished by teeing the internal standard solution into 
the sample line using an available position on the existing peristaltic pump. In this 
approach, the pump tubing used for the two solutions (sample and internal standard) 
will determine the degree of dilution of both the solutions. The combined solution flow 
of sample and internal standard should not exceed the uptake rate for which the 
nebuliser is designed. Accurate matrix compensation often requires intimate mixing of 
the internal standard with the sample (249). Accuracy of results is improved with 
matrix-matched standards calibration and the use of standard addition calibration 
(250). 
2.7. Summary 
A number of trace elements are essential for life and for the infant, are critical for 
normal growth and development. Over time, ‘new’ trace elements have been shown 
to be essential for human health. Trace element deficiency is often difficult to diagnose 
owing to often vague symptoms and clinical presentation. Therefore identification of 
prevalence and risk factors for deficiency has not been fully established. It is unclear 
if trace elements in human milk have any association with deficiencies in neonates 
who are exclusively breastfed. Some trace elements, including zinc, copper and 
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selenium have been investigated in more detail than others. However, data regarding 
the optimal concentrations of trace element in human milk is lacking. Data regarding 
any differences between trace element concentrations in preterm milk compared to 
term milk is also sparse. Factors that may influence concentration of trace elements 
in human milk that have not yet been considered in depth include gestation and 
lactation stage. The effects of the pasteurisation process on donated human milk also 
remain unclear. Recently ICP-MS has proven a reliable instrument to simultaneously 
analyse trace elements for biological and environmental studies. As such this 
instrument provides the opportunity to simultaneously analyse a number of trace 
elements in small quantities of milk. This is an important consideration for infants born 
prematurely where milk production by mothers is often minimal initially. 
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CHAPTER 3. THE SIMULTANEOUS ANALYSIS OF EIGHT ESSENTIAL 
TRACE ELEMENTS IN HUMAN MILK BY ICP-MS 
As discussed in Chapter 2 (Literature Review), various analytical methods have been 
available to simultaneously determine essential trace elements in human milk. 
Nevertheless, the previously reported methods have been relatively complex, 
expensive and time-consuming for milk analysis. The first objective of this study was 
to validate a simple method using alkaline dissolution to simultaneously determine 
several essential trace elements in minimal volume (0.2 mL) of human milk. The study 
aimed to report the sensitivity and reproducibility of the methods in quantifying several 
essential elements which are present in human milk. By specifically testing the results 
using the available laboratory instruments and conditions, a reliable and accurate 
method was determined to carry out other objectives for trace elements analysis in 
human milk. 
This chapter incorporates the paper that has been published in Journal of Food 
Analytical Method (accepted on 22nd December 2015; Impact factor 2.167; 01/2016; 
doi: 10.1007/s12161-015-0396-z). The formal citation is:  
Mohd-Taufek N, Cartwright D, Davies M, Hewavitharana AK, Koorts P, Shaw PN, et 
al. The Simultaneous Analysis of Eight Essential Trace Elements in Human Milk by 
ICP-MS. Food Anal Methods 2016:9(7):2068-2075. doi: 10.1007/s12161-015-0396-z.  
The full manuscript follows. The references have been revised to follow the format 
used in the thesis, as well as the numbering for Tables and sections. Additional note 
has been added following the Discussion section.
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Abstract  
Trace elements are commonly present as components of metabolic enzymes, 
hormones and antioxidants in human milk. Previous studies have reported single or 
few elements in relatively large volumes of human milk, using complex, time-
consuming and expensive methods involving microwave-assisted acid digestion, and 
extraction using tetramethylammonium hydroxide at various temperatures. This study 
reported here a validated alkaline dissolution method using 
ethylenediaminetetraacetic acid, ammonia solution, isopropanol and Triton X-100, to 
simultaneously determine trace elements in 0.2 mL samples of human milk by ICP-
MS. The trace elements zinc (Zn), copper (Cu), selenium (Se), manganese (Mn), 
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iodine (I), iron (Fe), molybdenum (Mo), bromine (Br), chromium (Cr), cobalt (Co), lead 
(Pb), nickel (Ni), silver (Ag), cadmium (Cd), arsenic (As), bismuth (Bi), aluminium (Al), 
antimony (Sb), vanadium (V), thallium (Tl), uranium (U) were detected and the method 
was applied quantitatively to 12 samples of human milk. The results for method 
validation showed good sensitivity, accuracy and repeatability for Zn, Cu, Se, Mn, I, 
Fe, Mo and Br. The mean ± SD of these elements in the above human milk samples 
(µg/L) were; 1390.6 ± 211.5, 220.8 ± 32.9, 14.3 ± 5.8, 1.37 ± 0.14, 113.5 ± 17.1, 47.3 
± 99.9, 0.37 ± 0.12 and 812.6 ± 127.7, respectively. This method is precise, reliable, 
straightforward and cost-effective in the determination of trace elements 
simultaneously in small sample volumes of human milk.  Method application permits 
routine monitoring of several elements and the ongoing assessment of trace element 
nutrition in breast milk. It was the first method to highlight the relatively high Br 
concentrations present in human milk. 
Keywords 
Trace elements, human milk, ICP-MS, method validation.
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3.1. Introduction 
Trace elements analyses in human breast milk have been previously reported using 
various methodologies such as atomic absorption spectrometry (24, 33, 34, 222, 245) 
neutron activation analysis (35), inductively coupled plasma atomic emission 
spectrometry (ICP-AES) (36, 37), total reflection X-ray fluorescence (38) and 
inductively coupled plasma mass spectrometry (ICP-MS) (7, 26, 246). ICP-MS has 
become one of the most sensitive, accurate and reliable analytical techniques for 
simultaneous determination of trace elements. It has also been reported to be a more 
sensitive and effective technique than inductively coupled optical atomic emission 
spectrometry (ICP-OES) for the simultaneous determination of trace elements in 
formula milk (39). It has also been used to measure essential and toxic trace elements 
in various matrices including environmental and biological samples. Recently, 
analytical methods using ICP-MS have shed some light on the nutritional importance 
of trace elements in human breast milk.  
Previous studies have reported single or relatively few trace elements (e.g. one to five) 
(31, 251, 252) in human milk using various techniques and sample preparation 
methods in relatively large samples e.g. 0.5 mL to 10 mL (7, 26, 31, 32). Such studies 
have reported various approaches of method optimisation, sample volume, 
temperature and dilution using a range of ICP-MS methodologies. Two different 
methods of sample preparation, prior to ICP-MS analysis, have been principally 
applied in studies of different types of milk including infants’ formulas, dairy products 
(39, 243), and human milk (7, 26, 32): these methods are microwave-assisted acid 
digestion and alkaline dissolution. Microwave acid digestion involves the digestion of 
breast milk samples at a temperature of 250°C for 30 min and also by applying 
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elevated pressures using a microwave digestion system (251, 253). Alkaline 
dissolution methods reported in the literature include sample dilution in 
tetramethylammonium hydroxide (TMAH) with potassium hydroxide solution (252), as 
well as method optimisation using TMAH extraction at different temperatures and time 
e.g. 80°C for 2.5 hr, 90°C for 1 hr and 90°C for 2.5 hr (31). Tetramethylammonium 
hydroxide has been used in the recent years as an alternative to the acid digestion of 
biological matrices in order to reduce the risk of losses by volatilisation; the method is 
also less prone to contamination and eliminates the hazardous use of mineral acids 
(254). One study reported a more simple dilution (1+9) of milk samples with a 2% (v/v) 
nitric acid and 0.01% (v/v) Triton X-100 solution (26). 
A certified reference material for human breast milk is currently not available and 
previous studies have used spiked human milk samples as well as standard reference 
materials for formula milk powder such as NIST 1849 (32), NIST 1549 (31), and BCR-
150 (26) to validate the methods for trace element determination in human milk. 
However, small volumes of human milk have not been used to determine trace 
elements simultaneously using an alkaline dissolution sample preparation method. 
This study aims to adapt and validate such a method using ethylenediaminetetraacetic 
acid (EDTA), ammonia solution, isopropanol and Triton X-100 followed by ICP-MS to 
simultaneously determine trace element in 0.2 mL samples of human milk.  
3.2. Materials and Methods 
Chemicals, standards, stock solutions, blanks and quality controls 
All reagents were of the highest available purity, ideally being manufactured for the 
purposes of ICP-MS analysis. Ultra-high purity (UHP) water (18MΩ resistance) was 
used throughout. The instrumental quality grade reagents for ICP-MS include the 
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concentrated nitric acid, concentrated hydrochloric acid, ethylenediaminetetraacetic 
acid (EDTA), ammonia solution 25% (Merck Suprapur), 2-propanol/isopropanol 
(Merck EMSURE), and Triton X100 (Sigma-Aldrich, Ultrapure). A solution of 1% Triton 
X100 was prepared by mixing 1 g of Triton X100 in 100 mL UHP water. Alkaline 
solution was used to clean 500 mL HDPE bottle using the following protocol. UHP 
water (250 mL) and EDTA (5 g) were added to the bottle, then 50 mL of ammonia 
solution was added and the contents agitated to achieve solution. Isopropanol (50 mL) 
and 5 mL of 1% Triton X-100 aqueous solution was added. The resultant solution was 
made up to 500 mL with UHP water. All surfaces, which came into contact with 
reagents or samples, were cleaned by acid washing. All containers and plastic wares 
were kept closed tightly or covered when not in use to avoid the possibility of 
contamination. All plastic tubes and lids were acid washed in accordance with 
“Forensic and Scientific Services Lab ware Washing Procedure”. Micropipettes used 
in the study had a precision of better than or equal to ±2% pipette volume. 
Alkaline solution was prepared as above. For the standards, a multi-element stock 
standard solution was purchased from the manufacturer (Multi Element Standard), 
containing 10 mg/L of each of the following elements: Ag, Al, As, Ba, Be, Ca, Cd, Co, 
Cr, Cs, Cu, Fe, Ga, K, Li, Mg, Mn, Mo, Na, Ni, Pb, Rb, Se, Sr, Tl, U, V, Zn (e.g. Agilent 
P/N 8500-6940) and was stored at room temperature. Single element standard 
solutions of 1000 mg/L (prepared from Australian Chemical Reagents or another high 
purity standard) were also used in place of a multi-element standard. The single 
element standard includes I, Br, Pt, Zn, Cu, Sc, Rh, Te, Ir and Sb. 
There were 10 sets of standards prepared to different concentrations for each element 
as the following: 
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Multi-elements, Bi and Sb: A 1 mL aliquot of multi-element stock solution containing 
Ag, Al, As, Ba, Be, Ca, Cd, Co, Cr, Cs, Cu, Fe, Ga, K, Li, Mg, Mn, Mo, Na, Ni, Pb, Rb, 
Se, Sr, Tl, U, V, and Zn was diluted with UHP water to prepare intermediate solutions 
of the following concentrations: 1000 µg/L 100 µg/L, 10 µg/L, 1 µg/L. These 
intermediate solutions were added to 1 mL alkaline solution, 0.4 mL pooled breast milk 
and was made up to 10 mL with UHP water to provide final working standards of the 
following concentrations: 0.1 µg/L, 1 µg/L, 10 µg/L and 100 µg/L. 
Zn and Cu: Intermediate solution for Zn and Cu were prepared to a concentration of 
10, 000 µg/L from single stock solution using UHP water. Then 1 mL of intermediate 
solution were added into 1 mL alkaline solution, 0.4 mL pooled breast milk and made 
up to 10 mL with UHP water to provide final working standards with concentration of 
1000 µg/L.  
I and Br: Intermediate solution for I from single stock solution to a concentration of 100 
µg/L and 1000 µg/L, whereas intermediate solution for Br was prepared to a 
concentration of 1000 µg/L and 10, 000 µg/L.  Then 1 mL or 0.5 mL of each 
intermediate solution were added into 1 mL alkaline solution, 0.4 mL pooled breast 
milk and made up to 10 mL with UHP water to provide final working standards of the 
following concentration: 10 µg/L and 100 µg/L for I, and 100 µg/L and 1000 µg/L for 
Br. 
One standard solution with zero concentration of any element was prepared by adding 
0.4 mL breast milk, 1 mL alkaline solution and 8.6 mL UHP water. All standard 
solutions were then analysed together with the breast milk samples. The results of all 
the diluted milk samples were within calibration range, and were then multiplied by the 
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appropriate dilution factor to obtain the final results for all trace elements in milk 
samples. 
Blanks preparation 
A series of 7 blank solutions was prepared by adding 1 mL of alkaline solution to 9 mL 
UHP water. For the clinical wash of the instrument during analysis, 2 mL of breast milk 
were added to 5 mL of alkaline solution and the solution was made to volume (50 mL) 
using UHP water. 
Internal standard 
Matrix effects were corrected using an internal standard solution for on-line/in-line 
addition of internal standards. Automatic addition of internal standard was carried out 
by adding, using a T-piece, the internal standard solution into the sample line using 
the existing peristaltic pump. The pump tubing used for the two solutions (sample and 
internal standard) determined the degree of dilution of both solutions (flow of sample 
and internal standard did not exceed the uptake rate for the specified nebuliser) for 
accurate matrix compensation (249). In particular for Te, the instrument sensitivity is 
lower than for Sc, Rh,and Ir and therefore the concentration in the original solution is 
higher (40 mg/L). In the pump tubing, Te was diluted by a factor of 10 with the sample 
and thus the final concentration introduced into spray chamber was 4000 µg/L. This 
concentration was in accordance with the instrument manufacturer’s 
recommendations (Agilent Technologies Ltd, Melbourne, Australia); to have a 
concentration of internal standard close to the concentration of analyte where the 
signal is just below the intensity which would result in analogue counts being used. 
For Te to I in this method, the ratio of intensities (counts per second) was 4:1. The 
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accuracy of results was improved with matrix-matched standards calibration and the 
use of standard addition calibration (250). 
The internal standard solution comprised 200 mL of UHP water, 5 mL of high purity 
concentrated nitric acid, 5 mL of high purity concentrated hydrochloric acid single 
element stock solutions (Table 3-1), and was made up to volume (1L) with UHP water. 
All containers and equipment used throughout the analysis were checked for trace 
elements contamination by using UHP water. 
Table 3-1. Internal Standard Solution 
Matrix: 0.5% w/v HNO3, 0.5% w/v HCl (aqueous) 
Element Mass Stock 
concentration 
(ppm) 
Aliquot 
of 
stock 
(mL) 
Final 
volume 
(mL) 
Final solution 
concentration 
(ppm) 
Sc 45 1000 5 1000 5 
Rh 103 1000 0.4 1000 0.4 
Te 125 1000 40 1000 40 
Ir 193 1000 0.4 1000 0.4 
 
During the analysis, the sample was nebulised and then carried via argon gas into the 
plasma for ion formation. Ions were directed through a series of focusing lenses, a 
collision/reaction cell and then carried into a quadrupole where the ions were 
separated according to their mass/charge ratio (m/z). Individual isotopes of singly 
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charged ions were detected on an electron multiplier detector and the resultant 
electrical current is amplified to provide an intensity measurement in counts per 
second. Intensities for individual isotopes in the test sample solutions were then 
compared with those derived from calibration standard solutions and converted into 
concentrations via the system software. 
The simultaneous determination of trace elements was carried out using an Agilent 
7700x ICP-MS with Autosampler and Integrated Sample Introduction System 
consisting of the Octopole Reaction Cell that is designed to remove polyatomic 
interferences. 
Helium (He) was used as collision or reaction gas in the reaction cell. The molecules 
of helium collide with the large, unwanted, polyatomic ions formed in the plasma 
enabling them to be separated in the quadrupole mass analyser. The instrument 
applied a third generation collision/reaction cell to remove spectral interferences thus 
preventing bias in the results. The helium mode has been established as the most 
reliable cell method to filter out polyatomic ions for complex and variable samples. 
Instrumental drift and matrix induced signal suppression and enhancements were 
compensated by the use of on-line internal standard addition. 
Quality Control 
The non-fat milk powder NIST 1549 was used as certified reference material in this 
study. Dry powder (0.2 g) was weighed and diluted to 10 mL using UHP water to 
produce a stock solution.  A 0.2 mL aliquot of this solution was added to 0.5 mL alkaline 
solution and 4.3 mL UHP water to make up the quality control samples. In addition, a 
series of 10 pooled breast milk samples were prepared in the same manner as for 
NIST 1549. 
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Study samples 
This study received ethical approval from the Royal Brisbane and Women’s Hospital 
(RBWH) and the University of Queensland ethics committee. A total of 12 samples of 
pasteurised pooled donor human milk were collected from the Human Milk Bank, 
RBWH. All samples were frozen at -80°C until analysis. Sample analysis was carried 
out at Queensland Health Forensic and Scientific Services (QHFSS), Queensland, 
Australia. 
Sample preparation 
All breast milk samples were thawed at room temperature, then heated in a water bath 
at 40°C to produce homogenous solutions before an aliquot of 0.2 mL of each sample 
was taken using a micropipette into a clean test tube containing 0.5 mL of strong 
alkaline solution, prepared as above. The samples were vortex mixed for 5 sec and 
were then made up to a volume of 5 mL with UHP water. All samples were then 
introduced into the ICP-MS. 
ICP-MS analysis 
The instrument used for sample analysis was an Agilent 7700x ICP-MS (Agilent 
Technologies Ltd, Melbourne, Australia). The ICP-MS was established and tuned in 
accordance with manufacturer’s recommendations and QHFSS “Procedure for ICP-
MS Setup and Operation”. The following correction was programmed into the 
instrument to account for varying isotopic abundances only: 
Pb 208 = Pb206 + Pb207 + Pb208 
Table 3-2 shows the operating conditions of ICP-MS instrument used in this study. 
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Table 3-2. ICP-MS instrument operating condition 
Agilent 7700x 
RF Power 1350 W 
RF Matching 1.95 V 
Sample Depth 8 mm 
Carrier gas 0.8 L/min 
Nebulizer Pump 
Speed 
0.1 mL/min 
Dilution Gas 
Plasma Gas 
0.25 L/min 
15.0 L/min 
Spray chamber Temp. 2°C 
Peak Pattern 1 point 
Replicates 3 
Reaction Cell Gas 
Flow 
Reaction Cell Gas 
He (4.5 mL/min), 
Helium was used as 
specific measured 
condition for all measured 
isotopes (Cr 52, Mn 55, Fe 
56, Co 59, Cu 63, Zn 66, 
As 75, Br 79, Cd 111, I 
127, Pb 207, U 238, Al 27, 
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V 51, Ni 60, Se 78, Mo 95, 
Ag 107, Sb 121, Tl 205, Bi 
209) 
Sample Loop Size 65 sec (at pump speed 
0.1) 
 
Data analysis 
The calibration data and raw results from the ICP-MS were analysed off-line, using 
customised Macros written in Visual Basic for Application (VBA) in Microsoft® Excel. 
The calculations for repeatability, accuracy and trace elements concentrations in 12 
human breast milk samples were carried out using Microsoft Excel 2013. 
 72 
 
Method application 
Essential trace elements in human breast milk are vital nutrients in early infants’ 
nutrition. The method reported here has been undertaken to support a clinical study 
to measure concentrations of trace elements in donated human milk samples (n=12) 
collected from the milk bank at RBWH. This study reported the quantitation of eight 
essential elements – zinc, copper, selenium, manganese, iodine, iron, molybdenum 
and bromine using this method. 
3.3. Results 
Calibration parameters are summarised in Table 3-3. Good linearity was obtained (r2 
> 0.99) for all trace elements within the specified concentration ranges. Calibration 
was achieved by addition of increasing amounts of each element into breast milk 
matrix. The limit of detection (LOD) was calculated at three times the standard 
deviation of ten sets of blanks, whereas limit of quantification (LOQ) was calculated as 
nine times the standard deviation of the blanks which were then multiplied by dilution 
factor 25.  Based on the LOQ, the concentrations of eight elements that are essential 
in human nutrition, Zn, Cu, Se, Mn, Fe, I, Mo and Br are reported. Other elements that 
presented in breast milk were lower than the method LOQ obtained. The lowest LOD 
values were found for Tl and U with 0.01 µg/L, whereas the highest LOD was for Br 
with 14.2 µg/L. 
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Table 3-3.Calibration data, limit of detection (LOD), and limit of quantification (LOQ) 
for 21 trace elements covered in alkaline dissolution methods. 
Trace 
element 
Calibration  
range 
[µg/L] 
Slope and 
intercept 
Correlation 
coefficient 
LOD (LOQ) 
[µg/L] 
Zn 0-1000 y=0.0016x+0.1072 0.9999 3.4 (10.1) 
Cu 0-1000 y=0.0094x+0.0996 0.9999 0.3 (1.0) 
Se 0-100 y=0.0023x+0.0021 0.9999 1.33 (3.98) 
Mn 0-10 y=0.0052x+0.0004 0.9999 0.18 (0.44) 
I 0-100 y=0.0308x+0.1980 0.9999 0.8 (2.6) 
Fe 0-100 y=0.0073x+0.0192 0.9999 8.1 (24.3) 
Mo 0-10 y=0.0043x+0.00006 0.9999 0.09 (0.28) 
Br 0-1000 y=0.0001x+0.0047 0.9999 14.2 (42.6) 
Co 0-10 y=0.0132x+0.0001 0.9999 0.04 (0.12)  
Cr 0-10 y=0.0083x+0.0023 0.9999 0.72 (2.15) 
Ni 0-10 y=0.003x+0.0008 0.9999 0.44 (1.31) 
Pb 0-10 y=0.0451x+0.0017 0.9999 1.62 (4.86) 
Ag 0-10 y=0.0083x+0.0011 0.9995 1.38 (4.13) 
Cd 0-10 y=0.0021x+0.00002 0.9999 0.08 (0.23) 
As 0-10 y=0.002x+0.00002 0.9999 0.06 (0.18) 
Bi 0-10 y=0.0368x+0.0005 0.9999 0.07 (0.21) 
Sb 0-10 y=0.0067x+0.00003 0.9999 0.24 (0.71) 
Al 0-100 y=0.0004x+0.0004 0.9999 1.98 (5.93) 
V 0-10 y=0.0054x+0.001 0.9999   0.77 (2.31) 
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Tl 0-10 y=0.0338x+0.0001 0.9999  0.01 (0.03) 
U 0-10 y=0.0489x+0.0004 0.9999  0.01 (0.03) 
 
The method reported here is precise with intra-day and inter-day repeatability values 
of < 7% and < 6% respectively, in pooled human breast milk samples, as seen in Table 
3-4. The intra-day and inter-day repeatabilities for certified reference material NIST 
1549 for eight elements were <12% and < 8%, respectively, and presented in Table 
3-5. The precision across all eight elements was good but the method was less precise 
with elements of lower concentration in human milk, as observed for Mo, Mn and Se, 
which exhibited relatively higher variability. 
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Table 3-4.Repeatability (expressed as percentage standard deviation, %RSD) for 
eight trace elements in pooled breast milk samples intra-day and inter-day. 
Trace element Intra-day (n=7)   
(%) 
Inter-day (n=5)  
(%) 
Zn 3.3  0.6 
Cu 3.2  2.3 
Se 4.6  2.6 
Mn 6.8  1.7 
I 3.7  1.4 
Fe 2.2  3.4 
Mo 6.9  5.5 
Br 4.1  1.5 
 
The accuracy was calculated by comparing the results obtained for each element from 
18 samples of NIST 1549 analysed on five different days to the certified value available 
from the manufacturer. The results obtained in µg/L were multiplied by dilution factor 
25, then converted into mg/kg by multiplying with the dilution factor for the NIST 1549 
milk solution, then divided by 1000. The accuracy values for the analysed certified 
reference material NIST 1549 for the eight elements reported in this study, zinc, 
copper, selenium, manganese, iodine, iron, molybdenum and bromine, were 
calculated and were observed to be within 80-120% (Tables 3-5 and 3-6). The 
concentrations of trace elements in the NIST 1549 is higher than human milk samples. 
It is known that trace elements are generally lower in human milk than formula milk 
(25). 
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Table 3-5. Repeatability (expressed as relative standard deviation, RSD) for certified 
reference material NIST 1549 non-fat formula milk and accuracies for eight elements. 
Trace 
element 
Intra-day (n=7) 
(%) 
Inter-day (n=5) 
(%) 
Accuracy 
(n=18) (%) 
Zn 2.8 3.6 97.1 
Cu 2.8 2.4 110.3 
Se 11.7 6.3 112.4 
Mn 3.8 6.4 88.25 
I 2.6 4.7 87.5 
Fe 4.1 3.9 99.2 
Mo 3.5 7.8 94.9 
Br 4.8 3.5 95.7 
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Table 3-6. Observed value and certified values for NIST 1549, mean ± SD (mg/kg). 
Element NIST 1549 (n= 18) 
Certified value Observed value 
Zn 46.1 ± 2.2 44.8 ± 2.6 
Cu 0.7 ± 0.1 0.7 ± 0.02 
Se 0.11 ± 0.01 0.12 ± 0.01 
Mn 0.26 ± 0.06 0.23 ± 0.02 
Fe 1.78 ± 0.1 1.77 ± 0.1 
I 3.38 ± 0.02 2.96 ± 0.13 
Mo 0.34 0.32 ± 0.02 
Br 12.0 11.5 ± 0.4 
 
Table 3-7. The median (range) and mean ± SD (µg/L) of eight essential elements in 
donor breast milk, n=12. 
Element Median (range) Mean ±SD 
Zn 1452 (908-1562) 1390 ± 211 
Cu 230 (142-249) 220 ± 32 
Se 13.0 (9.6-32.4) 14.3 ± 5.8 
Mn 1.37 (1.03-1.56) 1.37 ± 0.14 
Fe 48 (26-69) 47 ± 99 
I 119 (74-127) 113 ± 17 
Mo 0.4 (0.21-0.61) 0.37 ± 0.12 
Br 858 (535-928) 812 ± 127 
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Table 3-7 shows mean ± SD and range values for Zn, Cu, Se, Mn, Fe, I, Mo and Br in 
12 donor human milk samples. Zinc, iodine, iron and copper in breast milk have been 
reported in a number of studies. In the present study, significant inter-individual 
variability between milk samples for each element was observed. It is important, 
however, to note that zinc, copper, iodine, iron and bromine were observed in relatively 
higher quantities than selenium, manganese and molybdenum. However, the 
concentrations of trace elements found in this study were lower than those 
documented in other studies (25). This is potentially due to factors such as variation 
in lactation stage, socio-demographics and geographical origin. Such information was 
not collected since it was not a purpose of this study. Future studies may utilise this 
analytical method to investigate these factors. 
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3.4. Discussion 
This study reported herein a simple and straightforward method using alkaline 
dissolution to measure 21 trace elements in 0.2 mL samples of human milk. Although 
various methods have been reported previously for trace elements analysis in breast 
milk, many of the methods used relatively large volumes of breast milk and reported a 
single (31) or only a few elements (26, 32). This method was able to detect and 
quantify 21 trace elements in minimal amounts of breast milk and reported, with 
concentrations above the method quantification limit, eight essential elements that are 
vital for human nutrition.  
This is the first study that has reported bromine being present in relatively high 
concentrations in breast milk. Further studies are required to confirm bromine 
concentrations and its essentiality in relation to human nutrition. It has been 
speculated that bromine is masked by iodine and chlorine in chemical analysis (109) 
and, recently, bromine in the form of bromide has been reported to play a vital role in 
membrane integrity, tissue development and cellular structure (59). Few studies have 
reported on bromine essentiality and its role in man is, as yet, unclear and therefore 
more research is required.  
Zinc, iodine, iron and copper are essential elements that support growth and 
development in infants and are present at significant concentrations in human breast 
milk (29, 30, 62, 233). Selenium concentrations have also been reported in a number 
of studies (226, 255) and these values are confirmed here. However, manganese and 
molybdenum concentrations in human milk have not been extensively documented. 
Despite the fact that the roles of these elements are well established, monitoring of 
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concentrations in breast milk is lacking. Future studies may investigate whether the 
concentrations are within normal range to ensure trace element sufficiency. 
 In many circumstances, mothers of preterm infants are only able to produce very small 
quantities of breast milk, particularly during the first week after birth. This study allows 
the use of small amounts of breast milk to be analysed; this is invaluable for research 
involving the nutritional value of preterm milk. This method is the first to simultaneously 
quantify eight essential trace elements using small quantities of breast milk. This 
method is cost-effective, preserve samples and is time-efficient in reporting Zn, Cu, 
Se, Mn, I, Fe, Mo and Br simultaneously in 0.2 ml breast milk samples. This method 
was not able to report two essential elements Co and Cr due to undetectable 
concentrations in the study samples. However, the advantages of using this method 
include the stable oxidation state of analyte, speciation of several elements and 
compounds and simple preparation method as EDTA promotes metal solubilisation 
and ensures stable and efficient formation of complexes in alkaline media (41). 
The analysis of a large number of trace elements, which exhibited high variability in 
their concentrations in breast milk, is technically challenging. Using a simple alkaline 
dissolution method, simultaneous quantification of eight essential trace elements by 
ICP-MS in small volumes of breast milk was reported. This method is precise, reliable 
and sensitive in the reporting of Zn, Cu, Se, Mn, I, Fe, Mo and Br in breast milk. Good 
accuracy was achieved for these elements, and this method is applicable for future 
clinical studies particularly those examining trace element nutrition in human milk at 
population level. 
Additional note: The pH value of the alkaline solution was determined as pH 10 in 
the diluted samples using the above method. The contamination of trace elements 
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were checked in all containers used and in contact with the samples and there was no 
trace elements contamination found. 
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CHAPTER 4. THE EFFECT OF PASTEURISATION ON TRACE 
ELEMENTS IN DONOR BREAST MILK 
Following the successfully validated method as reported in Chapter 3, clinical studies 
were able to be undertaken to provide more data regarding trace elements 
concentration in human breast milk. The first clinical investigation aimed to provide 
information about the effect of pasteurisation on trace elements concentrations in 
donor breast milk. The concentrations of eight essential trace elements zinc, copper, 
selenium, manganese, iodine, iron, molybdenum and bromine were able to be 
reported using the current method. The hypothesis was that there was no significant 
difference in trace elements concentrations between pre- and post-pasteurisation. 
Currently donor breast milk is commonly collected and stored at milk banks and is 
widely indicated for feeding preterm infants when mother’s milk is unavailable. For this 
purpose, pasteurisation has been used to preserve milk ensuring its safety and quality 
for consumption. Few studies are available reporting the effect of pasteurisation on 
various nutritional and immunological factors in donor human milk. Information about 
trace elements is also limited. Human milk bank often adopt the popular Holder 
pasteurisation technique and therefore it is important to establish the effect of this 
particular approach. 
This chapter incorporates the paper that has been published in Journal of Perinatology 
(accepted on 21st April 2016; Impact factor; 2.072). The formal citation is:  
Mohd-Taufek N, Cartwright D, Davies M, Hewavitharana AK, Koorts P, McConachy 
H., Shaw PN, Sumner R., Whitfield K. The Effect of Pasteurization on Trace Elements 
in Donor Breast Milk. J Perinatology, 2016:36:897–900. doi:10.1038/jp.2016.88. 
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The full manuscript follows. The references, the numbering for Tables and sections 
and relevant sentences/words have been revised to follow the format used in the 
thesis.
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Abstract 
Objective - Premature infants often receive pasteurised donor human milk (PDHM) 
when mothers are unable to provide their own milk. This study aimed to establish the 
effect of the pasteurisation process on a range of trace elements in donor milk.  
Study Design - Breast milk was collected from 16 mothers donating to the milk bank 
at the Royal Brisbane and Women’s Hospital. Samples were divided into pre- and 
post-pasteurisation aliquots and were Holder pasteurised. Inductively coupled plasma 
mass spectrometry was used to analyse the trace elements zinc (Zn), copper (Cu), 
selenium (Se), manganese (Mn), iodine (I), iron (Fe), molybdenum (Mo) and bromine 
(Br). Differences in trace elements pre- and post-pasteurisation were analysed.  
Result - No significant differences were found between the trace elements tested pre- 
and post-pasteurisation, except for iron (p < 0.05). The median (interquartile range 
[IQR], 25% to 75%) (µg/L) of trace elements for pre- and post- pasteurisation aliquots 
were – zinc: 1639 (888 – 4508), 1743 (878 – 4143), copper: 360 (258 - 571), 367 (253 
– 531), selenium: 12.34 (11.73 – 17.60), 12.62 (11.94 – 16.64), manganese: 1.48 (1.01 
– 1.75), 1.49 (1.11–1.75), iodine:153 (94 – 189), 158 (93 – 183), iron: 211 (171 – 277), 
194 (153 - 253), molybdenum:1.46 (0.37 – 2.99), 1.42 (0.29 – 3.73), bromine: 1066 
(834 - 1443), 989 (902 - 1396). 
Conclusion – Pasteurisation had minimal effect on several trace elements in donor 
breast milk but high levels of inter-donor variability of trace elements were observed. 
The observed decrease in the iron content of pasteurised donor milk is, however, 
unlikely to be clinically relevant. 
Keywords: Donor breast milk; trace elements; pasteurisation; ICP-MS. 
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4.1. Introduction 
Donor breast milk is considered an excellent alternative for early feeding in premature 
infants in cases when mothers are unable to provide breast milk (214). In Australia, 
practice guidelines regarding use of donor milk have been well-established (215). The 
Royal Brisbane and Women’s Hospital (RBWH) Milk Bank was established in 2012 
and follows the National Institute for Health and Care Excellence (NICE) clinical 
guidelines for donor milk banks service operation (42). Donated breast milk was 
Holder pasteurised at 62.5°C for 30 minutes and stored frozen at -20°C for no longer 
than six months after the date of expression (42). Pasteurisation preserves the quality 
and safety of donor milk by killing harmful microorganisms, thus prolonging its shelf 
life (256). 
Previous studies have provided some evidence that the pasteurisation process can 
affect some nutritional components of human milk. Holder pasteurisation can 
significantly reduce concentrations of certain immunological components (44), 
hormones (257), antibacterial properties (43), growth factors (258), and immune-
modulatory proteins (259) in human milk. It has been found that the Holder 
pasteurisation can alter the immunological and antibacterial properties of milk. 
However, evidence is lacking to establish any clinically significant effects on health 
(43). The finding that antimicrobial properties are reduced but not abolished may 
explain the lack of observed difference in the rate of late onset sepsis in infants fed 
fresh milk when compared to infants fed PDHM (43). One study has reported that the 
pasteurisation process may effect trace elements causing a possible decrease in the 
concentrations of iron (p < 0.01), zinc and copper (p < 0.05) in the colostrum of preterm 
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and term milk (38). Another study reported lower than expected iodine concentrations 
in all 10 pasteurised milk samples collected from five donors and speculated the 
possibility that the Holder pasteurisation process caused a decrease in iodine 
concentrations (45). It remains unclear how trace elements in breast milk are affected 
following pasteurisation.  
Essential trace elements play important roles in early human development. It is 
thought that accretion of trace elements mainly occurs during the third trimester of 
pregnancy. Consequently, premature infants could be at risk of trace element 
deficiency because of low body stores and the high demand for rapid growth (260, 
261). 
Zinc is known to regulate rapid neurodevelopment in infants in early postnatal life (62). 
It participates in the structural roles of deoxyribonucleic acid (DNA) transcription 
protein especially in neurogenesis (62). The clinical manifestations of zinc deficiency 
as a result of abnormalities in enzyme function are associated with conditions such as 
acrodermatitis enteropathica (156, 262). There is evidence to suggest 
supplementation of zinc may be needed in a number of conditions. These include 
patients with prolonged or severe diarrhoea, gastrointestinal fistulas, and preterm 
infants with necrotising enterocolitis (NEC) who have had a bowel resection and 
ileostomy (16, 263, 264). 
Copper is a cofactor for redox enzyme activities to allow normal cellular metabolism 
(71). Copper is required as a catalytic cofactor in many enzymes such as 
ceruloplasmin and amine oxidases, whereas both zinc and copper are cofactors in 
superoxide dismutases (SODs); these enzymes function as potent antioxidant 
systems in the body (265). Deficiency in copper has been reported in infants and is 
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associated with Menkes disease (170).  Similarly, manganese is involved in many 
biological processes in the human body, such as clotting, skeletal system 
development, the immune system, cellular energy and connective tissue growth (77). 
These roles are regulated by manganese-dependent enzymes and metalloenzymes 
such as oxidoreductases and SODs (77). Manganese deficiency has not been 
reported in humans but manganese neurotoxicity in neonates has been highlighted as 
a result of manganese deposition in the brain (76).  
Selenium is a component of antioxidant selenoprotein enzymes that protect 
biomolecules from the risk of oxidative damage (72). Selenium deficiency has been 
reported in adults presenting with cardiorespiratory abnormalities (266-268). Selenium 
is a critical component in glutathione peroxidase. Supplementation of selenium in the 
preterm and very low birth weight (VLBW) infant may be important to reduce oxidative 
damage (269). Makhoul et al. suggest that supplementation of selenium should occur 
early in the management of the VLBW infants and at higher doses than currently used 
(261). Selenium supplementation in VLBW preterm infants has been associated with 
a significant reduction in the proportion of infants having one or more episodes of 
sepsis. However, it did not improve survival, nor did it reduce the incidence of chronic 
lung disease; or retinopathy of prematurity (19). 
Iodine is an important component of thyroid hormones, and its deficiency has been 
well established worldwide. Iodine deficiency has resulted in goitre, congenital 
anomalies and infant mortality (87). Iron is an essential element in cellular 
metabolisms, and its vital roles include the transport of oxygen in the blood and DNA 
synthesis (270). Molybdenum is involved in nervous system metabolism but little is 
known about the role of molybdenum in humans (21). Molybdenum is present in sulfite 
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oxidase, an enzyme located in mitochondria that is responsible for amino acid and 
lipid metabolism. Bromine, in the form of bromide, plays a vital part in membrane 
integrity at cellular levels (59). Very few studies report bromine and its role in humans, 
and any deficiency or toxicity is unknown. 
This study aimed to investigate the effect of pasteurisation on the concentrations of 
the following essential trace elements in donor milk: zinc, copper, selenium, 
manganese, iodine, iron, molybdenum and bromine. 
4.2 Material and methods 
This study received ethical approval from the Royal Brisbane and Women’s Hospital 
(RBWH) and the University of Queensland ethics committees. Participants were 
women wishing to donate milk to the RBWH milk bank and who had met the criteria to 
donate. The milk bank nurse asked women during the routine interview whether they 
would be interested in participating in this study. Information sheets were provided to 
all potential participants and any questions addressed. Mothers who were eligible to 
donate breast milk to the milk bank and who gave written consent to participate in the 
study were included.  
Sample collection 
A total of 16 participants over the age of 18 years were recruited to the study. A sample 
size of 16 provided 80% power, with an α = 0·05, to detect a difference of one SD. 
Sample size calculations are problematic in the absence of reliable pre-existing data 
and data on the clinical significance of various trace element concentrations in breast 
milk. It was considered reasonable that if the power to detect a difference was no 
greater than one standard deviation of the study samples that this would reassure that 
pasteurisation was not having a major effect on trace elements. Hence a sample size 
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of 16 was used to give an 80% power to detect such a difference. The volume of the 
breast milk sample taken from each participant was 4 mL. Milk from individual 
participant was pooled prior to pasteurisation. A 2 mL aliquot was used to analyse 
trace element concentrations pre-pasteurisation and the remaining 2 mL was used to 
analyse concentrations post-pasteurisation. Each aliquot was placed in a clean 
Eppendorf tube and given a unique identifier. Samples from this trial, in common with 
almost all trials involving biological fluids were frozen at -80°C prior to analysis.  Any 
effect, likely to be relatively minor in size, will be common to all samples. All samples 
were analysed using a previously validated and reported method (271). The sample 
preparation for the donor breast milk aliquots were carried out using alkaline 
dissolution with ethylenediaminetetraacetic acid, ammonia solution, isopropanol and 
Triton X-100.  Simultaneous determination of trace elements in 0.2 mL samples of 
human milk was then done with inductively coupled plasma mass spectrometry (ICP-
MS). The method used in the study showed good sensitivity, accuracy and 
repeatability for zinc, copper, selenium, manganese, iodine, iron, molybdenum and 
bromine. All donated breast milk samples were analysed in duplicate. The personnel 
who collected all the samples were trained in milk collection with precautions to 
minimise trace element contamination. All samples were treated in the same manner. 
Containers and tubes for milk collection were sterile, and contained no trace element 
contamination. Statistical comparisons were made using either Student’s t-test or 
Wilcoxon signed rank test as appropriate. 
4.3. Results  
The present study reported here the concentrations of eight essential trace elements 
that were present in the donor breast milk. No significant difference was found in the 
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concentrations of zinc, copper, selenium, manganese, iodine, molybdenum and 
bromine between pre- and post-pasteurisation samples (Table 4-1). This study found, 
however, a small, but statistically significant reduction of 6.52% (p < 0.05) in iron 
concentrations with mean ± SD values from 230 ± 93 μg/L to 215 ± 91 μg/L in post-
pasteurisation aliquots. 
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Table 4-1.Comparison of trace elements in pre-and post-pasteurisation aliquots donor 
milk, n=16, in µg/L. 
Trace 
element 
Mean ± SD Median Interquartile range 
(IQR) 25%-75% 
Observed % 
difference 
based on 
mean 
values 
p-
value 
Zinc      
Pre 2443 ± 1794 1639 888 - 4508 0.61 0.831 
Post 2458 ± 1739 1743 878 - 4143   
Copper      
Pre 398 ± 191 360 258 -571 0.25 0.861 
Post 399 ± 193 367 253 - 531   
Selenium      
Pre 14.4 ± 3.8 12.34 11.73 – 17.60 0.69 0.711 
Post 14.3 ± 3.6 12.62 11.94 – 16.64   
Manganese      
Pre 1.54 ± 0.7 1.48 1.01 – 1.75 0.65 0.882 
Post 1.53 ± 0.7 1.49 1.11 – 1.75   
Iodine      
Pre 143.9 ± 49.6 153 94 - 189 0.07 0.442 
Post 143.8 ± 50.6 158 93 – 183    
Iron      
Pre 230 ± 93 211 171 - 277 6.52 0.032 
Post 215 ± 91 194 153 - 253   
Molybdenum      
Pre 1.9 ± 1.8 1.46 0.37 – 2.99 0 0.882 
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Post 1.9 ± 1.8 1.42 0.29 – 3.73   
Bromine      
Pre 1212 ± 572 1066 834 - 1443 2.56 0.441 
Post 1243 ± 644 989 902- 1396   
1 Paired t-test,  
2 Wilcoxon Signed Rank test
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4.4 Discussion 
This study found that pasteurisation does not appear to affect concentrations of most 
trace elements, but causes a reduction of 6.52% in iron concentrations. The latter 
finding may require additional studies to determine its potential mechanism. A study 
conducted by Da Costa et al. using total reflection X-ray fluorescence technique with 
synchrotron radiation found lower concentrations of copper, zinc and iron in post-
pasteurisation colostrum of both preterm and term milk (38). The reported percentages 
reduction for copper and zinc were 4.48%, 2.88% and 9.26%, 3.16% (p < 0.05) 
respectively, whereas the observed differences for iron were 12.75% and 14.62% (p 
< 0.01), respectively (38). In contrast, the current findings suggested no significant 
differences (p > 0.05) in trace element concentrations following the pasteurisation 
process for zinc (0.61%), copper (0.25%), selenium (0.69%), manganese (0.65%), 
iodine (0.07%), molybdenum (0%) and bromine (2.56%). The current study used 
mature milk collected from donors, as opposed to colostrum used by Da Costa et al. 
and this may explain the difference in findings. The current study used a robust, 
reliable, and validated method to analyse trace elements in breast milk (271). 
Inductively coupled plasma mass spectrometry is recognised as the most sensitive 
and effective method available, for the quantitative analysis of trace elements in milk 
samples (39). 
A reduction in iron concentrations of 6.5% is likely to be clinically insignificant as in the 
neonatal population receiving PDHM, iron supplementation is usual. Thus, the 
differences observed in iron concentrations between pre- and post-pasteurisation 
samples, whilst found to be statistically significant are likely to cause minimal clinical 
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impact. Preterm infants are born with lower absolute iron stores than term infants, with 
lower iron stores at earlier gestational age and lower birth weight (272). 
However, iron is not thought to be beneficial in preterm infants in the first few weeks 
of life (especially if they have a blood transfusion) given the concerns regarding its 
possible contribution to oxidative stress (273, 274). Therefore, iron supplementation is 
probably unnecessary soon after birth but individual assessment will be required for a 
tailored intervention. However, the provision of a maintenance dose of iron at a later 
stage is important as this has been associated with lower rate of iron deficiency in very 
low birth weight preterm infants (5). In general, as enteral nutrition is provided to most 
preterm infants, the enteral iron supplementation route is preferred over parenteral. 
The findings from the present study suggest that the loss of iron in pasteurised milk 
samples may arise from possible protein precipitation following the heating process. 
A previous study has suggested the possibility of the re-distribution of elements into 
different protein fractions after pasteurisation (38). Future studies specifically looking 
at the changes in iron, its protein binding and the possible precipitates are required to 
provide additional information. Generally, proteins are less stable than essential 
elements and are affected by a variety of factors. Irreversible protein aggregation in 
milk products has been reported with its onset and rate depending on the solution 
environment, including temperature (275). Human milk proteins consist of mucins, 
caseins, and whey proteins (276). Iron is primarily bound to lactoferrin, and thermal 
aggregation of lactoferrin involves both whey proteins and casein in milk (277, 278). 
An increase in temperature has been reported to increase the amount of protein 
adsorbed onto solid surfaces (279). This study propose that the exposure of breast 
milk to temperatures of 63.5⁰C for 30 minutes during the pasteurisation process 
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changes the physical and chemical properties of iron-binding proteins and this may 
alter their adsorption to solid surfaces, resulting in a lower iron content in the 
pasteurised milk solution.  
The variabilities in the concentration of trace elements were observed between the 
samples from different donors. These differences could be due to differences between 
donor’s lactation stages, dietary intakes, trace element supplementation and/or 
lifestyle factors. There is some evidence suggesting that certain trace elements can 
decrease with the stage of lactation (24, 25). Routine trace element monitoring is not 
currently undertaken in pasteurised donor human milk. However, in light of the results 
from the current study this might be useful, although the cost of analysis may prohibit 
this. It is unknown whether the high variability of trace elements between donor milk 
samples has any clinical implications in infants who receive pasteurised donor human 
milk. Routine monitoring of trace elements in premature infants is not routinely done 
in most hospitals but maybe useful to ensure adequate levels are being achieved.  
Unlike other labile nutritional factors, trace elements appear to be more stable in 
human milk subjected to pasteurisation. It has been established previously that zinc is 
not oxidised or damaged by pasteurisation but that re-distribution in protein-binding is 
believed to occur in breast milk samples (38). However, evidence is lacking in this key 
area and more research is required. The effect of pasteurisation temperature on the 
binding proteins of trace elements is unknown. The current emphasis on standard 
screening methodologies for the quality of donor milk has overlooked the importance 
of quantitatively monitoring nutritional components. In conjunction with safe donor milk 
consumption, sufficient nutritional composition information should be prioritised to 
ensure the best clinical outcomes in infants. Our study has provided preliminary 
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evidence that the pasteurisation process currently used at the RBWH Milk Bank has 
only minimal effects on zinc, copper, selenium, manganese, iodine, iron, molybdenum 
and bromine concentrations in donor breast milk. 
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CHAPTER 5. THE LONGITUDINAL VARIATION OF EIGHT ESSENTIAL 
TRACE ELEMENTS IN PRETERM HUMAN MILK – A CASE 
STUDY 
As discussed in Chapter 2 (Literature Review), previous studies have reported that the 
concentration of certain trace elements such as zinc, copper and selenium can vary 
over time in human milk. However, little data is available that addresses optimal 
concentrations of essential trace elements during the postpartum period and stage of 
lactation. There is also very limited data looking at very preterm human milk. The third 
objective of this thesis was to investigate the variation in trace elements in human 
breast milk over an extended period of lactation using a previously validated and 
reported analytical method to quantify concentrations of zinc, copper, selenium, 
manganese, iodine, iron, molybdenum and bromine. 
This chapter presents a case study of a mother who delivered an extremely preterm 
infant. An investigation was undertaken looking at the variation of concentrations of 
eight essential trace elements over time. 
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5.1. Introduction 
Mother’s own milk is the benchmark standard of nutrition for healthy growth and 
development in infants (280). Breast milk is strongly recommended in premature 
infants as the benefits are well recognised to meet neonatal needs; nutritionally, 
immunologically and developmentally (134, 201, 202). Breast milk is known to lower 
the incidence of respiratory disease, infections, allergy, necrotising enterocolitis, 
sudden infant death syndrome, obesity, inflammation and retinopathy of prematurity 
in very low birth weight infants (203, 204). 
Human milk is classified into three types, based on the stage of lactation: colostrum, 
transitional and mature milk. Colostrum is produced during the first three days of 
lactation; transitional milk is produced typically between days 5-14 postpartum, 
whereas mature milk is produced after 14 days (22). Lactation period is known to affect 
trace element concentration in human milk. Certain elements have been found to 
decrease, or remain relatively constant over postpartum period, but any increase in 
trace element concentration has not been reported. Optimal trace element 
concentration in human milk often remains unclear and clarification regarding an 
acceptable range at different lactation stage requires further work to establish.  
Zinc is known to play a crucial role in several enzymes (e.g. oxidoreductases, 
transferases, hydrolases) metabolism involving catalytic, coactive and structural roles 
other than in DNA binding protein in gene expression (62). Copper participates in 
enzymatic activities such as a cofactor for ferroxidases to support normal biochemical 
and physiologic functioning (70). Selenium exists as a component in subsets of 
enzymes called selenoenzymes such as glutathione peroxidase and its subtypes play 
vital roles in reducing hydrogen peroxides within cytosol, protect against free radical 
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damage, and reduce unstable lipid peroxidases to more stable hydroxyl acids (72, 74).  
Manganese is utilised by many antioxidant enzymes such as superoxide dismutase 
that activates glycosyltransferase which is important for cartilage, bone and connective 
tissue (78). Iodine is important in the regulation of thyroid metabolism and its 
deficiency is well established, which is characterised by hypothyroidism and goitre 
(86). Iron is utilised in haemoglobin synthesis that occurs in blood cells (101). 
Molybdenum is present in mitochondrial enzyme sulfite oxidase and xanthine oxidase 
that supports amino acid and lipid metabolism (97). Bromine has recently been 
reported to be essential in humans in the form of bromide which supports the structural 
membrane in cells (59). Further research is needed to explore the utilisation of 
bromine in human metabolism as bromine in the form of bromide presents abundantly 
in the human body (281). Recent studies have found that bromine presents at 
relatively high concentrations in donor human milk (271, 282) but its nutritional roles 
in early human development has yet to be explored. 
Generally, breast milk produced at each stage of lactation contains important nutrients 
for early infant development. Variations in macronutrients including fat, lactose and 
protein, over lactation stage have been extensively reported (22, 47, 280). In addition, 
gestational age (GA) has also been suggested to affect the nutritional content of 
human milk. For example, significantly higher concentrations of macronutrients have 
been reported in extremely preterm milk (less than 28 weeks GA) than those of 
moderately preterm (32-33 weeks GA) and term milk (47). However, variations in trace 
element concentration over lactation stage have not been extensively studied. 
Trace element deficiency in infants, although rare, has been described in the literature 
for zinc (161, 283), copper (1) and selenium (284). The rare occurrence maybe due to 
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under-diagnosis or under-reporting as clinical signs are often vague. Subsequently the 
exact prevalence of many trace element deficiencies has yet to be established. There 
has been some tentative links made between zinc deficiency in exclusively breastfed 
infants and low levels of zinc in breast milk. Zinc deficiency in exclusively breastfed 
infants aged 4-6 months were associated with low maternal and breast milk levels 
(224). One case report found levels of zinc of 200 µg/L at 2-month and 20 µg/L at 6-
month, that was thought to be the cause of zinc deficiency in the infant (158). Some 
practitioners recommend zinc supplementation in all exclusively breastfed premature 
infants, but this is not routinely done in practice and remains controversial owing to 
lack of evidence (285). Little research has been undertaken investigating trace 
element deficiency of other elements and links with concentration in breast milk. 
The recommended ranges for nutritional requirements should consider the overall 
impact of trace element nutrients and prevention of deficiency (23). Research which 
examines the concentrations of trace elements in preterm and term milk, and 
identification of any suboptimal status, is limited. This study reported herein a case of 
one mother who delivered an extremely low birth weight infant and the subsequent 
concentrations of eight essential trace elements in mature preterm breast milk 
samples. 
5.2. Case presentation 
A 23-year old mother delivered a preterm neonate at 24 weeks of gestation with a birth 
weight of 740 grams. She voluntarily donated a total of 64 breast milk samples, 
collected at different times of the day, between days 16-68 postpartum, at her 
convenience, and were therefore classified as mature milk. Samples prior to day 16 
were absent owing to small amounts of milk being available that were essential for the 
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infant and unavailable for research purposes. A 2 mL aliquot was taken from each 
sample for the simultaneous analysis of eight trace elements.  
Samples were de-identified and given a unique code, frozen at -20°C until analysis, 
then thawed over minimal time, mixed to homogeneity, and transferred to trace 
element free Eppendorf tubes. The samples were then heated at 40°C in a water bath, 
and mixed again before sampling. Duplicate samples were assayed for trace elements 
using a previously validated and reported method (271), by inductively coupled plasma 
mass-spectrometry (ICP-MS), for the simultaneous quantification of zinc, copper, 
selenium, manganese, iodine, iron, molybdenum and bromine.  
Non-parametric data analysis was undertaken using Statistical Package for Social 
Sciences (SPSS) version 23. Medians and ranges were calculated, and Mann-
Whitney U test was used to identify any difference in trace element concentrations of 
mature breast milk between different weeks of lactation. Significance of differences 
was considered as p < 0.05. 
It was observed that the concentrations of zinc, copper, selenium, iodine and iron were 
highest (p < 0.05) in week three postpartum, and declined over time (Table 5-1). 
Whereas manganese and bromine were lower during week three and increased over 
time (p < 0.05). No significant difference was observed for molybdenum 
concentrations.  
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Table 5-1. The difference in median (range) in the concentrations of eight essential 
trace elements in mature preterm milk in week 3 and weeks 5-10 postpartum, in µg/L. 
Element Mature milk p-value# 
 Week 3  (N = 20) Week 5-10 (N = 44)  
 
          Zn 
 
6331 (3744-11,902) 
 
1328 (515-3132) 
 
< 0.0001 
Cu 378 (334-465) 226 (152-283) < 0.0001 
Se 18.03 (15.77-19.77) 12.66 (10.86-15.75) < 0.0001 
Mn 0.89 (0.59-1.42) 1.31 (0.80-2.69) < 0.0001 
I 144 (95-254) 102 (48-170) < 0.0001 
Fe 231 (178-292) 166 (94-236) < 0.0001 
Mo 1.06 (0.88-1.71) 1.17 (0.59-3.90) 0.246 
Br 777 (661-1026) 1014 (868-1387) < 0.0001 
#Mann Whitney u-test, significant effect is shown as p-value < 0.05 
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Figure 5-1.The variation of zinc concentrations between days 16 - 68 postpartum. 
 
 
 
 
 
Figure 5-2. The variation of copper concentrations between days 16 - 68 postpartum. 
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Figure 5-3. The variation of selenium concentrations between days 16 - 68 
postpartum. 
 
 
 
Figure 5-4. The variation of manganese concentrations between days 16 - 68 
postpartum. 
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Figure 5-5. The variation of iodine concentrations between days 16 - 68 postpartum. 
 
 
 
 
 
 
Figure 5-6. The variation of iron concentrations between days 16 - 68 postpartum. 
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Figure 5-7.The variation of molybdenum concentrations between days 16 - 68 
postpartum. 
 
 
 
Figure 5-8. The variation of bromine concentrations between days 16 - 68 postpartum. 
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5.3. Discussion 
This study reported herein the concentration of zinc, copper, selenium, manganese, 
iodine, iron, molybdenum and bromine in mature preterm breast milk, collected 
between days 16 - 68 (weeks 3 -10) postpartum from a mother who delivered a very 
low birth weight infant. As seen in Table 5-1, higher concentrations of zinc, copper, 
selenium, iodine and iron were observed in week 3 compared to those in weeks 5-10 
postpartum. In contrast, there was a steady increase in the concentrations of 
manganese and bromine over the time period. Molybdenum exhibited no such 
changes in concentration within the same time period, except for several days at the 
end of the collection period when concentrations were temporarily elevated 3-fold.  
In this case study the median zinc concentration in week 3 was 6331 µg/L whereas at 
weeks 5-10 was 1328 µg/L. A study by Aquilio et al. found lower concentrations of zinc 
than in this case study at week 3 postpartum of 2200 ± 300 µg/L in preterm milk of 6 
mothers (GA: 35 ± 2 weeks, birth weight: 2070 ± 230 g) (36). However, Kim et al. 
reported higher median zinc values (7400 - 8000 µg/L between weeks 6-8 postpartum) 
than the present case study, in preterm milk of 67 mothers (GA range : 25.1-37.4) (24). 
A study by Mendelson et al. involving 14 preterm mothers (GA: 28.7 ± 2.2 weeks) and 
eight term mothers (GA: 39.0 ±1.2 weeks) reported lower zinc concentrations than this 
case study, describing a mean ± SD at week 3 of 3370 ± 600 µg/L and 4310 ± 1350 
µg/L, respectively (222). In this case study, Figure 5-1 showed that zinc dropped to 
the lowest value of 511 µg/L in week 10 postpartum. This variability in zinc 
concentrations over time indicates that the monitoring of zinc status in mature preterm 
breast milk may provide important information for trace element sufficiency for preterm 
infants. 
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The median copper concentrations in this case study were found to be 378 µg/L (week 
3) and 226 µg/L (weeks 5-8), which were lower than those reported by Kim et al. in 
pre term milk (303 - 356 µg/L in weeks 6-8) (24). A lower copper concentration has 
been reported by Aquilio et al. at week 3 postpartum of mean ± SD values of 246 ± 20 
µg/L in preterm milk and 261± 16 µg/L in term milk (36). However, higher values have 
been reported by Mendelson et al. of concentrations mean ± SD at week 3 of 750 ± 
240 µg/L and 570 ± 80 µg/L and respectively (222). Copper concentrations in weeks 
5 - 10 in the present case study dropped to less than 200 µg/L (Figure 5-2). Optimal 
concentrations of copper in breast milk have yet to be established. However, studies 
reported to date appear to observe copper values above 200 µg/L. Copper deficiency 
has been reported in neonate but to date no link has been made between deficiency 
and breast milk concentration (171-174). 
The median selenium concentrations in this case study were 18.03 µg/L (week 3) and 
12.66 µg/L (weeks 5-10). These values were similar to those reported in other studies; 
17.4 ± 0.3 µg/L (week 3) (36), 11.4 ± 0.8 µg/L (week 6) and 10.8 ± 0.9 µg/L (week 8) 
(24). In term milk, selenium concentrations have been reported to be  17.3 ± 1.1 µg/L 
in week 3 postpartum (36). This case study suggests that selenium concentrations are 
relatively stable over postpartum period in mature milk (Figure 5-3). 
It was observed in this case study that manganese median concentrations increased 
from 0.89 µg/L (week 3) to 1.31 µg/L (weeks 5-10). This finding was found to be lower 
than those reported in a previous study with mean ± SD values of 3.9 ± 0.4 µg/L in 
preterm milk and 4.1 ± 0.1 µg/L in term milk at week 3 postpartum (36). Manganese 
concentrations rose slightly across the study period (Figure 5-4). Few studies have 
reported manganese in preterm milk and manganese deficiency has, to date, not been 
 110 
 
reported.  Further work on the relevance of monitoring manganese concentrations in 
human milk is required. 
The median iodine concentrations in this case study were found to be 144 µg/L in 
week 3 and 102 µg/L in weeks 5-10. Optimal ranges of iodine in human milk of 150 - 
200 µg/L, or greater than 200 µg/L have been recommended (45, 286). In low iodine 
regions, a range of 100 - 150 µg/L has been suggested as being acceptable (236). In 
this case study only three samples contained concentrations of iodine above 200 µg/L 
(Figure 5-5). Concerns remain with low concentrations of iodine over the postpartum 
period, that these maybe insufficient for normal growth and development in infants. 
Despite the use of iodine fortification and supplementation to address iodine 
deficiency, suboptimal status has remained prevalent in vulnerable groups of pregnant 
and lactating women owing to poor knowledge and practices (236, 287-289). Mild 
maternal iodine deficiency has been associated with adverse outcomes such as 
neurocognitive impairments in infants (290). Continuous monitoring of iodine status in 
lactating mothers therefore appears warranted to prevent both deficiency and toxicity. 
It can be seen that iodine concentrations in breast milk vary considerably, but low 
concentrations are concerning and may necessitate routine monitoring of iodine. 
This case study found median values of iron in week 3 (231 µg/L) and weeks 5-10 
(166 µg/L) which were lower than those reported by Mendelson et al. of mean ± SD 
values 930 ± 410 µg/L in preterm milk and 810 ± 200 µg/L in term milk at week 3 
postpartum (222). This study also demonstrated a range of iron concentrations in 
preterm milk (94 – 292 µg/L) across weeks 3-10 postpartum (Figure 5-6) that were 
lower compared to those recommended by Hernell et al., who stated that 
concentrations of 200 - 400 µg/L were acceptable in mature term milk (239). This 
recommended range, however, meets the requirements of healthy term infants during 
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the first six months of life, but not after six months, where there is rapid growth and an 
increase in physiological demands (239). In the present case study, it was highlighted 
that iron concentrations dropped nearly one-third in weeks 5-10 postpartum in preterm 
milk. Whether the range is sufficient for preterm infant feeding is unclear. Factors 
associated with iron concentrations in breast milk have been extensively reported but 
iron requirements in preterm infants remain a controversial and complex issue (272). 
Preterm infants are born with lower absolute iron stores than term infants and the gaps 
are wider within preterm groups of different gestation and birth weight (272). Potential 
benefits in overall health outcomes have been acknowledged following the provision 
of iron supplementation in infants who are exclusively breastfed after the age of four 
months, as the depletion of body stores of iron cannot be compensated even by the 
complete absorption of iron in human milk (291). Iron supplementation has effectively 
reduced the prevalence of iron deficiency in low birth weight/premature infants (5). 
Monitoring breast milk iron status maybe useful to identify infants at risk of receiving 
insufficient iron if exclusively breastfed without supplementation. 
Molybdenum has been rarely reported in human milk. The median concentrations of 
molybdenum in this case study were 1.06 µg/L (week 3) and 1.17 µg/L (weeks 5-10). 
Molybdenum exhibited no significant difference between week 3 and weeks 5-10 
postpartum. The concentration jumped 3-fold for several days at the end of weeks 5-
10 (Figure 5-7). The reasons for this remain unclear but possibly may have arisen 
from dietary intake by the mother, although no other trace elements were affected. 
Aquilio et al. did report significantly lower (p < 0.05) molybdenum concentrations in 
preterm milk than term milk at week 3 postpartum with mean ± SD values of 1.9 ± 0.9 
µg/L vs. 3.6 ± 1.4 µg/L, respectively (36). Despite molybdenum concentrations in 
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human milk being infrequently reported, its recommendation as an essential element 
in human nutrition has been documented (21, 97). Deficiency of molybdenum cofactor 
has been shown to lead to accumulation of toxic metabolites which can cause 
disturbances in neurotransmitters even before delivery (100). A few cases of 
molybdenum cofactor deficiency have been reported owing to genetic mutation and a 
rare autosomal recessive disorder (193). 
The median bromine concentrations in this case study were found to be 777 µg/L in 
week 3 and 1014 µg/L in weeks 5-10. Bromine showed a trend of gradual increase in 
its concentration during the study period (Figure 5-8). Bromine has been recently 
recognised as an essential element in humans (23, 59, 60) but the concentration of 
bromine in human milk has not yet been widely reported. Two studies have reported 
bromine concentrations in donor human milk, with median values of 858 µg/L (271) 
and 989 µg/L (282), respectively. However, a longitudinal increase of any trace 
element concentration with lactation stage has not been documented previously.  
The findings from this case study are interesting as there is limited research done on 
the trace element content of breast milk from mothers who deliver extremely preterm 
infants. Future studies may look at factors affecting fluctuations in concentrations over 
postpartum time. The optimal concentrations are difficult to determine due to variations 
in infant’s milk intake, and thus it has been suggested that nutritional compositions 
and outcome measures are important aspects to be studied (280). Unlike 
macronutrients, micronutrients in human milk are less well documented to date. The 
establishment of reference ranges for specific lactation stages; early milk and mature 
milk, and for specific gestation; preterm and term, would be beneficial to address 
optimal concentrations in different types of milk for infants. It remains unknown 
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whether the nutritional composition of breast milk is unique to an individual infant’s 
requirement (280). The present findings, suggest that the differences in concentration 
profiles of trace elements, such as increased concentrations of bromine and 
manganese in mature preterm milk, may be tailored to the needs of extremely low birth 
weight preterm infant. Stam et al. noted that there were variabilities of macronutrients 
at different stages of lactation (280), trace elements seem to exhibit similar 
variabilities.  
5.4. Conclusion and recommendations 
This case study is one of the first to describe the concentrations of eight essential trace 
elements in milk of a mother delivering an extremely premature infant. The present 
study found that postpartum time is a significant predictor in the variation of trace 
elements in mature preterm human milk. It was found that concentrations of trace 
elements zinc, copper, selenium, iodine and iron declined over the lactation period. 
There is a possibility that manganese and bromine exhibit different patterns, with 
increasing concentrations observed over the lactation period. The potentially 
suboptimal iron and iodine concentrations observed in this case necessitates further 
investigation. The present study poses the question whether monitoring of trace 
element concentrations in human milk would be beneficial for exclusively breastfed 
infants to avoid deficiency and ensure adequate nutritional requirements are met. 
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CHAPTER 6. A PILOT STUDY TO INVESTIGATE VARIATION IN TRACE 
ELEMENT CONCENTRATIONS OVER LACTATION STAGE IN 
PRETERM AND TERM HUMAN MILK. 
In this chapter, a clinical investigation was undertaken to investigate the variation in 
trace element concentrations over lactation stage in preterm and term breast milk. The 
concentration of eight essential trace elements: zinc, copper, selenium, manganese, 
iodine, iron, molybdenum and bromine were reported in the human milk of preterm (24 
to < 37 weeks gestation) and term (≥ 37 weeks gestation) over 12 weeks postpartum. 
The aim of this pilot study was to investigate the change in trace element concentration 
in human milk during this postpartum period. 
Currently, little research has been undertaken examining concentration of trace 
elements in preterm and term milk. This chapter presents three main findings which 
include:  
1) The changes in the concentrations of zinc, copper, selenium, manganese, iodine, 
iron, molybdenum and bromine in preterm and term breast milk over 12 weeks 
lactation. 
2) The descriptive findings of the concentrations of zinc, copper, selenium, 
manganese, iodine, iron, molybdenum and bromine in preterm and term breast milk 
at 1 month, 2 months and 3 months postpartum. 
3) The difference in concentrations of zinc, copper, selenium, manganese, iodine, iron, 
molybdenum and bromine in human milk collected in the morning and evening. 
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6.1. Introduction 
Breastfeeding is highly recommended to achieve optimal infant nutrition and improve 
short and long term health outcomes (134, 201). In premature infants, the benefits of 
receiving human milk include a reduced incidence of respiratory disease, infections, 
allergy, necrotising enterocolitis (NEC) (203), retinopathy of prematurity (204) and an 
improved gut maturity (203) owing to the unique nutritional content and bioavailability 
of human milk (205). Human breast milk contains bioactive molecules such as 
immunoglobulins and micronutrients that provide protection against infection and 
inflammation, and contribute to immune maturation, organ development and healthy 
microbial colonisation (22). It is recognised that the composition of human breast milk 
with regard to both carbohydrate and fat content varies in relation to gestational age 
(22). A meta-analysis of 41 studies involving 26 (843 mothers) preterm and 30 (2299 
mothers) term studies indicated that the protein content was higher in preterm milk 
compared to term milk. Such differences in protein composition were found to become 
less significant over time as the lactation period progressed (292). 
Essential trace elements have been recognised as fundamental for successful 
neonatal nutrition (25). Adequate amounts of essential trace elements are required to 
promote neurological development, enzyme function, metabolism, cell differentiation 
and maturation of organ systems (62). Since human milk is known to have a higher 
bioavailability of nutrients than formula milk and other complementary foods (127), an 
improved knowledge relating to the optimal intake of trace elements in human milk is 
needed. However, studies reporting the concentrations of trace elements in human 
milk, from which to derive optimal requirements of trace elements in infants at different 
stages of gestation, are generally lacking. The current knowledge of the total nutritional 
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requirements of preterm neonates largely stem from studies undertaken in term 
infants. Since preterm breast milk has been recognised to contain different nutrients 
compared to term breast milk e.g. higher protein, nitrogen, fat, sodium, chloride and 
energy content but lower lactose content (293, 294), this raises a question as to 
whether the trace elements and their concentrations also vary in preterm milk when 
compared to those in term milk.  
Certain trace elements including zinc, copper, selenium and manganese have been 
reported to decrease over the lactation period in preterm milk of mothers who delivered 
infants at less than 34 weeks gestation, and with birth weights of less than 1800 g (24), 
whereas several elements (iron, copper, zinc, manganese and selenium) have been 
found to vary greatly in the breast milk of mothers who delivered babies of birth weight 
greater than 2500 g (37). However, research identifying the optimal concentrations of 
trace elements in human milk produced at different gestational ages is lacking. 
Although the variations of certain trace elements occur with lactation stage, an 
evaluation of individual trace element differences in human milk produced at different 
gestational age is important in order to assist in the definition of optimal concentrations 
of trace element intake for preterm and term neonates. The lack of data concerning 
trace element concentration variability in human milk leads to a difficulty in identifying 
potentially suboptimal concentrations of trace elements in specific types of human 
milk. This may link to trace element deficiencies in preterm and term infants who are 
exclusively breastfed.  
A number of case reports have described transient symptomatic zinc deficiency, also 
known as acrodermatitis enteropathica (AE), occurring in both preterm and term 
infants who were exclusively breastfed for up to eight weeks postnatal age (3, 159, 
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161-163, 262, 283, 295, 296). A case report highlighted that the diagnosis of AE was 
challenging in the absence of hypozincaemia (serum zinc < 790 µg/L), but low 
maternal milk zinc concentrations were reported, at 600 µg/L in week 16, and at 500 
µg/L in week 20 postpartum (297). Copper deficiency often develops in individuals with 
a low dietary copper intake, resulting from dietary copper with poor bioavailability or 
by those with increased requirements for copper (1). Copper deficiency may lead to 
anaemia, bone abnormalities, and hypopigmentation of the hair (298). Cases of 
premature infants who developed copper deficiency have been reported with serum 
copper concentrations of: 330 μg/L at 8-months of age, 90 μg/L at 7.5-months of age 
(299), and at 300 μg/L at 6-weeks of age (298). However, any relationship between 
infants’ copper deficiencies and breast milk copper concentrations have not been 
reported.  
Selenium deficiencies, including cardiomegaly and abnormalities associated with 
heart disease, have been linked to low selenium status in humans (4). Selenium 
deficiencies have also been reported in 82 preterm (29.2 ± 3 weeks gestation) low 
birth weight infants (1110 ± 286 g) who received formula feeds (300) but any link 
between selenium content in mothers’ milk and their infants’ selenium status is 
unclear. 
Manganese is essential for certain enzyme activities but no cases of deficiency have 
been reported to date. Manganese has been associated with toxicity, owing to its 
passage across the blood brain barrier but few studies have researched manganese 
in human breast milk (76, 301). Iodine and iron deficiencies have been well-
established (2, 302, 303) and fortification/supplementation in pregnant women is 
common to prevent adverse outcomes in infants. It has been suggested that breast 
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milk should contain 200-400 µg/L of iron and 200 µg/L of iodine to avoid deficiency for 
term infants (45, 239). Recommendations for preterm infants are unclear. 
Molybdenum is essential for humans as it is a component of three enzyme systems: 
sulfite oxidase, aldehyde oxidase/dehydrogenase and xanthine oxidase. To date, no 
cases of molybdenum deficiency have been reported (304).  
Bromine is a newly recognised essential trace element in humans. It has been noted 
that bromine is an important cofactor for modification of tissue development and 
architecture found within the type IV collagen scaffold in the basement membranes to 
provide mechanical support for epithelial cells (59). Further research is needed to 
improve the understanding of the amounts required by infants for adequate nutrition. 
Historically, studies have concentrated on reporting the toxicity of bromine in humans 
which include methylbromide toxicity and bromism, characterised by the symptoms of 
lethargy, neurological disorders in adults as a result of excessive ingestion or through 
exposure to bromide-containing products (110-113). Consequently, it is suggested 
that the essentiality of bromine has been previously overlooked. In recent years 
however, experts have emphasised the importance of this key area and thus further 
studies are warranted to define bromine essentiality through nutritional research (23, 
60). 
This study aimed to investigate the concentration of eight essential trace elements: 
zinc, copper, selenium, manganese, iodine, iron, molybdenum and bromine in 
samples of preterm and term breast milk over three months postpartum. 
6.2. Methods 
This study received ethical approval from the Royal Brisbane & Women’s Hospital 
(RBWH) and the University of Queensland Ethics Committee. Participants were 
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women, aged over 18 years, who were admitted to RBWH to deliver their babies and 
who provided written consent to participate in the study. The participants were divided 
into two groups by gestational age: preterm (24 to < 37 weeks) and term (≥ 37 weeks). 
Women who were expressing breast milk and had lactation liaison support were 
approached to see if they would like to participate in the study, and to donate a 2 mL 
sample three times a day, if possible, on alternate days for a minimum of two weeks. 
Milk samples from mothers who were discharged from hospital but who were willing 
to continue to donate were collected from their home where possible. A medication 
history was taken from all participants, to identify if any mothers were taking trace 
element supplements that may have impacted the study findings. Women who 
delivered at less than 30 weeks gestation were not approached to participate in this 
study during the first week after delivery. The reason for this was that any expressed 
milk obtained during this period (often minimal) would be an essential requirement for 
the preterm infant. If their milk production was deemed sufficient from week two 
onwards, then the lactation liaison nurse considered approaching them to participate 
in the study. Participants were encouraged to express milk five to eight times per day. 
Breast Milk Samples Analysis 
Milk samples (2 mL) were collected in clean, sterile enteral feeding syringes. All 
samples were given a unique code according to sampling date and time. Samples 
were stored frozen at -80°C. Samples were thawed for a minimal time, mixed to 
homogeneity, and the contents transferred into clean Eppendorf tubes. The samples 
were heated at 40°C in a water bath and an aliquot (0.2 mL) subjected to analysis 
using a previously validated method (271). This method used inductively coupled 
plasma mass-spectrometry (ICP-MS) for the simultaneous quantification of zinc, 
copper, selenium, manganese, iodine, iron, molybdenum and bromine. 
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Data Analysis 
Data analysis was undertaken using Graph Pad Prism version 6 to examine trace 
element concentrations across study groups over 12 weeks postpartum. The data 
included in the study were from participants who donated at least two samples a day 
on alternate days for at least two consecutive weeks. The normality of the data was 
tested using the D'Agostino & Pearson omnibus test. The trace element 
concentrations for preterm and term groups were analysed using descriptive statistics, 
and reported depending on the normal or non-normal data distributions, respectively. 
To compare differences in trace element concentrations between samples collected 
in the morning and evening, data of two samples were selected: one sample from the 
morning expression (0600 – 1000 hours) and one sample from the evening expression 
(between 1800 - 2200 hours) on the same day from the participants. Participants 
without these data points did not meet the inclusion criteria and were excluded for the 
purposes of this particular analysis. Paired t-test and Wilcoxon signed rank test were 
used to analyse differences in trace element concentrations between morning and 
evening samples, depending on the normality of the data. The difference was 
considered significant at p value of < 0.05. 
6.3. Results 
A total of 549 samples of expressed breast milk (EBM) were collected over 12 weeks 
postpartum. The samples were divided into two groups depending on the gestational 
age (GA) of the infant: preterm (24 to < 37 weeks GA) and term (≥ 37 weeks GA). In 
each group, 384 and 165 EBM samples were donated by 21 and 9 mothers who 
delivered preterm and term infants, respectively. No participants were taking 
supplements that contained the essential trace elements being investigated in this 
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study. To determine the differences in trace element concentrations in breast milk 
between morning and evening expression, a total of 22 participants were included to 
give an 80% power to detect a difference of one SD. The calculation of sample size 
for this particular analysis was difficult as data on the clinical significance of various 
trace element concentrations in breast milk between morning and evening expression 
was unavailable. To detect a difference of one SD, a sample size of 22 provided 80% 
power, with an α = 0·05. It was considered reasonable that if the power to detect a 
difference was no greater than one standard deviation and reassures that time of the 
day was not having a major effect on trace elements. 
The means and standard deviations (SD) of infants’ gestational ages and birth weights 
for each group are presented in Table 6-1. The descriptive findings are shown in Table 
6-2 that presents the concentrations of zinc, copper, selenium, manganese, iodine, 
iron, molybdenum and bromine in preterm and term breast milk found at one month, 
two months and three months. As shown in Figure 6-1, higher zinc concentrations in 
preterm milk samples were observed compared to those of term breast milk in the first 
four weeks postpartum. Similar concentrations of copper were found in preterm and 
term milk that decreased gradually across the study period, with slightly higher copper 
concentrations in the latter group during weeks 11-12 postpartum (Figure 6-2). The 
median concentrations of selenium seemed to be slightly higher in preterm milk than 
term milk across 12 weeks postpartum (Figure 6-3). Manganese showed similar 
median concentrations in preterm and term milks although slightly higher 
concentrations were observed at the end of study period in term milk (Figure 6-4). The 
overall trend of median iodine concentrations indicates that concentrations were 
relatively stable and ranged between 100-200 µg/L in both groups despite slight shifts 
in the concentrations during weeks 3, 4, 6 and 11 in term milk (Figure 6-5). Although 
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similar concentrations of iron were observed in preterm and term milk during the first 
seven weeks postpartum, a decline in concentration in term milk was noticed from 
week 8 and resulted in quite lower concentrations (Figure 6-6). Molybdenum 
concentrations decreased gradually in both groups before fluctuation occurred during 
weeks 5, 6 and 7 postpartum then concentrations reached a plateau at week 10 
onwards in both groups (Figure 6-7). Bromine concentrations were higher in term milk 
in weeks 2-4 postpartum then remained stable between weeks 7-12 postpartum at 
about 1000 µg/L in both groups (Figure 6-8). Table 6-3 presents the differences in 
trace element concentrations between breast milk collected in the morning and 
evening. Zinc concentrations were found to be significantly higher (p = 0.001) in the 
morning than evening samples. In contrast, iodine concentrations were found to be 
significantly lower (p = 0.039) in breast milk expressed in the morning than evening. 
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Table 6-1.Characteristics of participants, presented as mean ± SD. 
 Preterm (N=21) Term (N=9) 
Gestational age of infants 
(weeks) 
30 ± 3.6 40 ± 1.0 
Birth weight of infants 
(grams) 
1502 ± 637.7 3486 ± 385.2 
Age of mothers (years) 33 ± 5.6 31 ± 4.4 
 
 
 124 
 
Table 6-2. The concentration of trace elements in preterm and term breast milk over 
a period of three months postpartum (µg/L). 
Month 
postpartum 
1  2 3  
Group Preterm 
(N = 271) 
Term  
(N=78) 
Preterm 
(N = 84) 
Term  
(N=46) 
Preterm 
(N = 29) 
Term  
(N=41) 
No. of 
participants 
17 7 7 4 3 3 
Trace Element       
Zinc       
Mean ± SD 3994±1564 2837±1012 1671 ±755 2087±511 985 ±641 1321±413 
Median 3647 2478 1378 2050 785 1206 
IQR (25%-
75%) 
2887-4996 2098-3329 1174-2312 1761-2477 597-1123 968-1651 
Minimum 1313 1419 720 1093 404 684 
Maximum 8983 6303 4362 3387 3538 2183 
Normality (N) Non-N Non-N Non-N N Non-N N 
       
Copper       
Mean ± SD 490± 138 462±120 292± 79 251±51 137 ±51 230±49 
Median 479 435 303 260 122 227 
IQR (25%-
75%) 
375-574 392-516 224-351 225-282 102-144 210-249 
Minimum 234 216 131 111 90 136 
Maximum 916 926 428 381 290 395 
Normality (N) Non-N Non-N Non-N Non-N Non-N Non-N 
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Selenium 
Mean ± SD 17.47±4.80 14.38±2.14 14.16±2.74 11.41±1.33 14.39±4.19 10.02±1.02 
Median 16.83 14.11 13.91 11.62 12.56 9.88 
IQR (25%-
75%) 
13.74-
20.52 
12.86-
15.72 
12.26-
15.79 
10.76-
12.36 
12.01-
14.29 
9.31-10.66 
Minimum 8.20 10.11 10.19 7.81 10.35 8.19 
Maximum 34.91 22.07 25.96 14.19 25.78 12.04 
Normality (N) Non-N Non-N Non-N N Non-N N 
       
Manganese       
Mean ± SD 1.61±0.70 1.66±0.80 0.84±0.68 1.61±0.42 1.28±0.47 1.75±0.62 
Median 1.46 1.36 0.68 1.45 1.2 1.53 
IQR (25%-
75%) 
1.09-1.98 1.17-1.95 0.47-1.08 1.32-1.91 1.01-1.45 1.26-2.15 
Minimum 0.22 0.73 0.05 0.91 0.55 0.88 
Maximum 3.92 4.73 4.33 2.93 2.81 3.15 
Normality (N) Non-N Non-N Non-N Non-N Non-N N 
       
Iodine       
Mean ± SD 242±776 189±76 123±55 145±54 106±47 188±121 
Median 139 170 106 131 96 133 
IQR (25%-
75%) 
95-189 137-245 88-133 110-179 67-156 84-304 
Minimum 40 42 52 55 37 43 
Maximum 9213 383 321 269 213 474 
Normality (N) Non-N N Non-N N N N 
       
Iron       
Mean ± SD 246±75 263±103 174±49 183±92 203±44 151±73 
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Median 239 242 164 152 197 147 
IQR (25%-
75%) 
191--286 188-349 141-196 121-215 177-227 94-194 
Minimum 114 103 103 82 110 32 
Maximum 523 660 351 459 303 346 
Normality (N) Non-N Non-N Non-N Non-N N N 
       
Molybdenum       
Mean ± SD 2.46±2.18 2.12±1.78 2.46±1.70 3.48±2.13 0.55±0.36 1.73±2.00 
Median 1.65 1.87 3.12 4.07 0.49 0.71 
IQR (25%-
75%) 
0.70-3.65 0.52-3.05 0.52-4.05 1.29-5.45 0.38-0.60 0.36-2.68 
Minimum 0.10 0.01 0.09 0.41 0.16 0.08 
Maximum 10.25 8.09 4.86 6.46 2.00 5.85 
Normality (N) Non-N Non-N Non-N Non-N Non-N Non-N 
       
Bromine       
Mean ± SD 1321±496 1796±482 1238±251 1258±509 1050±350 1127±367 
Median 1279 1726 1244 1108 906 952 
IQR (25%-
75%) 
974-1578 1463-2007 1026-1392 987-1316 861-1023 848-1470 
Minimum 516 901 701 840 788 747 
Maximum 1578 3193 1392 3238 1023 1950 
Normality (N) Non-N Non-N N Non-N Non-N Non-N 
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Figure 6-1.Concentration (median and IQR) of zinc in preterm and term breast milk 
over 12 weeks postpartum. 
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Figure 6-2. Concentration (median and IQR) of copper in preterm and term breast milk 
over 12 weeks postpartum. 
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Figure 6-3. Concentration (median and IQR) of selenium in preterm and term breast 
milk over 12 weeks postpartum. 
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Figure 6-4. Concentration (median and IQR) of manganese in preterm and term breast 
milk over 12 weeks postpartum. 
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Figure 6-5. Concentration (median and IQR) of iodine in preterm and term breast milk 
over 12 weeks postpartum. 
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Figure 6-6. Concentration (median and IQR) of iron in preterm and term breast milk 
over 12 weeks postpartum. 
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Figure 6-7. Concentration (median and IQR) of molybdenum in preterm and term 
breast milk over 12 weeks postpartum. 
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Figure 6-8. Concentration (median and IQR) of bromine in preterm and term breast 
milk over 12 weeks postpartum. 
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Table 6-3. Differences in trace element concentration (µg/L) in breast milk collected in 
the morning (AM) and evening (PM), n = 22. 
Trace elements AM PM p-value 
    
Zinc   0.001* 
    
Mean ± SD 3524 ± 2048 3064 ± 1771  
    
Median 3407 2924  
    
IQR (25%-75%) 2086 - 4548 1745 - 3914  
    
Minimum 467 644  
    
Maximum 8555 7594  
    
Copper   0.178* 
    
Mean ± SD 416 ± 184 403 ± 177  
    
Median 405 387  
    
IQR (25%-75%) 293 - 522 289 - 486  
    
Minimum 122 96  
 
Maximum 772 765  
    
Selenium   0.560* 
    
Mean ± SD 14.81 ± 4.66 14.46 ± 4.69  
    
Median 14.02 14.30  
    
IQR (25%-75%) 12.00 - 18.69 10.65 - 16.98  
    
Minimum 6.40 8.22  
    
Maximum 24.14 24.56  
    
Manganese   0.880# 
    
Mean ± SD 1.67 ± 0.99 1.60 ± 0.71  
    
Median 1.47 1.38  
 
 132 
 
IQR (25%-75%) 1.10 - 1.83 1.11 - 1.98  
    
Minimum 0.29 0.58  
 
Maximum 4.73 3.34  
    
Iodine   0.039# 
    
Mean ± SD 146 ± 131 173 ± 97  
    
Median 108 133  
    
IQR (25%-75%) 82 - 151 95 - 252  
    
Minimum 52 68  
    
Maximum 665 417  
    
Iron   0.835* 
    
Mean ± SD 210 ± 86 206 ± 100  
    
Median 195 208  
    
IQR (25%-75%) 147 - 306 124 - 282  
    
Minimum 81 32  
    
Maximum 361 394  
    
    
Molybdenum   0.152* 
    
Mean ± SD 2.89 ± 2.50 2.47 ± 1.99  
    
Median 2.92 1.85  
    
IQR (25%-75%) 0.58 - 4.94 0.70 - 4.00  
    
Minimum 0.2 0.12  
    
Maximum 8.89 6.48  
    
Bromine   0.776* 
    
Mean ± SD 1256 ± 461 1245 ± 454  
    
Median 1203 1192  
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IQR (25%-75%) 924 - 1575 917 - 1398  
    
Minimum 587 616  
    
Maximum 2432 2465  
*Paired t-test  
#Wilcoxon Signed Rank test.  
The differences were significant at p < 0.05.
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6.4. Discussion 
This study included the analysis of expressed breast milk samples from 21 preterm 
mothers and 9 term mothers over a three month period. This study observed higher 
median zinc concentrations in preterm breast milk than term milk, with concentrations 
of 3647 µg/L and 2478 µg/L respectively at one month postpartum.  However, this 
appeared to change from the second month onwards where term milk contained 
higher median zinc concentrations than preterm milk (2 months: 2050 vs. 1378 µg/L 
and 3 months: 1206 vs. 785 µg/L, respectively). Zinc deficiency has been reported in 
a few isolated cases where milk concentration of zinc has fallen below 200 µg/L (158, 
305). It is recognised that preterm infants have lower body reserves of zinc compared 
to term infants and therefore predisposed to zinc deficiency (285). Zinc concentrations 
dropped rapidly in the current study to below 1000 µg/L in preterm milk at three months 
postpartum. Further work is needed to establish if the concentration would fall even 
further and raises the question of monitoring milk concentrations of zinc in infants if 
they are exclusively breastfed. 
There are limited studies reporting zinc concentration over lactation stage. A study of 
67 Korean mothers reported higher median zinc concentrations than the present study 
in preterm milk, ranging from 8000-7400 µg/L at two months and 6600 µg/L at three 
months postpartum (24). It can be seen that these concentrations are much higher 
than in the current study and could be due to dietary differences. A study in Turkey 
that involved mothers who delivered preterm (N=20) and term (N=20) infants found 
similar mean zinc concentrations during the first month postpartum to the current study 
(2280-2410 µg/L and 2650-3080 µg/L, respectively) (223). A study in Guatemala found 
that mean zinc concentration of 1307 µg/L during 4-6 months postpartum (231) and 
appear to follow a similar trend to the current study. A review by Hunt and Nielsen 
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reported that in term breast milk, zinc declines rapidly during the first six months of 
lactation from mean values of 3000 µg/L at one month, 2000 µg/L at two months, 1500 
µg/L at three months and 1200 µg/L at six months postpartum (25). 
During the first, second and third months postpartum, the median copper 
concentrations in preterm milk appeared to decrease more rapidly with concentrations 
of 479 µg/L, 303 µg/L and 122 µg/L when compared to those in term milk, of 435 µg/L, 
260 µg/L and 227 µg/L, respectively. Copper deficiency has been rarely reported in 
infants and is usually associated with gastrointestinal malabsorption (299). Slightly 
higher median copper concentrations in preterm milk have been reported at two 
months, that ranged from 303 to 356 µg/L, and dropped to  301 µg/L at three months 
(24). Much higher concentrations of copper were found by Ustundag et al. at one 
month in preterm milk (870 - 930 µg/L) and term milk (1030-1120 µg/L), and again 
could be due to dietary differences (223). The differences found in copper 
concentrations in preterm and term human milk between studies may be due to 
variabilities in study design and population characteristics including diet. Optimal 
concentrations in breast milk remains to be determined. However, most studies report 
copper concentrations in human milk above 200 µg/L. It is concerning that in the 
current study copper concentrations dropped to a median value of 122 µg/L in preterm 
milk at three months. 
The median selenium concentrations in the present study were highest at one month 
postpartum compared to the later stages which were relatively stable in both groups. 
During the first, second and third months postpartum, the median selenium 
concentrations in preterm and term milk decreased gradually but concentrations were 
slightly higher in preterm milk, with values 16.83 µg/L, 13.91 µg/L and 12.56 µg/L 
compared to term milk of 14.11 µg/L, 11.62 µg/L and 9.88 µg/L, respectively. Kim et 
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al. reported slightly lower median selenium concentrations in  preterm breast milk (11.4 
-12.7 µg/L) at  one month (24). They have also reported selenium concentrations in 
preterm milk that ranged 10.8 -11.4 µg/L (2 months) and 10.5 µg/L (3 months) (24). 
These values were slightly lower than the present study. A review by Dorea 
summarised that median selenium concentrations from studies worldwide ranged 
between 12.2-32.4 µg/L (preterm) and 14.8-33.3 µg/L (term) in the first month 
postpartum which were higher than reported in the present study (226). No studies 
have reported any significant differences in selenium concentrations of preterm and 
term breast milk to date. Optimal concentrations of selenium in breast milk still remain 
to be clarified (261). 
The current study found median manganese concentrations to be lower in preterm 
compared to term milk over the three months postpartum (range: 0.68-1.46 µg/L and 
1.36-2.46 µg/L respectively). These findings were similar to a study of 120 healthy 
mothers in four regions in China that reported manganese concentrations in term 
breast milk in the first month postpartum (0.5 - 2.1 µg/L) (230). In direct contrast 
however, Li et al. reported concentrations of manganese in term breast milk that 
ranged from 9.33 to11.53 µg/L during the first two months postpartum, which then 
decreased to a mean value of 7.69 µg/L during 4-6 months postpartum (231). These 
values were more than five-fold higher than the findings of the present study. The 
different findings between these studies is difficult to explain but maybe due to dietary 
differences between countries and regional areas. 
Optimal amounts of manganese remains unclear for the preterm and term infant as 
manganese deficiency has not been reported in this population. It can be seen that 
few studies have reported manganese concentrations in human breast milk and 
results are conflicting. In the current study there were small fluctuations in 
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concentration but probably these are insignificant. It would appear that these low 
concentrations of manganese are sufficient for preterm and term infants as deficiency 
remains unreported. 
Manganese toxicity has been reported more frequently than deficiency (76). A review 
has emphasised that there is a concern of neonates developing hepatic dysfunction 
and cholestasis due to excessive manganese intake as in neonates when they receive 
intravenous parenteral nutrition, it bypasses the intestinal absorption regulation 
whereas its excretion through intestines is also minimal (77). Manganese nutrition has 
received less attention, but its role in neonatal health and disease may necessitate 
further studies to improve our understanding in this key area. Nevertheless, 
manganese concentrations in human milk appear to be relatively stable when 
compared to other trace elements reported in the present study. 
In term milk, median iodine concentrations decreased gradually over the three month 
study period. Median iodine concentrations were higher in term milk than preterm milk 
with values 170 vs. 139 µg/L (1 month), 131 vs. 106 µg/L (2 months) and 133 vs. 96 
µg/L (3 months), respectively. Iodine dropped to less than 100 µg/L at three months in 
preterm milk (median concentration 96 µg/L). Whether iodine concentrations during 
this postnatal period are sufficient for exclusively breastfed preterm and term infants 
is unclear. No studies have reported any significant differences in iodine 
concentrations between preterm and term human milk to date. Additionally, the 
present study found that at one month postpartum, the range of values of iodine 
concentration in preterm milk was comparatively high, of 40 – 9213 µg/L; the upper 
value being some 65-fold greater than the median values. This clearly suggests 
significant inter-individual variability. However, iodine concentrations were noted to 
return to a more restricted range of average values after the first month postpartum.  
 138 
 
The present findings of elevated iodine concentrations were similar to those observed 
in the study by Chung et al., which reported relatively high iodine concentrations in 
preterm breast milk that ranged 198-8484 µg/L (1 month) and 236-1836 µg/L (2 
months) (234). These authors found that subclinical hypothyroidism was prominent in 
preterm Korean infants who received breast milk containing very high iodine 
concentrations (234). They proposed that the traditional dietary preferences among 
postpartum Korean mothers may have contributed to the changes in breast milk iodine 
concentrations, especially the intake of a brown seaweed soup that was seen to 
decrease gradually during the postpartum period. It has also been suggested that the 
sodium/iodide symporters expressed in the mammary gland may be responsible for 
the excessive iodine in the breast milk of the lactating mothers and thus its direct 
transfer to the infant. Spontaneous sodium/iodide symporter mutations and the 
regulation of sodium/iodide symporter transcription have been identified as causing 
congenital iodide transport defects resulting in hypothyroidism (306). Similarly, a case 
report by Connelly et al. has reported iodine toxicity in an infant after receiving breast 
milk from a mother who had received iodine supplementation (12.5 mg/daily) and had 
breast milk iodine concentration of 3228 μg/L (307). It has been suggested that optimal 
iodine concentrations in breast milk should be above 200 μg/L (45). In the present 
study, despite large variations in concentrations, median concentration of iodine for 
both preterm and term milk over three months were below this recommendation. 
Iron concentrations found in this study were slightly higher in preterm than term milk 
despite both gradually decreasing over the study period. The median concentrations 
were 239 vs. 242 µg/L (1 month), 164 vs. 152 µg/L (2 months) and 197 vs.147 µg/L (3 
months) respectively. Iron started to fall below 200 µg/L after the first month of lactation 
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in both groups. Iron concentrations that fall below 200 µg/L in breast milk may be 
insufficient to provide appropriate iron nutrition in exclusively breastfed infants as the 
acceptable concentrations have been suggested to range between 200-400 µg/L in 
term milk during the first six months postpartum (239). Whilst premature infants are 
commonly provided with iron supplementation during hospital stay to compensate for 
the risk of anaemia of prematurity, term infants are generally discharged a few days 
after birth. A study in Guatemala reported higher mean values of iron that ranged from  
558-580 µg/L during 1-2 months postpartum that then decreased to 320 µg/L during 
4-6 months postpartum (231).  A study by Mendelson et al. noted no significant 
differences in iron concentrations between preterm and term human milk in the first 
month postpartum, with the range of mean concentrations of 900-1100 µg/L and 810-
1110 µg/L, respectively. Lower concentrations described in this study require further 
investigation and could be due to study population variability and dietary intake. 
This study found that concentrations of molybdenum in preterm milk and term milk 
were similar across the study period, with observed overall median values of 0.32-3.12 
µg/L and 0.35-4.07 µg/L respectively. Although the median of molybdenum 
concentrations fluctuated during the second month postpartum in both groups, the 
concentrations dropped and continued to remain below 1.0 µg/L at later stages of the 
study. The reason behind these changes remains unknown and is difficult to explain 
since molybdenum requirements and the effects on infants during postnatal growth 
are not completely understood. Few studies have reported molybdenum 
concentrations in human milk. A study by Bougle et al. investigated the milk of mothers 
of 11 preterm and 6 term newborns and reported similar mean concentrations of 
molybdenum in preterm milk that ranged 1.4 - 4.0 µg/L (1 month) and 0.2 ± 0.5 µg/L 
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(2 months), and in term milk of 1.5-10.2 µg/L (1 month) and 1.2 ± 0.5 µg/L (2 months) 
(308). To date, molybdenum deficiency has not been reported in humans. Based on 
the present findings, it is suggested that the concentrations of molybdenum in breast 
milk may be appropriately sufficient for infants. There is a lack of data reporting 
molybdenum concentrations in human milk and this is one of only few studies reporting 
the pattern of molybdenum concentration changes across an extended period 
postpartum. 
This study observed that bromine concentrations were slightly higher in term milk than 
in preterm milk at one month postpartum with median values of 1726 vs. 1279 µg/L, 
respectively. Both groups showed a gradual decline in bromine concentrations at two 
months and three months postpartum with median concentrations of 1244 µg/L and 
906 µg/L (preterm) and 1108 µg/L and 952 µg/L (term), respectively. This is the first 
study that has reported that lactation stage appeared to affect the concentration of 
bromine in human milk, in a similar way to other elements investigated in this study. 
Future studies are needed to elucidate the roles of bromine in infants’ development 
and to establish the physiological roles of bromine. Bromine deficiency has not been 
reported and may have been overlooked; the symptoms may overlap with those of 
other disease conditions. Previous studies have not reported bromine concentrations 
in preterm and term milk over the postpartum period. However, bromine 
concentrations in donor human milk have been reported in previous studies with 
median (range) values of 1066 (834–1443) µg/L (282) and 858 (535–928) µg/L (271), 
and appear to be similar to the concentrations found in the present study. Previous 
studies have assessed bromine as bromide, as bromide toxicity has been reported in 
humans owing to excessive exposure to bromide containing products (111, 113). 
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There is a concern regarding the safe and acceptable range of bromine concentrations 
in human milk in relation to the needs of preterm and term infants. 
This study reported that over 12 weeks postpartum, median concentrations of zinc, 
copper and bromine showed a general decreasing trend in both preterm and term 
breast milk. However, the concentrations of selenium, manganese, iodine, iron and 
molybdenum were relatively stable across the study period. 
The findings of the present study revealed that the zinc concentrations were 
significantly higher (p = 0.001) in milk expressed in the morning than in the evening. 
Whereas copper, selenium, manganese, iron, molybdenum and bromine seem not to 
be affected by diurnal differences. Iodine concentrations however, were found to be 
significantly lower (p = 0.039) in the morning than in the evening. Previous studies 
have not reported differences in the concentrations of elements in the morning and 
evening. The reasons for these findings are unclear but dietary intake may be a 
contributing factor. None of the participants in the study were taking trace element 
supplements but variation in dietary intake may influence the levels of iodine and zinc 
during the day. It may be useful for future studies to document a food diary to explain 
in more detail these findings. 
A limitation of this study was the recruitment of term mothers. Term mothers stay in 
hospital for a limited period of time only, if there are no mother or infant complications 
and makes recruitment more challenging. Therefore, this study can be regarded as a 
pilot study only and indicates why descriptive statistical analysis was only used in 
certain parts of the analysis. However, the findings are interesting and indicate that 
further work is essential to understand this complex but highly relevant field in the 
optimal nutrition of preterm infants. 
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The findings are in line with those that have been reported in the literature at one 
month, two months and three months for several elements, as discussed above. 
Research surrounding molybdenum and bromine is sparse and this study has added 
new knowledge concerning the concentration of molybdenum and bromine in preterm 
and term milk over a period of three months postpartum. Future studies with a larger 
sample size are needed to improve the reliability and applicability of the findings. 
It is unknown whether the concentration of trace elements in breast milk is unique to 
individual infants who are born preterm or term. Premature infants can weigh as little 
as 450 g at birth and, when considering the multiple complications associated with 
preterm births, a tailored nutrient profile for sick premature infants would seem 
beneficial. The optimal concentrations of essential trace elements in human milk 
represent important nutritional information and to date have not been fully established. 
Future studies may investigate factors associated with variation in trace element 
concentrations in human milk and its clinical relevance to infants’ health outcomes. 
6.5. Conclusion 
This pilot study found that trace element concentrations exhibit unique individual 
longitudinal changes in preterm and term human milk over a three-month postnatal 
period. Zinc concentrations in preterm mothers’ milk were found to be higher 
compared to those in term milk during the first month postpartum.  Relatively, similar 
concentrations of copper, selenium, manganese, iodine, iron and molybdenum were 
found in preterm and term milk over the period of three months postpartum.  Bromine 
concentrations initially were higher in term milk than those seen in preterm milk but 
dropped to similar concentrations at later stages of lactation. Concentrations of iron 
and iodine were found to be at times, below those recommended for human breast 
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milk and warrant further investigation. This pilot study has highlighted the potential for 
monitoring trace elements in breast milk to ensure concentrations do not appear lower 
than would be expected, from the literature available to date.  Trace element analysis 
in neonates is not routinely undertaken to assess for deficiency as this requires 
invasive sampling. A monthly sample of breast milk may be a cost-effective and safe 
way to ensure optimal trace element nutrition in infants.
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CHAPTER 7. GENERAL DISCUSSION AND CONCLUSION 
7.1. Introduction 
This thesis comprises two papers that have been published and two chapters drafted 
as papers for publication.  This chapter discusses the main findings of the studies 
reported in this thesis. The strengths and limitations of the thesis are addressed and 
the implications for future research are presented. 
7.2. Overview of Thesis Results 
This research started by asking the question if the concentration of trace elements 
differ in preterm human milk compared to term milk. A review of the literature identified 
that studies investigating trace elements in human milk were limited and optimal 
concentrations in breast milk had not been fully determined. Some reports indicated 
concentration of trace elements varied depending on lactation stage, however reports 
were conflicting. This research has considered a number of gaps in the literature to 
enhance the understanding of the nutritional components of human breast milk with 
specific reference to essential trace elements. 
Essential trace elements are known to facilitate a number of biochemical cascades; 
serve as components of metabolic enzymes and support cellular and tissue 
differentiation. Trace elements are widely recognised as vital early life nutrients for 
infants’ development. Nevertheless, trace element content in human milk have not 
been comprehensively reported in the literature. Few studies have reported trace 
elements in human milk at different stages of lactation, or comparisons between 
preterm and term milk. Different types of analytical methods have been used including 
atomic absorption spectrometry and total reflection X-ray fluorescence that have 
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allowed individual analysis of elements and as such previous studies have reported 
certain trace elements including zinc, copper, iodine and iron.  
This thesis developed and validated a method to quantify several trace elements 
simultaneously using minimal volumes of breast milk. Once the analytical method had 
been fully validated it was used to conduct the study looking at the effects of the 
pasteurisation process on trace elements in donor human milk. The Royal Brisbane 
and Women’s Hospital is one of three hospitals across Australia with a Human Milk 
Bank. The pasteurisation process, undertaken to ensure the safety of donor milk, has 
been shown to adversely affect the nutritional and immunological content of the milk. 
However, few studies have considered the effect of the pasteurisation process on the 
concentration of trace elements.  
Using the validated assay a clinical investigation was undertaken looking at trace 
element content in human breast milk. A case study of a women delivering an 
extremely preterm infant was one of very few examining the content of trace elements 
in extremely preterm milk over an extended postpartum period. 
The clinical study was extended to investigate differences in trace element 
concentration between preterm and term milk over postpartum period. Evaluating the 
changes and differences in concentrations of several trace elements closely over time 
enables an examination of the content of these elements received by infants during 
early life from mothers’ own milk. Understanding the differences and similarities of 
trace element concentration may subsequently assist in tailoring the trace element 
requirement in infants. 
The purpose of this thesis was therefore to add to the body of evidence about the 
content of trace elements in human milk, by using a newly validated analytical method, 
to investigate the effect of pasteurisation on concentrations in human milk, and to 
 146 
 
explore potential factors, including gestation, affecting the concentration of these 
elements over the postpartum period.  
The following research questions were posed: 
1) What are the currently available methods to analyse trace elements 
simultaneously and effectively in minimal amounts of human milk? 
2) Does the pasteurisation process adversely affect trace element concentrations 
in human milk? 
3) Do trace element concentrations vary in human breast milk over an extended 
postpartum period? 
4) Do trace element concentrations differ between preterm and term breast milk? 
To address these questions, a series of studies were undertaken including; validating 
an analytical method for trace elements using minimal volumes of human milk, 
investigating the effect of the pasteurisation process on human donor milk, 
investigating a case study for longitudinal change of trace elements in preterm milk, 
and investigating any differences in trace element concentrations in preterm and term 
milk over postpartum period. 
These studies were undertaken at the Royal Brisbane and Women’s Hospital (RBWH) 
and ethical approval was granted from the RBWH Human Research and Ethical 
Committee (HREC) and the University of Queensland, Brisbane, Australia. 
7.3. Main Findings 
7.3.1. What are the currently available methods to analyse trace elements 
simultaneously and effectively in minimal amounts of human milk? 
The first stage of the research was to develop a method using an alkaline dissolution 
method to quantify eight essential trace elements present in 0.2 mL human milk. Trace 
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elements that were quantifiable included zinc, copper, selenium, manganese, iodine, 
iron, molybdenum and bromine. Elements that were detected but not able to be 
quantified included: chromium (Cr), cobalt (Co), lead (Pb), nickel (Ni), silver (Ag), 
cadmium (Cd), arsenic (As), bismuth (Bi), aluminium (Al), antimony (Sb), vanadium 
(V), thallium (Tl) and uranium (U). Cobalt and chromium are recognised as essential 
trace elements for humans and nickel and vanadium are considered to be probably 
essential. Therefore, further development of this method maybe useful in the future to 
investigate these particular trace elements in more detail. The method was fully 
validated and followed the standard validation method reporting calibration data, 
repeatability and accuracy. All study samples were analysed in duplicate and 
acceptable precision was provided. Despite small sample volume (0.2 mL) and 
necessitating a higher dilution factor compared to previously reported methods (7, 26, 
31), excellent accuracy was obtained using the certified reference material NIST 1549.  
This thesis found that the newly developed and validated method involving 
ethylenediaminetetraacetic acid, ammonia solution, isopropanol and Triton X-100 
solution of pH 10, was relatively simple to use, proved to be time efficient and 
preserved breast milk samples. Previous studies have reported complex sample 
preparation of human milk using microwave-assisted acid solution digestion involving 
high pressure and temperatures (251, 253) or tetramethyammoniumhydroxide 
solution for digestion at various temperatures (31). The method developed in this 
thesis, in contrast, involved mild heating of samples to 40°C in water baths to ensure 
homogenous sample solution prior to dilution in the alkaline solution. This method was 
also the first to analyse bromine in human milk, an essential trace element, present at 
relatively high concentrations in human breast milk (271). The importance of using 
small sample volume (0.2 mL) cannot be underestimated when undertaking research 
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using preterm milk. This is often available in minimal quantities initially and therefore 
using large amounts of sample for the purposes of research is inappropriate. The 
successful validation of this method has enabled the simultaneous analysis of zinc, 
copper, selenium, manganese, iodine, iron, molybdenum and bromine in small 
samples of human milk. 
7.3.2. Does the pasteurisation process adversely affect trace element 
concentrations in human milk? 
The benefits of human milk have been well-established over formula milk. Pasteurised 
donor human milk (PDHM) is considered the second-best option after mothers’ own 
milk. Pasteurised donor human milk is used when mothers are unable to produce 
sufficient milk of their own and is primarily provided to premature infants after parental 
consent is given. 
This study found that the Holder pasteurisation process used to heat pooled donor 
milk to 62.5°C for 30 mins did not significantly affect trace element concentrations, 
except for iron (p < 0.05). The decrease in iron concentrations of 6.52% post-
pasteurisation despite statistically significant, was concluded not to be clinically 
significant. Most preterm infants generally receive iron supplementation and 
sometimes blood transfusions which replenish the iron body stores more effectively. 
The findings reported in this study were contrary to those reported previously by Da 
Costa et al. (38) that found significant differences post-pasteurisation of zinc (9.26%, 
p < 0.05), copper (3.16% p < 0.05) and iron (14.62%, p < 0.01) in colostrum of preterm 
and term milk. The differences could be due to different types of instruments/methods 
used for trace element analysis as they used total reflection X-ray fluorescence 
technique with synchrotron radiation, and different types of human milk (colostrum of 
preterm and term milk)  (38). Decrease in iron concentrations post-pasteurisation were 
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proposed to be due to potential protein precipitation (282). Iron is primarily bound to 
protein lactoferrin in human milk that consist of whey and casein proteins which 
change with thermal aggregation following exposure to high temperature. Proteins are 
less stable and react differently following heat exposure and their chemical and 
physical properties alterations may affect the adsorption to solid surfaces and affect 
the iron contents in PDHM (282). The thesis findings suggest that pasteurisation does 
not cause significant loss of trace elements in human milk. 
7.3.3. Do trace element concentrations vary in human breast milk over an 
extended period postpartum? 
A case study was undertaken using the milk samples donated by a 23-year old mother 
between days 16-68 (weeks 3-10) postpartum, who delivered an extremely preterm 
neonate at 24 weeks gestation (birth weight: 740 g). It was observed that all trace 
elements in breast milk decreased over the study period of three to ten weeks, except 
for manganese and bromine which showed increasing trends over the same time. 
Some studies have reported a decrease in zinc, copper, selenium and manganese 
concentration in the first few weeks postpartum of preterm breast milk (24, 223).  
This is the first case study to report bromine concentration in extremely preterm human 
milk. Bromine has recently been established as an essential trace element and the 
observations from the case study reveal useful information to further understand infant 
requirements and its concentration in human milk. This case also found that 
concentrations of iodine an iron in the study samples were lower than those 
recommended in the literature and require further investigation. 
This case study found that lactation stage is an important factor when considering the 
concentration of trace elements in mature preterm human milk. There is a possibility 
that manganese and bromine exhibit different patterns than those of zinc, copper, 
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selenium, iodine, iron and molybdenum. However, further research is required to 
confirm these observations. 
This is one of only a few case reports describing the concentration of trace elements 
in mature milk from a mother delivering an extremely preterm infant. Whether the 
findings in this case study are unique to breast milk of mothers who deliver extremely 
preterm and very low birth weight neonates is unknown. Studies with larger sample 
size are required to provide more reliable data and address this question. 
7.3.4. Do trace element concentrations differ between preterm and term breast 
milk over postpartum period? 
The final main finding of this thesis is that during the first three months postpartum, 
certain trace element concentrations vary in breast milk of mothers who deliver 
preterm and term neonates. This thesis divided the groups into preterm (24 to < 37 
weeks gestation) and term (≥ 37 weeks gestation) and found that zinc concentration 
was higher in preterm milk than term milk in the first month postpartum. Concentrations 
of zinc during second and third months postpartum appeared to be similar in preterm 
and term milk. No clear differences in the concentrations of copper, selenium, 
manganese, iodine, iron and molybdenum in breast milk were observed between the 
groups. Bromine exhibited lower concentrations in preterm milk than term milk in the 
first month postpartum, but similar concentrations were observed during second and 
third months for both groups.  
The literature available investigating trace elements in breast milk is conflicting and 
optimal ranges for many trace elements has not been clearly defined. Information 
regarding concentrations in breast milk for iron and iodine have been suggested but 
this remains unclear for other trace elements. However, the findings from this study 
add to the body of knowledge about expected concentrations of trace elements in 
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breast milk and concentrations that may be too low and risk possible deficiency or 
suboptimal levels.  
Routine monitoring of trace elements is not undertaken in infants as this is an invasive 
procedure thought not to be warranted as trace element deficiency occurs rarely. In 
addition, information regarding the appropriate timing of a blood sample to test for 
trace element deficiency is lacking and as can be seen by the literature deficiency can 
occur at different times postpartum depending on the individual trace element. From 
the findings of this thesis it may be useful to monitor mothers’ milk monthly in infants 
who are exclusively breastfed to ensure that concentrations of trace elements are 
above those that are expected from the available literature. It was observed that few 
trace elements are largely unaffected by diurnal variation and therefore timing of the 
sample could be at mothers’ convenience.  
7.4. Thesis Strengths and Limitations 
7.4.1. Strengths 
There are a number of strengths identified from the studies reported in this thesis. 
Firstly, this thesis reported an original analytical method to simultaneously analyse a 
number of essential trace elements in human breast milk by using the most advanced 
and sensitive analytical technique available to date. The relatively high concentrations 
of the newly recognised essential element, bromine were found in human breast milk. 
The relatively high concentrations were confirmed during the subsequent clinical 
studies and further research is needed to understand the essentiality of bromine in 
humans, and any potential risk factors for deficiency.  
Secondly, the thesis integrated the experimental methods and clinical aspects of the 
analysis of human breast milk. This approach adds to the body of knowledge 
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investigating concentrations of trace elements in preterm and term milk and assisting 
with providing further evidence of expected concentrations in breast milk. Validated, 
reliable and robust laboratory methods are vital to undertake valuable research in 
specific biological fluids in the neonatal population. This application can be extended 
to further investigate trace element concentration in breast milk in the clinical settings, 
or at a population level. 
Thirdly, the thesis involved primary data collection and prospective analysis. The data 
on trace element content in human milk over time was found to be influenced by 
postpartum time and gestational age particularly for zinc and bromine. 
7.4.2. Limitations 
The limitations of the studies were discussed in detail in each chapter. In summary, 
the analytical method reported in this thesis was not able to quantify two elements of 
interest that have been previously reported in human breast milk, which are chromium 
and cobalt owing to low concentration in study samples. The potential factors affecting 
donor milk variability of trace element concentrations at Human Milk Bank is unknown 
and were not investigated in the study. The ‘reference ranges’ used for certain 
elements outlying results were found in the study for certain elements and may 
indicate certain influencing factors (e.g. dietary intake, specific medical conditions) that 
may alter trace element concentration in milk. These factors were not investigated in 
this study. However, based on the comparison between preterm and term milk, it is 
clear that the differences were only found for zinc and bromine in the first month 
postpartum. The study did not have sufficient women delivering term infants to detect 
statistical significance between preterm and term groups and therefore descriptive 
results were presented to demonstrate the findings. Larger studies are required in the 
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future to investigate any significant differences in trace element concentration between 
preterm and term milk over postpartum period. 
7.5. Implications and Future Research Directions 
The analytical method developed and implemented in this thesis can be applied to 
future research examining trace elements in human milk. With further development an 
extended range of trace elements could be studied including the probably essential 
trace elements nickel and vanadium.  This thesis provided answers that the current 
practice of Holder pasteurisation method at milk banks did not cause significant loss 
of trace elements in human milk. It is suitable to preserve trace element content in 
pasteurised donor human milk for preterm infants. However, the variation in trace 
element concentrations in donor breast milk warrants further investigation. The 
question of whether premature neonates receive sufficient trace elements from 
pasteurised donor human milk is unknown.  
Addressing the need to determine optimal concentration ranges for individual trace 
elements in preterm and term breast milk may become one of the most effective 
measures to ensure adequate amounts of trace elements in infants exclusively 
breastfed. 
Future studies may focus on linking trace element status of the mother with breast milk 
concentrations and status in the infant. This would require invasive monitoring and a 
validated analytical assay for blood analysis, but is worthy of investigation. A study 
investigating correlation over time would also be beneficial as trace element deficiency 
for certain elements appears to occur at different times. 
Additionally, bromine deficiency in unknown and lack data reporting its essentiality to 
date. The monitoring of its concentration in mothers’ milk will improve recognition of 
cases associated with low or high bromine status. 
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In cases where trace element deficiency in neonates has been detected, there is little 
evidence supporting effective dosing regimens for supplements. Therefore, future 
work may investigate effective supplementation in mothers to ensure adequate 
amounts in breast milk as well as effective dosing regimens in the infant. 
Human milk is considered extremely complex and highly variable in its composition. It 
contains about 400 different proteins which serve different roles including nutritional, 
immunological and bioavailability of nutrients (309). Recently, it has been discovered 
that human milk serum proteome has been quantified and found to differ between 
mothers. For example, selenium-binding protein 1 (SELENBP1) has been found to 
decrease over lactation stage (310). Further studies are needed to explore trace 
element-binding proteins in human milk particularly in preterm and term milk. 
7.6. Thesis Conclusion 
The thesis provided original contributions to the current knowledge in several ways. 
Firstly, a simple and effective method to simultaneously determine eight essential 
trace elements in human milk was established. Then the concentration profiles of trace 
elements zinc, copper, selenium, manganese, iodine, iron, molybdenum and bromine 
in human milk were documented. Following this, the concentrations of these elements 
in pasteurised donor human milk were examined. This thesis found trace elements 
were not affected by the pasteurisation process, except for iron but the small decrease 
was considered not to be clinically significant. This thesis found that postpartum day 
influenced the concentration of zinc, copper, selenium, manganese, iodine, iron, 
molybdenum and bromine differently in extremely preterm breast milk. This thesis 
provided new evidence that preterm human milk contains higher concentrations of zinc 
but lower bromine than term milk in the first month postpartum. Concentrations of 
copper, selenium, manganese, iodine, iron and molybdenum were similar in both 
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groups during the first three months postpartum. Zinc, copper and bromine exhibited 
a general decrease in concentrations over 12 weeks postpartum period, whereas 
selenium, manganese, iodine, iron and molybdenum were relatively stable. Breast milk 
expressed in the morning contained higher zinc but lower iodine than milk expressed 
in the evening. 
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